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A photolabel displacement method was developed to resolve the separate kinetic 
properties of the glucose transporters GLUT1 and GLUT4 in 3T3-L1 adipoc/tes, which 
contain both transporter isoforms. The photolabel, 2-N-[4-(1-azi-2,2,2- 
trifluoroethyl)benzoyl]-1,3-bis-(D-mannos-4-yloxy)-2-propylamine, was displaced with 
3-0-methyl-D-glucose. The half maximal displacement by 3-O-methyl-D-glucose 
occurred at 20 mM for GLUT1 and 7.0 mM for GLUT4. The calculated transport 
capacities (turnover number/Km) were 0.36 x 104 mM’-min1 for GLUT1 and 1.13 x 
104 mM'1-min'1 for GLUT4. The » 3-fold higher transport capacity of GLUT4 at low 
glucose concentrations is mainly due to the higher Km of GLUT1.
The potential role of phosphorylation in the insulin signalling pathway to the glucose 
transporter was investigated using the phosphatase inhibitor okadaic acid. This was 
found to increase both 3-O-methyl-D-glucose uptake and the level of cell surface 
GLUT4 photolabelling in unstimulated adipocytes. In insulin stimulated rat adipocytes 
okadaic add reduced the transport rate and the level of cell surface transporter 
photolabelling. Okadaic acid appears to alter both the intrinsic activity and 
translocation of transporters. The tyrosine kinase inhibitor cr-cyano-3,4- 
dihydroxythiocinnamide (453C89) was used to examine the role of tyrosine kinases in 
the insulin induced increase in glucose transport. The inhibitor appeared not to inhibit 
the insulin receptor tyrosine kinase but to inhibit 3-O-methyl-D-glucose uptake perhaps 
by reducing the intrinsic activity of GLUT4.
In adipocytes GLUT1 and GLUT4 have a different distribution between the cell surface 
and the intracellular pools. The subcellular distribution of GLUT4 was shown to be 
intrinsic to the protein since when it was expressed in insulin-insensitive fibroblasts it
Contents v
adopted a distribution different to that of GLUT1. In order to determine which 
regions of GLUT4 are involved in its sorting and sequestration peptides corresponding 
to different regions of GLUT1 and GLUT4 were added to streptolysin-0 permeabilized 
3T3-L1 adipocytes. The addition of a peptide corresponding to the N terminus of 
GLUT4 increased the transport rate and the level of cell surface GLUT4 suggesting that 
the N terminus of GLUT4 may be involved in its sequestration from the plasma 
membrane.
The GTP-binding rab proteins are involved in the regulation of vesicular trafficking. 
Both rab4 and rab3d have been implicated in the trafficking of GLUT4 containing 
vesicles. Rab4 was detected in the supernatant of rat adipocytes using an anti-rab4 
antiserum. The expression of Rab3d in CHO fibroblasts expressing GLUT4 appeared 
not to affect the subcellular distribution of GLUT4 but may have affected the 
distribution of GLUT1. The addition of the nonhydrolyzable GTP analogue, GTPyS, to 
streptolysin-0 permeabilized 3T3-L1 adipocytes caused a small increase in basal 2- 
deoxy-D-glucose uptake but had little effect on the insulin stimulated transport rate. 
GTPyS appears to cause GLUT4 to accumulate at the cell surface, with most 
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B _  Cell surface transporter abundance
DMF N tN-dimethylformamide
DMSO Dimethyl sulphoxide
DMEM Dulbecco’s modification o f Eagle’s medium
DMEM-FCS Complete DMEM with 10 % foetal calf serum (section 2 .2 .1 )
DMEM-NCS Complete DMEM with 10 % newborn calf serum (section 2 .2 .1 )
G LUT Facilitative glucose transporter isoform
GTPyS Guanosine 5'-0-(3-thiotriphosphate)
lAPS-forskolin 3-iodo-4-azidophenethylamido-7-0-succinyldeacetyl-forskolin
IC buffer Intracellular buffer (section 2 .3 .6 )
IIC buffer Intracellular incubation buffer (section 2 .3 .6 )




KRH Krebs-Ringer-HEPES buffer for 3T3-L1 adipocytes (section 2 .3 .3 )
KRM Krebs-Ringer-MES buffer for 3T3-L1 adipocytes (section 2 .3 .5 )
LDM Low density microsomes
MAP kinase Mitogen activated protein kinase




Rat KRH Krebs-Ringer-HEPES buffer for rat adipocytes (section 2 .3 .3 )
SGLT1 N a+/glucose cotransporter
SLO Streptolysin-0
TBS Tris buffered saline (section 2 .6 .6 )
TE buffer T ris /E D T A  buffer (section 2 .7 .1 )
TEMED N.N.N'.N'-tetramethylethylenediamine
TES Tris/ED TA /sucrose buffer (section 2 .6 .1 )
TK Transporter transport capacity
TKI Tyrosine kinase inhibitor
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1.0 Introduction  
I . I The need for glucose transport
Glucose is a major source of energy for many mammalian cells and some, such as the 
brain, are virtually dependent on it. The blood of mammals delivers glucose to the 
cells at a concentration of 5 to 10 mM. Because cells possess an impermeant polar 
plasma membrane the hydrophilic sugar molecules are unable to diffuse into the cells 
unaided. To allow glucose entry, all cell surface membranes contain specific 
transporters that facilitate the energy independent diffusion of glucose across the 
membrane and into the cell. In addition to these facilitative glucose transporters 
certain mammalian cells, such as the epithelial cells that line the small intestine and the 
proximal tubule of the kidney, also possess an active glucose transporter, the 
Na+/glucose cotransporter, SGLT1. This transports glucose against the concentration 
gradient, the energy being supplied by the Na+/K + ATPase.
Different cells within the mammalian body have different requirements for glucose and 
play different roles in the maintenance of blood glucose homeostasis. While most cells 
simply require a minimum intake of glucose some, such as the brain, require a much 
higher rate of uptake. Other cell types, such as hepatocytes, muscle and adipocytes 
are involved in removing glucose from the blood while the liver also releases glucose. 
In order to provide the range of differing glucose transport capacities required, 
mammals possess a family of facilitative glucose transporters, designated GLUT1-7, 
whose kinetics are designed to meet the specific requirements of the cells in which they 
are found. One of the roles of glucose transporters is the regulation of the blood 
glucose concentration. After a meal the blood glucose level rises, stimulating the 
release of insulin which binds to receptors on the surface of insulin sensitive muscle and 
adipose cells increasing the rate of glucose uptake into these cells thus maintaining 
glucose homeostasis (Bell eta/., 1990; Baldwin, 1993; Birnbaum, 1993).
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1.2 The facilitative glucose transporter family
Even before the isolation of a specific glucose transporter protein it was recognised 
that the sensitivity to inhibitors and the kinetics of glucose uptake varied in a tissue- 
specific manner (Baldwin, 1993). In 1977 Kasahara and Hinkle successfully purified 
the human erythrocyte glucose transporter from Triton X-100 solubilized cells using a 
sonication method that included a freeze-thaw step. The purified protein gave a broad 
band of Mr 55,000 on SDS-PAGE. It was stained by periodic acid-Schiff reagent, a 
glycoprotein stain. When the purified protein was reconstituted into liposomes it was 
found to catalyse D-glucose transport. This transport activity was inhibited by 
cytochalasin B and mercuric ions at the same concentration as that of erythrocyte 
membranes. Because the protein was glycosylated and antibodies against the purified 
protein were absorbed by inside-out erythrocyte vesicles they proposed that the 
protein spanned the membrane (Kasahara and Hinkle, 1977). The protein was later 
shown to have the same kinetic properties as the erythrocyte glucose transporter and 
to be inhibited by phloretin and diethylstilbestrol (Wheeler and Hinkle, 1981).
The protein was first sequenced by Mueckler et al (1985). A cDNA library was made 
from a human hepatoma cell line, HepG2. This was expressed using the phage 
expression vector X.gt11 and screened with an antiserum against the purified 
erythrocyte glucose transporter. The largest positive plaque was sequenced and found 
to code for a polypeptide of 492 residues. A hydropathy plot of the amino acid 
sequence led to the proposal of a model of the transporter with 12 membrane 
spanning domains and with two intracellular termini.
Once one sequence was obtained other cDNA libraries were screened and to date six 
other glucose transporter gene sequences have been obtained. All have a very similar 
hydropathy plot and have « 40 % amino acid sequence identity. They were designated 
GLUT1 to 7 by Fukumoto et al. (1989). The six transporter proteins are compared in 















54.117 492 Erythrocyte, brain, kidney, 
colon, foetal tissue




57.000 524 Liver, pancreatic B-cell, kidney, 
small intestine
3 42.3 Fukumoto et al., 1988 
Gould et al.. 1991
GLUT3
(Brain)





54.797 509 Brown and white adipocytes, 
heart and skeletal muscle




54.983 501 Small intestine 1 N.D. Kayano et al., 1990
GLUT7
(Hepatic microsomal)
53,000 528 Hepatocyte endoplasmic 
reticulum
N.D. N .D . Waddell eto/., 1992
Table I . I The facilitative glucose transporter family
The sizes and chromosomal locations given are those o f the human glucose transporters except for those 
of the rat G LUT7. The Km given is that o f 3-O-methyl-D-glucose equilibrium exchange for the human 
(G LU T1-6) o r rat (G LU T4) transporter expressed in Xenopus oocytes (Baldwin, 1993).
1.2.1 G LU TI
GLUT1 is perhaps the most ubiquitous of the facilitative glucose transporters. Both 
the protein and the mRNA have been identified in most tissues although the level of 
expression varies between tissues (Flier et a/., 1987a). GLUT1 is very abundant in 
endothelial and epithelial cells at the blood-tissue barrier (Takata et al., 1990) with a 
high concentration of transporters at the blood-nerve barrier (Froehner et a/., 1988). 
It is expressed in foetal tissue at much higher levels than occur in the adult tissue 
(Asano et a/., 1988). In humans, GLUT1 is most abundant in erythrocytes where it is 
the only glucose transporter. Here it accounts for over 5 % of the total membrane 
protein (Allard and Lienhard, 1985). GLUT1 occurs in insulin responsive tissues such 
as muscle and fat, tissues that also express GLUT4 at much higher levels (Gould and 
Holman, 1993). GLUT1 is expressed at high levels in transformed (Flier et a/., 1987b) 
and cultured cells (Flier et a/., 1987a) and this is increased by stimulation with growth 
factors (Hiraki et a/., 1988), by mitogens (Weber et a/., 1984) and by glucose 
starvation (Haspel eta/., 1986).
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O u ts id e  (q '
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Figure 1.1 A  model for the G LU T I glucose transporter
The model shows the proposed membrane spanning domains based on hydropathy plots. The sequence 
given is that of the 3T3-L1 adipocyte GLUT1 (Kaestner et al., 1989).
The GLUT1 transporter protein is 492 residues long in humans (Mueckler et al., 
1985), rats (Birnbaum etal., 1986), mice (Kaestner etal., 1989), pigs (Weiler-Guettler 
et al., 1989) and rabbits (Asano et al., 1988). On the basis of hydropathy plots and 
computer modelling GLUT1, in common with all the facilitative glucose transporters, is 
proposed to contain 12 membrane spanning a-helicer as described in figure 1.1. The 
protein has been orientated and arranged in the membrane on the basis o f a range of 
experiments. Ultraviolet circular dichroism analysis of GLUT1 indicated that it is 
composed of approximately 82 % a-helices, 10 % p-turns and 8 % random coil (Chin 
et al, 1987). Tryptic digestion cleaved residues 213-269, the loop between helices 6 
and 7, and 457-492, the C terminus, from the cytoplasm face of human erythrocyte 
membranes (Cairns et al, 1987). A number o f other potential cleavage sites on the 
smaller loops were not cleaved, presumably because the phospholipid polar head 
groups prevented trypsin gaining access to them. Anti-peptide antibodies against many
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regions of the protein were able to confirm the predicted locations of the loops and 
termini (Davies et al., 1990). W ith the exception of the loops between
transmembrane helices 2 and 3 and 6 and 7 the loops are short and constrain the 
possible packing o f the helices (Gould and Holman, 1993). The most likely 
arrangement is in two groups o f six helices from the N- and C- terminal halves of the 
transporter, as shown in figure 1.2. In this model the glucose carrying channel is 
formed within the C-terminal half o f the transporter by transmembrane helices 7, 8, 
10 and 11. When the N- and C-terminal halves of GLUT1 were expressed separately 
neither bound ATB-BMPA or cytochalasin B. When both were expressed in the same 
cell the C-terminal half bound both labels, suggesting that both halves must pack 
together to obtain the correct ligand-binding conformation (Cope etal., 1994).
Figure 1.2 A proposed model for the arrangement of membrane helices
Helices are numbered from the N  terminus. The small circle represents a sugar molecule in the 
proposed channel (Baldwin, 1993).
In addition to the 12 membrane spanning a-helices other physical features o f GLUT1 
include the intracellular N- and C-terminal regions and the large loop between 
transmembrane helices 1 and 2. This loop contains a potential glycosylation site. The 
C-terminal region of the facilitative glucose transporter family shows the greatest 
sequence diversity. This makes the C terminus a suitable region for raising antibodies 
against specific members of the facilitative glucose transporter family.
An alternative model o f the glucose transporter was proposed by Fischbarg et al. 
(1993). Based on antibody studies and analysis o f the hydrophobicity, amphiphilicity 
and turn propensity o f GLUT1 they proposed a porin-like structure formed from a
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16-stranded transmembrane antiparallel (3-barrel. In this model the glucose carrying 
channel is located down the centre of the (5-barrel. Both termini remain intracellular.
The possible involvement of various residues or regions in conformational changes and 
transport have been investigated by observing the effect of mutations on transport 
rates, ATB-BMPA binding to the exofacial site and the binding of cytochalasin B and 
forskolin at an intracellular site. A glycine/proline rich region, residues 382-387, in a - 
helix 10 of the 12 transmembrane a-helix model introduces a flexible region into the 
protein which allows a conformational change enabling helices 10 and 11 to either 
expose or close the external binding site (Hodgson et a/., 1992; Gould and Holman, 
1993). The role of Pro385 in conformational flexibility was demonstrated by two 
substitutions. When this proline was substituted by glycine (P385G) then ATB-BMPA 
labelling was half that of the wild type transporter while 2-deoxy-D-glucose transport 
and cytochalasin B binding at the internal site was not reduced. When it was 
substituted by isoleucine (P385I) then both ATB-BMPA binding and glucose transport 
were greatly reduced and only binding at the internal binding site was unaffected, 
suggesting that this mutation prevents the transporter adopting an outward facing 
conformation (Tamori et al., 1994). The substitution of Trp388 in helix 10 by leucine 
(W388L) decreased both lAPS-forskolin binding and transport activity (Katagiri et al., 
1993; Schurmann et al., 1993). This suggests that Trp388 is also involved in the 
conformational change between the inside and outside-facing conformers (Katagiri et 
a/., 1993).
The C-terminal region has also been implicated in the conformational change. When 
the last 37 residues of GLUT1 were deleted both the transport rate and ATB-BMPA 
labelling were reduced but cytochalasin B binding was unaffected. This suggests that 
the C terminus may be involved in stabilising the outward facing conformation (Oka et 
a/., 1990). When only the last 12 residues of the C terminus of GLUT1 was deleted 
there was no effect on transport activity, labelling or protein stability suggesting that 
residues between the last 12 and 37 are important for transport activity (Lin et al.,
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1992). Deleting the last 24 residues had no effect on labelling at either the inside or 
outside while deleting the last 25 residues reduced ATB-BMPA labelling. Thus deleting 
more than the last 24 residues appears to lock the transporter into a stable inward 
facing conformation (Mori et a/., 1994). Another mutation which significantly reduces 
ATB-BMPA labelling is Q282L. Gin282 occurs in transmembrane helix 7 and appears to 
be involved in the hydrogen bonding of glucose at the exofacial binding site 
(Hashiramoto eta/., 1992).
The opposite effect occurred with substitutions at Tyr252 and Tyr293 in transmembrane 
helix 7. These residues are believed to create a hydrophobic patch on the external 
face of the transporter, helping to isolate the bound glucose from the extracellular 
solution. The substitutions Y292I/F and Y293F were without effect but Y293I 
abolished cytochalasin B binding without affecting ATB-BMPA labelling. It was 
suggested that the substitution Y293I locks GLUT1 in an outward facing conformation 
and that Tyr253 is required to close the exofacial site (Mori et a/., 1994).
When Asp415 in transmembrane helix 11 was substituted by an asparagine (D415N) 
both the transport activity and cytochalasin B binding were greatly reduced. This 
residue was proposed as being near the inner glucose binding site and involved in the 
conformational change (Ishihara et a/., 1991). The substitution of Leu412 for a 
tryptophan (W412L) in helix 11 also reduced the intrinsic activity of GLUT1 but did 
not abolish cytochalasin B or IAPS forskolin binding on the inner face or affect ATB- 
BMPA binding to the extracellular site. This tryptophan residue must therefore be at 
or near the inner glucose binding site but it is not the cytochalasin B binding site 
(Katagiri eta/., 1991; Schurmann eta/., 1993).
GLUT1 is N-glycosylated at a single site on Asn45. This was confirmed by mutational 
analysis. When the Asn was substituted for an Asp, Tyr or Gin (N45D, N45Y or 
N45Q) a single sharp band at 38 kDa was obtained on Western blots confirming that 
Asn45 is the only N-glycosylation site. These substitutions also reduced cytochalasin B
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and ATB-BMPA labelling and raised the Km for 2-deoxy-D-glucose uptake. This suggests 
that N-glycosylation may have a role in maintaining the correct structure of GLUT1 
(Asano et al., 1991). GLUT1 N-glycosylation also affects the distribution and stability 
of the transporter. Whereas most of the wild type GLUT1 expressed in CHO 
fibroblasts was expressed at the cell surface the glycosylation defective GLUT1 mutants 
were mostly intracellular. The half-life of GLUT1 with any of the three substitutions at 
Asn45 was about a third shorter than that of the wild type (Asano et al., 1993).
1.2.2 GLUT2
Liver cells express only low levels of GLUT1 and the kinetics of liver glucose transport 
are very different to those of erythrocytes. The Kd for cytochalasin B binding to liver 
membranes is an order of magnitude higher than to erythrocytes. This led to the 
proposal that liver cells may possess a unique glucose transporter (Axelrod and Pilch, 
1983). This assumption was proved to be correct with the sequencing of GLUT2 from 
a human and rat liver cDNA library. Fukumoto et al. (1988) sequenced the human 
GLUT2 and found it to be 524 residues long. The rat sequence, with 522 residues, 
was isolated by Thorens et al. (1988). There is about 55 % sequence identity between 
GLUT1 and GLUT2. Human GLUT2 is 32 residues longer than GLUT1 and has an 
additional 34 residues in the first extracellular loop making it twice the size of that in 
GLUT1. In addition very few of the last 28 residues in the C terminus of GLUT1 are 
the same in GLUT2 (Fukumoto et al., 1988). Hydropathy plots suggest that GLUT2 
adopts the same 12 membrane spanning a-helical secondary structure as GLUT1. 
GLUT2 is expressed in the liver, intestine, kidney and pancreatic islet p-cells.
When expressed in Xenopus oocytes human GLUT2 was found to have a Km of 42 mM 
for 3-O-methyl-D-glucose under conditions of equilibrium exchange. This is more than 
twice that of GLUT1 and much higher than the concentration of glucose in the blood 
(Gould et al., 1991). The Km for glucose has been reported as 66 mM making GLUT2
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a high capacity high Km glucose transporter (Elliott and Craik, 1983). GLUT2, unlike 
GLUT1, can transport fructose with a Km of 66 mM (Gould et al., 1991; Gould and 
Holman, 1993). Unlike GLUT1 and GLUT4, liver membrane GLUT2 does not exhibit 
glucose inhibitable binding of cytochalasin B or forskolin (Hellwig and Joost, 1991).
Two properties of the liver glucose transport system enable rapid transport in and out 
of hepatocytes without transport becoming rate limiting. Because GLUT2 is a high 
capacity high Km transporter it is able to respond to changes in the glucose 
concentration in a linear manner. Secondly the high concentration of GLUT2 in the 
liver ensures a high V ^ . In the pancreatic P-cells GLUT2 is part of the glucose sensing 
mechanism, allowing the rapid equilibration of glucose across the plasma membrane. 
The P—cell glucose sensor is believed to be a high Km glucokinase. The kinetics of 
GLUT2 therefore allow the glucokinase to respond linearly to the blood glucose 
concentration (Matschinsky, 1990).
In the small intestine and kidney GLUT2 is localised at the basolateral membrane of the 
epithelial cells. Glucose is actively transported across the apical membrane and 
concentrated in the cell by SGLT1. The accumulated glucose is then released into the 
blood via the high<apacity GLUT2 (Thorens et al., 1990).
1.2.3 GLUT3
GLUT3, the third member of the facilitative glucose transporter family to be 
sequenced, was isolated from a human foetal skeletal muscle cDNA library by Kayano 
et al. (1988). GLUT3 is 496 residues long, only 4 residues longer than GLUT1. It has 
about 64 % sequence homology with GLUT1. In rodents GLUT3 mRNA can only be 
detected in the brain (Yano et al., 1991). In humans GLUT3 mRNA can be detected 
in the placenta, liver, heart, kidney and brain. The protein, however, can only be 
detected at high levels in the brain and other neural tissue (Shepherd et al., 1992).
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When expressed in Xenopus oocytes the Km of GLUT3 for 3-O-methyl-D-glucose under 
equilibrium exchange conditions is 10 mM, nearly half that of GLUT1 (Gould et al., 
1991). The brain is a tissue with a high demand for glucose. The combination of 
GLUT1 and GLUT3 in the brain ensures that it receives a constant plentiful supply. 
The low Km of GLUT3 ensures glucose uptake by neurones even when the 
concentration of glucose in the blood is low (Asano et a/., 1992a).
1.2.4 GLUT4
The discovery of GLUT1-3 lead to the idea that a unique transporter might be 
involved in the insulin stimulated glucose transport rate in adipose and muscle tissue. 
Indeed a monoclonal antibody which only detected a 45 kDa doublet in muscle and 
adipose tissue had already been used to immunoprecipitate a rat adipocyte protein that 
could be labelled with cytochalasin B in a glucose displaceable manner and whose 
plasma membrane concentration increased with insulin (James et al, 1988). The 
search for the insulin sensitive glucose transporter led to the simultaneous isolation of 
the GLUT4 sequence from human (Fukumoto et a/., 1989), rat (Charron et al, 1989; 
James et al., 1989a and Birnbaum 1989) and mouse (Kaestner et al., 1989) cDNA 
libraries. The major sites of GLUT4 expression are the heart, skeletal muscle and 
adipose tissue. Glucose uptake in these tissues is the most sensitive to insuli,',.
GLUT4 is 509 amino acid long, 17 residues more than GLUT1 except in the mouse, 
including 3T3-L1 adipocytes, where GLUT4 is 510 amino acids long (Kaestner et al., 
1989). Most of the additional residues are located at the N terminus. GLUT4 has an 
approximately 65 % sequence identity with the GLUT1 amino acid sequence. Many of 
these differences occur in the two termini and the loops between helices 1 and 2 and 6 
and 7. The hydropathy plots of GLUT1 and GLUT4 are almost superimposible and 
both have a putative glycosylation site on the first loop. The sequence and proposed 




Figure 1.3. A  model for the G LUT4 glucose transporter
The model shows the proposed membrane spanning domains based on hydropathy plots. The sequence 
given is that of the 3T3-L1 adipocyte G LUT4 (Kaestner et al., 1989).
O Amino acids identical with those o f GLUT1. O A m in o  acids that differ from GLUT1. 0  Amino 
acids unique to GLUT4.
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When expressed in Xenopus oocytes the Km of rat GLUT4 is 1.8 mM for 3-O-methyl-D- 
glucose compared to a Km of 21 mM for the human GLUT1 under conditions of 
equilibrium exchange (Keller et a/., 1989). Under the same conditions the Km for rat 
GLUT1 and GLUT4 were 26 mM and 4.3 mM respectively (Nishimura et a/., 1993). 
The low Km of GLUT4 ensures that the transporter will be operating near its Vmax and 
so will be able to efficiently remove glucose from the blood. The rate of uptake is 
governed by the concentration of GLUT4 at the cell surface. The primary mechanism 
for the insulin stimulated increase in transport is the translocation mechanism, see 
section 1.4.1. In addition, the intrinsic activity of the transporter in basal adipocytes 
appears to be about 2-fold lower than in the insulin stimulated cells. This suggests than 
insulin may also regulate the intrinsic activity of the transporter (Clark et a/., 1991).
1.2.5 GLUT5
GLUT5 was isolated from a human small intestine cDNA library with a GLUT1 cDNA 
probe (Kayano et a/., 1990). The gene codes for a 501 amino acid protein. This 
transporter has a 41.7 % sequence identity with GLUT1. In the human, GLUT5 
mRNA expression was detected in the intestine with lower expression levels in the 
kidney, skeletal muscle and adipose tissues. In the intestine GLUT5 is localised to the 
brush border membrane of mature enterocytes (Davidson et a/., 1992) where glucose 
is transported by the Na+/glucose cotransporter, SGLT1.
When expressed in Xenopus oocytes GLUT5 was found to transport 2-deoxy-D-glucose 
very poorly. Instead GLUT5 was found to transport fructose with a Km of 6 mM. 
Unlike the fructose transport mediated by GLUT2, GLUT5 fructose transport is 
insensitive to cytochalasin B (Burant et a/., 1992). GLUT5 mRNA and protein was 
subsequently detected in human testis and spermatozoa. This enables spermatozoa to 
utilise the fructose in seminal fluid. The distribution and kinetics of GLUT5 are 
consistent with it being a fructose transporter (Burant et a/., 1992).
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1.2.6 GLUT6
The GLUT6 cDNA clone was isolated from a human jejunum cDNA library. Within a 
3400 base pair sequence of the GLUT6 cDNA is a 1495 base pair region which has
79.6 % identity with GLUT3. However, because the sequence contains multiple 
nonsense codons and frame shifts it cannot encode a functional transporter protein. 
The GLUT6 pseudogene has been detected in all the tissues tested, both tumour and 
normal, with varying levels of expression (Kayano et al., 1990).
1.2.7 GLUT7
The latest member of the facilitative glucose transporter family is GLUT7. This was 
obtained by screening a rat liver cDNA library using an antibody which bound to T3 of 
the glucose-6-phosphatase system (Waddell et al., 1991). Sequence analysis found that 
it encodes a protein of 528 amino acids with 68 % sequence identity to GLUT2 
(Waddell et al., 1992). GLUT7 is 6 amino acids longer than GLUT2 and the additional 
residues are located at the C terminus. The 6 amino acids, KKMKND, contain a
consensus motif (KK-K ) which retains transmembrane proteins in the endoplasmic
reticulum. The intracellular location of the transporter was confirmed by the transient 
expression of GLUT7 in COS-7 fibroblasts. Using a microsomal 3-O-methyl-D-glucose 
uptake assay and immunocytochemical localisation the protein was observed in the 
endoplasmic reticulum but not the plasma membrane. Transport across the plasma 
membrane of hepatocytes is facilitated by GLUT2. GLUT7 is required in the 
endoplasmic reticulum because the liver, unlike other tissues, in addition to absorbing 
glucose also releases it into the blood. The liver produces glucose by glycogenolysis 
and gluconeogenesis. The last step of both is catalysed by glucose-6-phosphatase which 
is located within the endoplasmic reticulum lumen. GLUT7 is required to allow the 
newly synthesised glucose to cross the endoplasmic reticulum membrane into the 
cytoplasm and leave the cell via GLUT2 (Waddell et al., 1992).
Introduction 14
1.3 The kinetics of glucose transport
Because of the ready availability of GLUT1 in human erythrocytes, where it is the only 
transporter isoform, the kinetics o f GLUT1 have been widely studied. GLUT1 
facilitated transport in the erythrocyte is a purely passive process. Widdas recognised 
that simple diffusion was insufficient to explain the transfer o f glucose across the sheep 
placenta. Instead he proposed a carrier model. He characterised the transport 
mechanism as simple hyperbolic Michaelis-Menten kinetics (Widdas, 1952). From this 
was developed the asymmetric alternating conformation model o f glucose transport 





Figure 1.4. The alternating conformation model of glucose transport
T o is the outward facing and T ( the inward facing conformation o f the glucose transporter, b /a  and e / f  
are the dissociation constants for the binding of the sugar (G ). c, d, g and h are the reorientation rate 
constants (Baldwin, 1993).
For the single site model the sugar binding site can be inward facing (T,) or outward 
facing (To) and free (Tx) or bound (TxG) but the four states are mutually exclusive. The 
conformational change involved in reorienting the substrate binding site from an 
outward to an inward facing site can occur in the presence or absence of bound 
glucose. This conformational change could be the result o f the movement predicted to 
occur around the flexible glycine/proline rich region o f helix 10 (as discussed in section
4911
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1.2.1). This model is not consistent with all the available kinetic data so other models 
have been proposed such as the simultaneous site model of Carruthers (1986). Such 
inconsistencies could, however, simply be due to technical difficulties in measuring 
transport. Most of the recent evidence points towards the simple alternating 
conformation model (Baldwin, 1993). Positive evidence for this model was provided 
by Lowe and Walmsley (1987). They demonstrated a single half-turnover of the 
glucose carrier. Transporters were recruited to the outward facing conformation 
either by pre-equilibrating erythrocytes with maltose, which cannot be transported, or 
by pre-warming the cells to 38 *C. The simultaneous addition of glucose and dilution 
of the maltose or cooling to 0 *C respectively resulted in a burst of glucose uptake 
consistent with that predicted by the alternating conformation model.
While the kinetics of GLUT1 is passive, simple, Michaelis-Menten kinetics, the Km and 
values that are measured depend on the conditions under which they are 
measured, equilibrium exchange, zero-trans, infinite c/s, etc (Baldwin 1993). There is 
also a difference between the kinetics of zero-trans efflux and zero-trans influx. This 
asymmetry was demonstrated by Lowe and Walmsley (1986) who found that the 
affinity for glucose is about 2.5 fold higher for the outward facing than the inward 
facing binding site at physiological temperatures. Unlike GLUT1, GLUT2 and GLUT4 
do not exhibit asymmetric transport, the others are unknown (Gould and Holman,
1993). Carruthers and Helgerson (1986) have shown that GLUT1 binds ATP. They 
have suggested that GLUT1 transport is intrinsically symmetrical, the asymmetry being 
regulated by the binding of cytosolic factors such as ATP.
GLUT1 transport shows trans-acceleration whereby, for example, the presence of 
unlabelled sugar on one side of the membrane stimulates the uptake of labelled sugar 
on the other side of the membrane. The phenomenon of trans-acceleration is due to 
the rate constants for the reorientation of the loaded site, (c, d) being higher than 
those for the empty site (g, h) (Lowe and Walmsley, 1986). Thus transport occurs 
faster under equilibrium exchange conditions than under net flux conditions as during
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net flux it is necessary for the transporter to undergo the slower unbound 
conformational change. Both NMR studies (Wang et a/., 1986) and low temperature 
kinetics have revealed that the rate of binding and dissociation at both sites are higher 
than the turnover of the transporter. Thus the limiting step in transport is transporter 
reorientation rather than glucose binding. The asymmetry of transport is due to two 
factors. One is the higher proportion of inward facing conformations which increases 
with lower temperatures. The second is the 2.5-fold higher affinity for glucose at the 
outward facing conformation relative to the inward facing conformation. At 
physiological temperatures, where the distribution of the two conformations is fairly 
equal, the latter of these factors is the more important (Lowe and Walmsley, 1986).
The thermodynamic basis for the asymmetry of GLUT1 is believed to lie in the 
hydration state of the transporter. The binding of glucose excludes water from the 
binding site and the glucose molecule. New hydrogen bonds are then formed between 
glucose and the binding site. This stabilises the binding site and lowers the 
reorientation energy barrier. This makes the reorientation of the loaded transporter 
more favourable than that of the unloaded transporter. It is believed that the changes 
in hydrogen bonding result in a reorientation of the helices around the channel causing 
the closing of the hydrophobic cleft at the external binding site. This is now the inner 
binding site and the bound glucose is now exposed to the cytosol. A decrease in 
enthalpy for the inward facing conformation is thought to be due to an increased level 
of hydration. Transporter conformations are also believed to be stabilised by lipid 
interactions. Under physiological conditions the kinetics of GLUT1 allow rapid 
equilibration of glucose across the membrane in either direction (Walmsley, 1988).
The kinetic properties of GLUT4 have been studied in rat adipocytes where GLUT4 is 
the predominant transporter isoform (Taylor and Holman, 1981). Unlike GLUT1, 
GLUT4 exhibits symmetrical 3-O-methyl-D-glucose transport. Insulin stimulation does 
not alter either the internal or external affinity constants of the transporter system. 
Insulin increases adipocyte transport by increasing Vmax without altering the Km.
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1.4 The regulation of glucose transport and transporter translocation
1.4.1 Insulin stimulated glucose uptake and translocation in adipocytes
It has been recognised since the mid 1950’s that insulin acts to facilitate the transfer of 
extracellular glucose into the cell (Levine and Goldstein, 1955). In kinetic experiments 
with frog muscle, insulin increased the Vmax of 3-0-methyl-D-glucose penetration without 
appreciably altering the Km (Narahara and Ozand, 1963). Such kinetic experiments 
were unable to ascertain whether the increase in V was the result of an increase inmax
the intrinsic activity of the transporters or an increase in the number of sites 
participating in sugar transport as postulated by Narahara and Ozand (1963). This 
question was answered following the discovery that cytochalasin B, a metabolite of 
Helminthosporum dermatoideumt is a specific hexose transport inhibitor (Mizel and 
Wilson, 1972). Wardzala et al. (1978) used the ability of cytochalasin B to bind to the 
transport system to quantify the number of glucose transporter systems in the plasma 
membrane of rat adipocytes. They found that insulin stimulation increased the number 
of cytochalasin B binding sites four-fold without changing the cytochalasin £  binding 
characteristics. This increase, they proposed, was due to the activation of identical but 
basally inactive glucose transport systems. This could have been due to an uncovering 
of latent transporters or the recruitment of transporters from an intracellular pool. In 
1980 Cushman and Wardzala and Suzuki and Kono independently published results 
which supported the idea that insulin induces the translocation of transporters from an 
intracellular pool to the plasma membrane. Cushman and Wardzala (1980) detected 
glucose displaceable cytochalasin B binding sites at the plasma membrane and in a 
microsomal fraction. In basal adipocytes most of the labelling was associated with the 
microsomal fraction but insulin stimulation caused a rise in the number of plasma 
membrane sites and a reciprocal decrease in the microsomal fraction sites. Suzuki and 
Kono (1980) showed the same translocation effect on transport activity. They 
fractionated rat adipocytes on a sucrose density gradient and separated two peaks of 
activity. One peak was associated with the plasma membrane marker 5'-nudeotidase
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while the other was associated with a Golgi marker. The two peaks were 
incorporated into liposomes. Under basal conditions most of the transport activity was 
associated with the Golgi marker pool. Insulin caused an increase in the transport 
activity of the plasma membrane peak and a corresponding decrease in the activity of 
the Golgi marker peak. The Km of both peaks was about 10-15 mM. Both groups 
suggested that insulin caused the translocation of transport activity or systems to the 
plasma membrane from an intracellular microsomal pool.
Translocation was found to be a reversible process with a time course very similar to 
that for the reversal of insulin stimulated hexose uptake (Karnieli et al., 1981). Both a 
D-glucose-inhibitable cytochalasin B binding assay and a 3-O-methyl-D-glucose transport 
assay were used to demonstrate that the insulin stimulated decrease in the 
concentration of glucose transporter systems in the intracellular pool and their increase 
at the plasma membrane both had a half time of 2.5 min. When insulin was removed 
and insulin stimulation reversed, the transporter systems were redistributed away from 
the plasma membrane with a half time of 9 min. There was a similar half time for the 
decrease in 3-O-methyl-D-glucose transport following the removal of insulin. During 
insulin stimulation, however, there was a 1.5 min lag between the arrival of 
cytochalasin B binding sites at the plasma membrane and the increase in the transport 
rate (Karnieli eta/., 1981).
Translocation is an energy dependent process. Metabolic inhibitors that lower the 
cellular ATP levels, such as 10 mM sodium azide, 2 mM potassium cyanide and 1 mM 
2,4-dinitrophenol, also inhibit the translocation of transporters to and from the low 
density microsomes (Ezaki and Kono, 1982). Translocation is also a temperature 
sensitive process. Low temperatures of, for example, 10 *C induce the slow 
translocation of transporters to the cell surface but they also slow the rate of insulin 
stimulated translocation (Ezaki and Kono, 1982).
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The intracellular pool of transporters was characterised by Cushman’s group (Simpson 
et al. 1983). They characterised the subcellular fractions of rat adipocytes and 
identified a specialised species of low density microsomes which contained the 
transporters. These specialised microsomes were associated with but were distinct 
from the Golgi markers. In basal adipocytes 90 % of the glucose transporters were 
associated with the intracellular pool while insulin stimulation resulted in 50 % of the 
transporters being found at the plasma membrane. They also found that in whole cells 
insulin increased the turnover number of the transporters in the plasma membrane in 
addition to their concentration.
The development of the membrane impermeant photoaffinity label 2-N-[4-(1-azi-2,2,2- 
trifluoroethyl)benzoyl]-1,3-bis-(D-mannos-4-yloxy)-2-propylamine (ATB-BMPA) (see 
section 1.4.3) enabled the adipocyte cell surface transporters to be quantified. 
Holman’s group used ATB-BMPA to photolabel GLUT1 and GLUT4 at the surface of 
basal and insulin stimulated rat adipocytes (Holman et a/., 1990). They were able to 
demonstrate that the 20-30-fold increase in 3-O-methyl-D-glucose uptake is associated 
with a 15-20-fold increase in surface GLUT4 and an » 5-fold increase in surface 
GLUT1. Using ATB-BMPA to determine the rates of the appearance and 
disappearance of transporters at the surface of rat adipocytes they found that both 
GLUT1 and GLUT4 appeared at the cell surface with a t% of » 2.3 min. The insulin 
stimulated transport rate increased with a t„ of 3.2 min but with a lag of 47 s. The lag, 
they suggested, may represent the time required for the « 2-fold increase in the 
intrinsic activity of the transporters or may be the result of labelling transporters at the 
cell surface which are occluded from participating in transport. Following the removal 
of insulin the t,A for the disappearance of transporters from the cell surface was « 12 
min, consistent with the t% of 9-11 min for the decrease in the transport rate at 37 *C 
(Clark et a/., 1991). They were also able to confirm that incubating basal rat 
adipocytes at the low temperature of 18 *C raises both the transport rate and the 
levels of transporters at the cell surface by « 3-fold. They also observed that at 18 *C
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following the removal of insulin stimulation there was no significant decrease in the 
transport rate or the cell surface transporter levels, suggesting that transporter 
internalisation is a more temperature sensitive process than transporter recruitment.
ATB-BMPA was also used to follow the trafficking of transporters in 3T3-L1 adipocytes 
(Yang et a/., 1992a). In these cells, as in the rat adipocytes, there is a lag in the insulin 
stimulated increase in the transport rate of 3T3-L1 adipocytes incubated at 27 * C. At 
this temperature they measured a t„ of 5.4 min for the appearance of GLUT4 at the 
cell surface and 5.7 min for the appearance of GLUT1. The t1/4 for the increase in the 
transport rate was 8.6 min. When insulin stimulated adipocytes were treated with 
phenylarsine oxide (PAO), an inhibitor of receptor and fluid-phase endocytosis, the 
decrease in the transport rate corresponded with the decrease in cell surface GLUT4. 
The level of GLUT1 in the plasma membrane, however, remained high. They 
suggested that PAO may inhibit the exocytosis of transporters. The transport activity 
of the cell surface GLUT1 appears to be reduced by the presence of PAO, perhaps 
because of an inability of the transporter to dissociate from the trafficking proteins 
(Yang et a/., 1992a). These trafficking proteins have been shown to include dathrin 
(Robinson et o/., 1992).
The accessibility of transporters at the plasma membrane to glucose and ATB-BMPA 
was investigated in rat adipocytes by Cushman’s group. Compared to insulin 
stimulation alone, insulin plus adenosine increased both the accessibility of GLUT4 to 
ATB-BMPA and the rate of transport without affecting the level of immunodetectable 
surface GLUT4. Isoprenaline had the opposite effect, reducing the insulin stimulated 
transport rate and the accessibility of the transporter to ATB-BMPA without causing 
GLUT4 to be lost from the plasma membrane. These results suggested that the 
transporter exists in the plasma membrane in two distinct states one of which is 
functional while the other is inaccessible and so non-functional (Vannucci et a i (1992).
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Cushman’s group then used ATB-BMPA to track the recycling of GLUT4 between the 
cell surface and intracellular pools in rat adipocytes. After the insulin stimulated plasma 
membrane pool of GLUT4 had been photolabelled, the insulin stimulation was either 
maintained or reversed by the addition of collagenase. The trafficking of the labelled 
transporters was followed and the distribution was compared with the total level of 
immunodetectable transporters in both pools. Following collagenase treatment the 
half times were similar for the decrease in the level of photolabelled and 
immunodetectable GLUT4 in the plasma membrane and for the decrease in the 
transport activity. When the collagenase treated adipocytes were restimulated with 
insulin then a proportion of both the labelled and non labelled transporters were 
recycled from the low density microsomal intracellular pool to the plasma membrane. 
Under conditions of continued incubation with insulin, while there was no alteration in 
the transport rate or in level of immunodetectable GLUT4 at the plasma membrane, 
there was a drop in the level of cell surface photolabelled GLUT4 as a result of 
internalisation. This effect is the result of all the transporters being continuously 
recycled so that the original cell surface pool of labelled transporters: and the 
intracellular pool of unlabelled transporters eventually become mixed with the labelled 
transporters being distributed between the two pools (Satoh et al., 199B). Kinetic 
analysis of the translocation of the labelled transporters shows that insulin stimulates 
exocytosis rather than inhibiting endocytosis. The endocytosis rate constant k^ was 
not significant different whether the cells were stimulated with insulin or the insulin 
stimulation was reversed. Insulin did, however, increase the exocytosis rate constant, 
K** by » 10-fold (Satoh et a/., 1993). Increases in cell surface GLUT4 are 
immunodetectable before they can be photolabelled and both of these increases occur 
before the transport rate increases. This, they suggested, may be the result of an 
intermediate step between the transporters in the occluded vesicles and the fully active 
transporters. Transporters in these partially occluded vesicles are immunodetectable 
and can be photolabelled but can not participate in transport (Satoh et o/., 1993).
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They also suggested that insulin might act at the docking and fusion steps o f 







Figure 1.5 Model of the insulin regulated translocation of glucose 
transporter to  and from  an intracellular pool
GLUT4 is continuously recycled between the cell surface and tubulo-vesicular structures in both the 
presence and absence of insulin. In basal adipocytes most of the GLUT4 is located in the tubulo-vesicular 
structure. Insulin stimulation increases the rate of exocytosis resulting in an increase in cell surface 
GLUT4. Occluded and partially occluded vesicles form as vesicles fuse with the membrane.
OV: occluded vesicle. PO: Partially occluded vesicle. H : GLUT4. (From Gould and Holman, 1993)
The insulin stimulated steady state recycling o f both GLUT4 and GLUT1 in 3T3-L1 
adipocytes were kinetically analysed by Yang and Holman (1993). They were able to 
confirm that both GLUT1 and GLUT4 are continuously recycled between the cell 
surface and the low density microsome membrane fraction in both basal and insulin 
stimulated adipocytes. In basal adipocytes the GLUT4 exocytosis rate is low. Insulin
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stimulation decreases the endocytosis rates of both isoforms by « 30 % but increases 
the exocytosis rate for GLUT1 and GLUT4 by 3- and 9-fold respectively.
When ultrathin cryosections of 3T3-L1 adipocytes were analysed by
immunocytochemistry a large proportion of the glucose transporter (probably GLUT1) 
population was detected in the trans-Golgi reticulum and in cytoplasmic vesicles. Insulin 
stimulation caused a decrease in the population of GLUT1 in the tubulovesicular 
structure but did not affect the level of transporter labelling in the cytoplasmic vesicles 
(Blok et al., 1988). The vesicles involved in transporter translocation in 3T3-L1 
adipocytes were isolated by immunoadsorption and were further characterised by 
Brown et al. (1988). They found that transporters constituted 3 % of the 50 nm 
vesicles which equates to about 8 transporters per vesicle. Insulin stimulation did not 
alter the degree of vesicle protein phosphorylation.
1.4.2 Separate sorting of GLUT4 and G LUT I
The plasma membrane of basal rat adipocytes contains low levels of both GLUT1 and 
GLUT4 but GLUT4 is twice as abundant as GLUT1. Following insulin stimulation the 
level of GLUT4 at the cell surface increases by 15-20-fold while GLUT1 increases by 
only 5-fold (Holman et al.t 1990). In 3T3-L1 adipocytes where GLUT1 is the 
predominant isoform GLUT1 is most abundant at the cell surface in basal cells. Here 
insulin causes a 17-fold increase in GLUT4 and a 6.5-fold increase in GLUT1 
(Calderhead et o/., 1990). Thus in both rat and 3T3-L1 adipocytes GLUT1 and 
GLUT4 have a unique distribution between the cell surface and the intracellular pool 
with a higher proportion of GLUT1 at the surface of basal adipocytes while insulin 
stimulation has a different effect on the translocation of the two transporter isoforms.
In basal adipocytes the majority of both the GLUT4 and GLUT1 transporters reside in 
the low density microsomes within the cell. Zorzano et al. (1989) reported the
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presence of at least two transporter containing vesicle populations in rat adipocytes, 
one recognised by an anti-GLUT4 antibody and the other recognised by an anti- 
GLUT1 antibody. The transporter containing vesicles in 3T3-L1 adipocytes were 
characterised by Calderhead et al. (1990). The vesicles were found to have an average 
diameter of 72 nm. When they immunoadsorbed vesicles with anti-GLUT1 antibodies 
they precipitated 95 % of the GLUT4 while immunoadsorption with anti-GLUT4 
antibodies precipitated 85 % of the GLUT1. A later study on 3T3-L1 adipocytes found 
further evidence for the differential sorting of GLUT4 and GLUT1 with the proportion 
of total GLUT1 at surface of basal cells being 1:2 while it was 1:30 for GLUT4. Using 
an anti-GLUT4 antibody they were able to immunoisolate vesicles which contained 90 
% of the GLUT4 but only 30 % of the GLUT1 (Piper et a/., 1991). Double labelling 
immunocytochemical experiments also showed distinct compartments enriched with 
one, but not the other, transporter isoform. Differences between these two 3T3-L1 
adipocyte studies may be due to different homogenisation techniques but both show 
that sorting is less rigorous in 3T3-L1 adipocytes where there are much higher levels of 
GLUT1 than in rat adipocytes.
The differential localisation of GLUT4 and GLUT1 in rat and 3T3-L1 adipocytes 
between the plasma membrane and microsomes and the two vesicle populations 
requires some mechanism whereby the two isoforms can be distinguished and 
differentially sorted. The GLUT4 protein itself is an obvious candidate for such a 
mechanism. The sorting of transporters is isoform specific rather than dependent on 
the cell type. GLUT1 and GLUT4 have been expressed in a number of different insulin 
insensitive cell types. 3T3-L1 fibroblasts and HepG2 hepatoma cells were transfected 
with GLUT1 and GLUT4 by Haney et al. (1991). In 3T3-L1 fibroblasts GLUT1 was 
concentrated in the plasma membrane and increased the transport rate. GLUT4 
transfection did not increase transport even following treatment with insulin and the 
protein was concentrated in the trans-Golgi reticulum. A similar isoform specific 
distribution with GLUT1 at the plasma membrane and GLUT4 in intracellular stores
Introduction 25
was seen in the HepG2 cells (Haney et al., 1991), NIH-3T3 fibroblasts (Hudson et a/.,
1992), CHO fibroblasts (Shibasaki et a/., 1992), COS-7 fibroblasts (Schurmann et a/., 
1992b) and Xenopus oocytes (Thomas et al., 1993). When GLUT4 was expressed in 
the neuroendocrine cell line PC12 it was specifically sorted to the specialised secretory 
compartment of the cells (Hudson et al., 1993). These results all showed that the 
targeting of GLUT4 must be intrinsic to the transporter protein itself.
The major regions of sequence deviation between GLUT4 and GLUT1 occur in the 
cytoplasmic portions of the transporters and three such regions have been implicated 
as containing specific targeting information. The first region to be implicated in the 
sorting of GLUT4 was the N-terminal domain. Piper et al. (1992) found that either 
deleting the first eight amino acids from the N terminus or the mutation at Phe5, F5A, 
both resulted in the accumulation of GLUT4 in the plasma membrane when the 
mutants were transiently expressed in CHO fibroblasts. These mutations also 
abolished the colocalization of GLUT4 with the dathrin lattices (Piper et al., 1993a). 
Other substitutions around Phe5 had a similar but smaller effect on cell surface 
expression. When the N terminus of GLUT1 was replaced with that of GLUT4 the 
mutant adopted a GLUT4-like distribution. The opposite effect was seen when the N 
terminus of GLUT4 was replaced with that of GLUT1 (Piper et al., 1992). When the 
C terminus of the H1 subunit of the asialoglycoprotein receptor was replaced with the 
N terminus of GLUT4 the mutant protein was sequestered into an intracellular 
compartment similar to that of GLUT4 while the wild type protein was localised at the 
cell surface. The sequence within the N-terminal domain of GLUT4 that is responsible 
for this targeting has been identified as a phenylalanine based motif, PSGFQQI, residues 
2 to 8 (Piper et al., 1993a). This internalisation motif occurs in other internalised 
proteins such as the mannose-6-phosphate/IGF-ll receptor (Jadot et al., 1992) and 
surface glycoproteins (Ktistakis et al., 1990). The main features of the motif are an 
aromatic residue and a bulky hydrophobic residue with two amino acids between 
them. The aromatic residue can be a tyrosine or a phenylalanine but the latter is less
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efficient which would allow GLUT4 to accumulate in the plasma membrane to the 
required extent. At the same time Asano et al. (1992b) stably transfected CHO 
fibroblasts with mutant transporters containing different segments of GLUT1 and 
GLUT4. They identified two domains in a region containing transmembrane helices 7 
and the N-terminal half of the loop between helix 7 and 8 rather than the N -  or C - 
terminal domains.
More recently the C-terminal domain has been shown to be involved in the localisation 
of the glucose transporters. Verhey et al. (1993) made chimeric transporters and 
expressed them in NIH 3T3 and PC12 cells. They found that the N-terminal half of 
GLUT4 and the last 30 amino acids of the C-terminal tail were responsible for the 
differential targeting of GLUT1 and GLUT4. Of these two regions, however, the C- 
terminal domain was found to be the more important region. The C-terminal domain 
was also identified as being responsible for the targeting of GLUT4 by Czech et al. 
(1993). They made GLUT1/GLUT4 chimeras and expressed them in COS-7 and 
CHO fibroblasts. They also found that the last 30 amino acids of GLUT4 could 
promote the intracellular sequestration of GLUT1. Within this region they identified 
two leucines, Leu48’ and Leu490 in GLUT4. This dileucine motif is important for the 
targeting of proteins such as the mannose-6-phosphate/IGF-lI receptor (Johnson and 
Kornfeld, 1992) to the endocytic pathway. It has been suggested that the C- and N- 
terminal targeting sequences of GLUT4 may play different roles in the intracellular 
sequestration, the N-terminus involved in dathrin coated pit mediated internalisation 
and the C-terminus retaining it within the intracellular pool (Garippa et a/., 1994).
1.4.3 ATB-BMPA, the exofacial glucose transporter photolabel
2-N-[4-( 1-azi-2,2,2-trifluoroethyl)benzoyl]-1,3-bis-(D-mannos-4-yloxy)-2-propylamine, 
ATB-BMPA, was developed as a specific cell surface glucose transporter label. It is 
based on a bis-D-mannose with the two mannose joined at the C4 position by a 2-
Introduction 27
propylamine bridge. The bis-D-mannose makes the compound sufficiently hydrophilic 
to be soluble in physiological buffers and membrane impermeant. Thus it is unable to 
label intracellular transporters (Clark and Holman, 1990). The outward facing binding 
site will not accept glucose analogues with a bulky substitution at the C1 position but is 
unaffected by substitutions at the C4 position. A t the inward facing binding site the 
situation is reversed (Barnett et al., 1975). Thus the 2-propylamine substitution at the 
C4 position does not prevent binding at the outward facing site but does prevent the 
label being transported or binding to the inner binding site. The bulky photolabile 4- 
(1-azi-2,2,2-trifluoroethyl)-benzoic acid group is coupled to the 2-propylamine bridge 
where it does not interfere with the binding o f mannose to the outer binding site. 
Irradiating the diazirine portion o f ATB-BMPA with 300 nm ultra violet light generates 
a carbene which binds irreversibly to the glucose transporter at helix 8 (Baldwin,
1993) and adds to its specificity (Clark and Holman, 1990). ATB-BMPA it is a 
powerful tool for labelling and quantifying cell surface transporters without the need 
for subcellular fractionation and the inherent danger of contamination by intracellular 
transporters.
The affinity constant o f ATB-BMPA is approximately equal for all transporter isoforms 
so far investigated. In 3T3-L1 adipocytes the Kd of GLUT1 and GLUT4 for ATB-BMPA 
is « 150 pM (Palfreyman et al., 1992) and 250 pM for GLUT2 in liver plasma 
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Figure 1.6 The  structure of A T B -B M P A  (Clark and Holman, 1990)
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1.5 Insulin and the insulin receptor
1.5.1 Insulin secretion and its effects
The effect of insulin on metabolism and cell growth have been well characterised and 
the sequence and 3-D structure of the insulin protein itself have been known since the 
early fifties yet the molecular basis for the actions of insulin at the cellular level are 
proving more elusive. Insulin is synthesised by the p-cells of the Islets of Langerhans 
and is the only hormone that can effectively decrease the blood sugar concentration. 
After a meal the blood glucose concentration rises. This is detected directly within the 
p-cells, the kinetics of GLUT2 allowing the intracellular glucose concentration to change 
in tandem to the blood glucose concentration (as described in section 1.2.2.). The p- 
cells glucokinase is activated by glucose and phosphorylates glucose with a higher Km 
than hexokinase, (Matschinsky, 1990). Thus glucose-6-phosphate, ADP and H+ are 
produced within p-cells at a rate proportional and specific to the blood glucose level. 
Glucose phosphorylation is believed to be important as inhibitors of glucose 
phosphorylation also inhibit glucose induced insulin secretion (Hedeskov, 1980). The 
exact mechanism linking glucokinase to insulin secretion is unclear but an increase in 
ATP inducing an influx of Ca2+ appears to be involved (Prentki and Matschinsky, 1987).
Once secreted insulin has a range of physiological effects on insulin sensitive cells. 
Some effects occur instantly while others take minutes or hours (Denton, 1986). 
Insulin affects both cell metabolism and cell growth (Rosen, 1987). Effects requiring 
longer exposures to insulin, such as those on cell growth and transformation, are 
probably the result of changes in gene expression. For example in 3T3-L1 adipocytes 
chronic exposure to insulin results in an increased level of expression of GLUT1 mRNA 
and protein (Tordjman et o/., 1989). Insulin induced changes in cell metabolism 
generally require a shorter exposure to the hormone (Denton, 1986). Many of these 
events are the result of increases and decreases in the phosphorylation of particular 
proteins. These metabolic changes are anabolic in nature, and result in a reduction in
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the level of blood glucose. In muscle, insulin induces the translocation of GLUT4 to the 
plasma membrane, decreases the phosphorylation of glycogen synthase which increases 
glycogen synthesis and increases amino acid uptake and general protein synthesis. In 
the liver glycogen, fatty acid, cholesterol and general protein synthesis are increased 
while gluconeogenesis, fatty acid oxidation and ketogenesis are decreased. In 
adipocytes insulin increases glucose uptake by raising the concentration of GLUT4 in 
the plasma membrane. Fatty acid synthesis is increased by activating pyruvate 
dehydrogenase by dephosphorylation and acetyl CoA carboxylase by phosphorylation. 
Triglyceride synthesis is probably increased by the activation of glycerol phosphate acyl 
transferase. Glycogen synthesis and general protein synthesis are increased as well as 
more specific changes in protein synthesis such as GLUT1. Insulin also decreases the 
activity of triglyceride lipase in adipocytes by the dephosphorylation of the enzyme.
1.5.2 Structure of the insulin receptor
While it is known that insulin increases glucose uptake in adipocytes by increasing the 
translocation of GLUT4 to the plasma membrane and so raising the V ^ , the precise 
signalling mechanism is unknown. Insulin is believed to produce all its effect by binding 
to the insulin receptor rather than by entering the cell itself.
The cells of the major insulin responsive tissues, the liver, muscle and adipose tissues, 
contain between 20,000 to 100,000 insulin receptors per cell although insulin only 
needs to bind to 1,000 to 2,000 receptors to produce a maximal insulin effect 
(Denton, 1986). The insulin receptor is a heterotetrameric glycoprotein with the 
structure p-a-a-p. The complex is held together by disulphide bonds. It has an 
apparent mass of 350-400 kDa. The molecular weight of the a-subunit is 95 kDa 
while that of the p-subunit is 135 kDa. The receptor is synthesised as a precursor 
which is cleaved to give the a- and p-subunit. The human insulin receptor cDNA was 
independently cloned by two groups (Ullrich et a/., 1985, Ebina et a/., 1985). There
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are two isoforms of the receptor which differ with the presence or absence of a 12 
amino acid sequence near the C-terminus of the a-subunit. Ullrich et al. (1985) 
sequenced the 1370 amino acid precursor while Ebina et al. (1985) sequenced the 
longer 1382 amino acid precursor which contains the additional mini-exon. The 
nomenclature used here is that o f Ebina et al. (1985). The distribution o f the two 
isoforms is both specific and distinct but the physiological significance o f this is unclear 
(Goldstein and Dudley, 1990).
Insulin binding dom ain
Tyr 9 6 5 /9 7 2  (JM ) 
ATP binding Lys 1 0 3 0  (TK) 
Tyr 1 1 5 8 / 1 1 6 2 / 1 1 6 3  (TK) 
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Figure 1.7 A  model of the insulin receptor
The two insulin receptor a-subunits are joined to one another and the two P-subunits by disulphide 
bonds. The relative positions of the receptor domains are shown on the right and the 
autophosphorylation and other functional sites are shown on the left (from W hite and Kahn, 1994).
The 719 or 731 amino acids o f the insulin receptor a-subunit are entirely extracellular 
and bind insulin. Insulin binds between the L1 domain o f one a-subunit and the L2 
domain o f the other (Schumacher et al., 1993). The insulin-like growth factor I binds 
to the cysteine rich domains (Schumacher et al., 1991). The 620 amino acids o f the p- 
subunit spans the plasma membrane. It has two globular domains, one extracellular
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and the other intracellular. They are linked by the 23 uncharged membrane spanning 
amino acids of the transmembrane domain. The receptor is a member of the tyrosine 
kinase family of receptors that includes the epidermal growth receptor and the platelet 
derived growth factor receptor and oncogenic proteins such as v-erb-B. The insulin-like 
growth factor 1 receptor and the insulin receptor are similar both having the same 
heterotetrameric structure (Ullrich and Schlessinger, 1990). The tyrosine kinase 
domain is the most similar region among this family of tyrosine kinase receptors.
1.5.3 The activation of the insulin receptor
The binding of insulin to the a-subunit of the insulin receptor is believed to cause a 
conformational change in the receptor which is transmitted to the intracellular domain 
thus allowing the tyrosine kinase to be active. It has been demonstrated in several 
ways that the role of the extracellular domain of the receptor is to inhibit kinase 
activity in the absence of insulin rather than to activate the kinase in its presence. 
Trypsin treatment of the insulin receptor cleaves the a-subunit at Arg576 - Arg577. This 
results in the loss of the insulin binding site and the separation of the receptor into two 
heterodimers. The tyrosine kinase of this truncated receptor was constitutively 
activated (Shoelson et al., 1988). A similar effect was seen when mouse L cells were 
transfected with a recombinant membrane-anchored insulin receptor kinase which has 
only 15 extracellular residues. This too possessed insulin independent tyrosine kinase 
activity and enhanced 2-deoxy-D-glucose uptake (Lebwohl etal., 1991).
The role of the transmembrane domain in the activation of the receptor has been 
investigated by a number of groups but with contradictory results. While most groups 
consider this region to play an essentially passive role others disagree. The role of the 
transmembrane region in the activation of the receptor by insulin therefore remains 
unclear (Tavare and Siddle, 1993). An intact juxtamembrane region is essential for the 
activity of the receptor. This region contains two XPXY motifs which may adopt a (3-
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turn and be involved in insulin stimulated, coated pit mediated, receptor endocytosis 
(Backer et o/., 1992b). Replacing the two tyrosines with alanines did not affect insulin 
binding or receptor autophosphorylation but did reduce receptor internalisation by 
70 %. Essential to the correct activity of the insulin receptor is the ATP binding 
residue, Lys1030 (McClain et a/., 1987). The mutation K1030A prevented insulin 
activation of the tyrosine kinase, blocked insulin stimulation of glucose transport and 
glycogen synthase activity and inhibited receptor internalisation.
Crucial to the activity of the insulin receptor is the tyrosine kinase and its 
autophosphorylation. Three phosphorylation sites have been identified in the insulin 
receptor p-subunit; the juxtamembrane region, the tyrosine kinase domain and the C- 
terminal region. Within the juxtamembrane region tyrosine residues 965 and 972 
(Kohanski, 1993b) are slowly phosphorylated in the absence of insulin and this is 
favoured by a low ATP concentration (Kohanski, 1993a). Tyrosine residues 1158, 
1162 and 1163 within the kinase domain are phosphorylated in response to insulin 
(Tavare and Denton, 1988). Unlike the juxtamembrane site these tyrosines are 
rapidly phosphorylated in response to insulin (Kohanski, 1993a). The insulin receptor 
is symmetrical and possesses two binding sites but it only binds one insulin molecule 
with high affinity and only one site need be occupied to fully stimulate receptor 
autophosphorylation (Shoelson et a/., 1993). Once insulin has bound, the activated 
insulin receptor tyrosine kinase of one p-subunit trans-autophosphorylates the other p- 
subunit of the receptor. This has been demonstrated using hybrid receptors of kinase 
defective and insulin/IGF-1 binding domains (Treadway et o/., 1991) and by the use of 
covalently bound insulin (Lee et o/., 1993). Autophosphorylation has a range of 
physiological responses including increases in glycogen and DNA synthesis (Wilden et 
a/., 1992a) and glucose transport. A comparison of the concentration-response curves 
for insulin stimulation of the tyrosine kinase and glucose uptake found that only 4 % 
and 14 % of the maximal kinase activity was required for half maximal and maximal 
insulin stimulation of glucose uptake respectively (Klein et o/., 1991). Replacement of
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any of the three tyrosine kinase domain tyrosines with phenylalanine reduced insulin 
stimulated autophosphorylation by over 50 %. Double replacements reduced it by 60- 
70 % while the triple substitution decreased it over 80 % (Wilden et al., 1992b). 
These mutations also decreased IRS-1 tyrosine phosphorylation and insulin stimulated 
receptor internalisation (Wilden et al., 1992a). Mutation of Y1162F or Y1162/63F, 
in addition to reducing autophosphorylation, also reduced or almost completely 
blocked insulin stimulated glucose transport (Ellis et al., 1986). The mutation of these 
two tyrosines did not affect the long term insulin stimulated increase in GLUT1 mRNA 
and protein levels (Desbois et al., 1992). These contrasting results indicate a 
divergence of pathways at the level of the insulin receptor itself.
The third site of autophosphorylation in the C-terminal region of the receptor is at 
residues Y1328 and Y1334 (Tornqvist et al., 1987). When a mutant human insulin 
receptor lacking the last 43 amino acids (hlRACT43) was expressed in rat-1 fibroblasts 
it was found to inhibit insulin stimulated glucose transport without affecting 
autophosphorylation or mitogenic effects (Maegawa et al., 1988). Others have 
reported that this deletion mutation has no effect but this could be related to the cells 
used for expression (Tavare and Siddle, 1993). The C-terminal region also contains 
the Ser/Thr phosphorylation sites Thr1348 and Ser1305/6 (Chin et al., 1993). The serines 
are phosphorylated by the insulin sensitive serine kinase, a kinase which is closely 
associated with and copurifies with the insulin receptor (Lewis et al., 1990). This 
phosphorylation does not inhibit the receptor tyrosine kinase but it can inhibit insulin 
stimulated responses (Chin etal., 1993).
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1.6 Potential second messenger systems
1.6.1 The insulin receptor substrate-1 and phosphatidylinositol 3'-kinase
Insulin induced autophosphorylation of the insulin receptor p-subunit increases the 
activity of the insulin receptor tyrosine kinase toward other substrates. White et al. 
(1985) identified two proteins whose tyrosine phosphorylation was increased by 
insulin stimulation. One of these, pp95, was the insulin receptor p-subunit. This 
remained phosphorylated throughout the hour long insulin stimulation. The second 
was the specific substrate pp185 which, like pp95, was maximally phosphorylated 
within 30 s. However, unlike pp95 this protein was dephosphorylated during the one 
hour insulin stimulation. pp185, the major insulin stimulated tyrosine phosphorylated 
protein, was purified, partially sequenced, (Rothenberg et al., 1991) cloned and called 
IRS-1 (insulin receptor substrate-1) (Sun et al., 1991). IRS-1 contains 21 potential 
phosphorylation sites six of which have the motif YMXM while a further three are 
YXXM. Synthetic peptides containing these motifs are phosphorylated by the purified 
insulin receptor, supporting the idea that they are insulin receptor tyrosine kinase 
phosphorylation sites in IRS-1 (Shoelson et al., 1992). When phosphorylated, these 
motifs are thought to act as docking sites for proteins possessing SH2/3 domains, the 
large number of sites allowing it to act as a multisite docking protein, see figure 1.8.
Once phosphorylated IRS-1 forms a stable complex with the p85 subunit of 
phosphatidylinositol 3'-kinase (PI3-kinase) with the SH2 domains of p85 associating 
with the phosphorylated YXXM motifs. This association activates the PI3-kinase p110 
subunit which phosphorylates phosphatidylinositols (PI) at D3 producing PI(3)P, 
PI(3,4)P2 and PI(3,4,5)P3 (Backer et al., 1992a). Most PI3-kinase activity is associated 
with intracellular membranes, the IRS-1/PI3-kinase complex being localised in a very 
low density membrane fraction which is not enriched in either GLUT4 or insulin 
receptors in rat adipocytes (Kelly et al., 1993). A link between PI3-kinase and insulin 
stimulated glucose transport was made by comparing the effect of okadaic acid on
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transport and PI 3-kinase activity. Although okadaic acid stimulates basal transport it 
inhibits insulin stimulated glucose uptake in adipocytes and muscle and inhibits the 
association of phosphorylated IRS-1 with PI 3-kinase as detected by 
immunoprecipitation with antiphosphotyrosine antibodies. Okadaic acid, however, 
does not inhibit the activity of the insulin receptor tyrosine kinase. Okadaic acid did 
not block insulin stimulated aminoisobutyric acid uptake in muscle so IRS-1 and PI 3- 
kinase are not required for all the effects of insulin (Jullien et a/., 1993). Wortmannin, 
believed to be a specific PI 3-kinase inhibitor, supports this link. Wortmannin inhibits 
both PI3-kinase activity and insulin stimulated glucose uptake (Clarke eta/., 1994).
1.6.2 Serine and threonine phosphorylation second messengers
1.6.2.1 G LUT4 phosphorylation
GLUT4 phosphorylation was first detected by James et al. (1989b). When rat 
adipocytes were treated with either isoproterenol, dibutyryl-cAMP or 8-bromo-cAMP 
GLUT4 phosphorylation was stimulated 2-fold. The phosphorylation site was identified 
as Ser488 using 32P labelling and CNBr cleavage (Lawrence et a/., 1990a). This site has 
also been confirmed by Piper et al. (1993b) who substituted Ser488 for Ala (S488A) 
and abolished GLUT4 phosphorylation.
There are two possible regulatory roles for transporter phosphorylation. One is the 
regulation of translocation and the other is the regulation of intrinsic transporter 
activity. Lawrence et al. (1990a, b) were unable to report an insulin induced change in 
GLUT4 phosphorylation but they suggested that phosphorylation may promote 
transporter internalisation. Reusch et al. (1993) were able to demonstrate a decrease 
in GLUT4 phosphorylation in the presence of insulin. They, however, did not find 
evidence that GLUT4 phosphorylation affected transporter translocation. They 
treated rat adipocytes with parathyroid hormone which increased GLUT4
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phosphorylation but did not alter the translocation of the transporter to the plasma 
membrane. Phosphorylation of rat adipocyte GLUT4 did reduce the intrinsic activity 
of GLUT4 in both intact adipocytes and reconstituted vesicles. In plasma membrane 
vesicles GLUT4 phosphorylation resulted in a 35 % reduction in intrinsic activity. They 
were unable to confirm that phosphorylation itself rather than a conformational 
change was responsible for the change in activity.
1.6.2.2 Protein phosphatases and okadaic acid
Okadaic acid is produced by dinoflagellates and concentrated in the marine sponges 
Halichondria okadaii and Halichondria melanodocia. It was first identified as the cause of 
diarrhetic seafood poisoning (reviewed in Cohen et al., 1990). Okadaic add was found 
to be a potent inhibitor of the two major serine/threonine phosphatases PP1 and 2A 
(Bialojan and Takai et al., 1988) Purified PP1 is inhibited by okadaic acid with an ICS0 
of 20 nM while for PP2A it is only 0.2 nM. In intact cells the maximal inhibitory effects 
of okadaic acid are obtained at a concentration of 1 pM (Haystead et al., 1989). The 
effects of okadaic acid on hexose transport in rat adipocytes were first described by 
Haystead et al. (1989) who showed that okadaic acid stimulates 2-deoxy-D-glucose 
uptake in a manner similar to that of insulin but with a 5 min lag. The effect of okadaic 
acid on GLUT4 in rat adipocytes was further investigated by Lawrence et al. (1990b). 
They found that in adipocytes fully stimulated with okadaic acid (1 pM for 20 min) the 
rate of uptake of 2-deoxy-D-glucose was only half of that for insulin. Furthermore 
when the cells were stimulated with both insulin and okadaic acid the rate was less 
than for insulin alone. They also looked at the effect of okadaic acid on the 
distribution of GLUT4. They found that okadaic acid alone stimulated the 
translocation of GLUT4 by only » 40 % of that with insulin. With insulin and okadaic 
acid together the stimulation was only « 70 % of that for insulin alone. They found 
that okadaic acid but not insulin increased the level of GLUT4 phosphorylation. From
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this the/ concluded that okadaic acid stimulates transport as a result of the 
translocation of GLUT4 to the plasma membrane by causing the phosphorylation of 
proteins that regulate vesicle movement perhaps including proteins within the GLUT4 
containing vesicles. A similar study was carried out by Corvera et al. (1991). They 
too looked at the effect of okadaic acid on insulin stimulated glucose uptake in rat 
adipocytes. They found that okadaic acid caused a small increase in transport and the 
level of cell surface transporters but blocked insulin stimulated transporter 
translocation. They also found a discrepancy between plasma membrane levels of 
GLUT4 and the rate of 3-O-methyl-D-glucose uptake. This led them to suggest that 
okadaic acid may cause a 10-20 % decrease in the intrinsic activity of GLUT4.
Okadaic acid causes the phosphorylation and activation of a number of proteins 
including the myelin basic protein kinase (Haystead et c/., 1990), cAMP 
phosphodiesterase (Shibata et o/., 1991) and the Na+/ H + antiport (Bianchini et a/.,
1991). Although okadaic acid does not alter the insulin induced autophosphorylation 
of the insulin receptor it does inhibit the insulin induced tyrosine phosphorylation of 
IRS-1 (Jullien et al., 1993). This lack of IRS-1 tyrosine phosphorylation prevents IRS-1 
associating with and activating PI 3-kinase. Okadaic acid alone had no effect on anti- 
phosphotyrosine immunoprecipitable PI 3-kinase activity. They suggested that okadaic 
acid may inhibit insulin induced IRS-1 tyrosine phosphorylation by causing the 
phosphorylation of either the insulin receptor or IRS-1 so impairiiig their binding.
Other links have been made between the insulin receptor and protein phosphatases. 
The insulin receptor can phosphorylate the catalytic subunit of PP-2A on Tyr307. This 
deactivates the phosphatase. Phosphorylation is enhanced by the presence of okadaic 
acid. It was therefore suggested that the transient deactivation of PP-2A may allow 
insulin to activate kinase cascades including ribosomal protein S6 kinases and mitogen- 
activated protein kinases (Chen et al., 1992). Insulin appears to have the opposite 
effect on PP-1. The activity of PP-1 was studied in rat-1 fibroblasts expressing either 
the human insulin receptor (hIR) or a mutant receptor lacking the last 43 amino acids
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(hlRACT43). When insulin binds to the mutant receptor autophosphorylation occurs 
normally but metabolic effects, including the stimulation of glucose transport, are 
blocked. In cells expressing hIR, insulin caused a 25-30 % increase in the activity of PP- 
1 toward phosphorylase a. In cells expressing hlRACT43 insulin did not activated 
PP-1. This suggests that PP-1 may interact with the C terminus of the insulin receptor 
and that PP-1 my be involved in the metabolic actions of insulin (Begum et a/., 1993b).
1.6.2.3 Protein kinase C
Protein kinase C is activated by a number of hormones and growth factors including 
insulin. So far ten isoforms in three subfamilies have been identified. Ca2+ 
phosphatidylserine, free fatty acids and diacylglycerol (DAG) are required for the 
activation of the classical protein kinase C group. The new protein kinase C group and 
the atypical protein kinase C group have less requirements for activation (Nishizuka,
1992). The concentration of diacylglycerol within a cell can be increased by hydrolysis 
of phosphatidylinositol (PI) or phosphatidylcholine (PC) by phospholipase C or by de 
novo synthesis of DAG by glycerol-3-phosphate acyl transferase. Insulin has been 
shown to increase DAG levels in adipocytes both by PC hydrolysis and de novo 
synthesis (Farese et a/., 1985). PI hydrolysis is pertussis toxin sensitive while PC 
hydrolysis is pertussis toxin insensitive (Hoffman et a/., 1991; Luttrell et a/., 1988).
Tumour promoting phorbol esters (Shoyab and Todaro, 1980) such as phorbol 12- 
myristate 13 acetate (PMA) can activate protein kinase C in addition to DAG 
(Nishizuka, 1988). PMA increases the basal glucose transport rate by 2-fold (Kirsch et 
a/., 1985) to » 3-fold in rat adipocytes (Holman et a/., 1990) and by « 2-fold in 3T3-L1 
adipocytes (Gibbs et a/., 1991), several fold less than insulin. The stimulatory effect of 
PMA is not additive with that of maximal stimulating concentrations of insulin (Gibbs et 
a/., 1986). At submaximal insulin concentrations, however, PMA does have an 
additive effect on the insulin stimulation of transport (Gibbs eta/., 1991).
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!n addition to stimulating protein kinase C, PMA also down-regulates the enzyme. 
Incubating 3T3-L1 fibroblasts with PMA for 16 h results in the loss of 
immunodetectable protein kinase C and the kinase activity (Blackshear et al., 1985). In 
3T3-L1 adipocytes this down-regulation, while inhibiting PMA stimulated transport, had 
no effect on insulin stimulated transport (Gibbs et al., 1991).
PMA also affects the translocation of GLUT1 and 4 in adipocytes. In rat adipocytes 
PMA stimulates the translocation of GLUT1 by 100 % and GLUT4 by 18 % of the 
maximal insulin stimulated level (Holman et al., 1990). In 3T3-L1 adipocytes GLUT1 
increases by only 40 % and GLUT4 by 10 % of the insulin stimulated level (Gibbs et al.,
1991). Since the translocation of GLUT4 to the plasma membrane is the major 
mechanism for the insulin stimulated increase in transport, the small stimulatory effect 
of PMA can be explained by its small increase in cell surface GLUT4. In addition to 
overnight exposure to PMA, PMA stimulated transport in 3T3-L1 fibroblasts can be 
inhibited by the selective protein kinase C inhibitor Roche 31-8220. This inhibitor, 
however, has no effect on the insulin stimulated transport rate (Merrall et al., 1993).
Taken together these results indicate that in adipocytes while PMA does cause a small 
stimulation in glucose transport insulin and PMA work through different mechanisms. 
However such experiments, especially those involving the down regulation of protein 
kinase C by PMA, do not preclude all the protein kinase C subspecies from a role in 
the action of insulin. Yano et al. (1993) reported that staurosporine (SSP), a protein 
kinase C inhibitor to which certain protein kinase C isoforms are particularly sensitive, 
inhibits insulin stimulated glucose transport and transporter translocation. While their 
results do indicate a potential role for protein kinase C in the insulin stimulated glucose 
transport pathway they did not rule out the effect of SSP being due to the inhibition of 
other protein kinases such as the insulin receptor tyrosine kinase. The different 
subspecies of protein kinase C also have different sensitivities toward PMA induced 
down-regulation (Huang et al., 1989). A possible candidate for an insulin activated 
protein kinase C is the ubiquitous atypical ^ subspecies. Protein kinase C ^ is not
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translocated or down-regulated by phorbol esters or diacylglycerol derivatives (Ways 
et a/., 1992) and is calcium and DAG insensitive (Nishizuka, 1992). Instead this kinase 
is activated by phosphatidylinositol 3,4,5 triphosphate (Nakanishi et a/., 1993). Thus 
insulin could activate this enzyme via IRS-1 activation of PI3-kinase (see 1.6.1). While 
the substrate for protein kinase C C, is unknown it is involved in insulin induced 
maturation of Xenopus oocytes and mitogenic signalling (Berra et a/., 1993).
1.6.2.4 Ca2+ as a second messenger for insulin
Ca2+ is unlikely to be a second messenger for insulin in the stimulation of glucose 
transport as insulin does not increase cytosolic free calcium levels in adipocytes 
(Blackmore and Augert, 1989). Indeed at high intracellular concentrations Ca2+ has an 
inhibitory effect on insulin action. High levels of cytosolic free calcium significantly 
inhibit the dephosphorylation of the insulin receptor (Begum et a/., 1991) and induce 
the phosphorylation of inhibitor-1. Inhibitor-1, when activated by phosphorylation 
inhibits the phosphoserine phosphatases and may therefore block some of the actions 
of insulin (Begum et a/., 1992). While a high intracellular [Ca2+] does not inhibit the 
insulin stimulated translocation of transporters to the plasma membrane it does inhibit
2-deoxy-D-glucose uptake and increases GLUT4 phosphorylation (Reusch eta/., 1991). 
Thus high [Ca2+],, as a result of the inhibition of the phosphatase PP-1, causes the 
phosphorylation of GLUT4 and lowers its intrinsic activity (Begum eto/., 1993a).
1.6.2.5 The role of cAMP
The effect of cAMP on glucose transport was first recognised by Joost et al. (1986) 
who found that when the p-adrenergic agonist isoproterenol was added to rat 
adipocytes in the presence of adenosine deaminase, while there was no effect on 
transporter translocation the insulin stimulated transport rate decreased by 60 %.
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Since incubating rat adipocytes with isoproterenol or with the cAMP analogues 
dibutyryl-cAMP or 8-bromo-cAMP at 5 mM increases GLUT4 phosphorylation 2-fold it 
was suggested that GLUT4 is phosphorylated by a cAMP dependent protein kinase 
(James et a/., 1989b). GLUT4 can also be phosphorylated by incubating rat adipocyte 
microsomes with the catalytic subunit of cAMP dependent protein kinase. The 
phosphorylation of GLUT4 at Ser488 was proposed as a mechanism for p-adrenergic 
agonist inhibition of insulin stimulated glucose transport (Lawrence et a/., 1990a).
In contrast to this Clancy and Czech (1990) found that a 4 h incubation with either 
cholera toxin or dibutyryl cAMP caused the translocation of transporters to the plasma 
membrane and an increase in the rate of hexose uptake in 3T3-L1 adipocytes. A 12 h 
incubation increased the total cellular levels of GLUT1 but with little change in GLUT4. 
Since the increase in the level of cell surface transporters could not fully explain the 
increase in hexose transport they suggested that prolonged exposure to cholera toxin 
increases the intrinsic activity of the transporters. The effect of cAMP on GLUT1 and 
GLUT4 expression in 3T3-L1 adipocytes was studied using 8-bromo-cAMP. After a 16 
h incubation with 8-bromo-cAMP GLUT4 decreased by 70 % while GLUT1 increased
3-fold as a result of mRNA stabilisation and transient transcriptional activation of 
GLUT1 and repression of the GLUT4 transcription rate (Kaestner et a/., 1991). The 
stimulatory effects of cAMP were also reported using dibutyryl-cAMP with rat 
adipocytes. At low concentrations (10 pM) it stimulated transport by causing the 
translocation of GLUT4 to the plasma membrane. At higher concentrations (1 mM), 
GLUT4 translocation was further increased but the transport rate decreased as a result 
of a decrease in intrinsic activity (Kelada et a/., 1992).
The inhibitory effect of cAMP on transport was further investigated in CHO cells 
transfected with transporters (Piper et a/., 1993b). While dibutyryl cAMP had no 
effect on either the concentration or distribution of transporters it did inhibit GLUT4 
but not GLUT1 mediated 2-deoxy-D-glucose transport. The role of cAMP-dependent 
protein kinase was investigated using 8-bromo-cAMP, which activates the kinase, and
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8-bromo-AMP, which does not. The former had no effect but the latter inhibited 
transport suggesting that the kinase is not involved in the inhibitory effects of cAMP. 
Nishimura et al. (1991) were also unable to find a link between the cAMP-dependent 
protein kinase, GLUT4 phosphorylation and the cAMP inhibition of glucose transport.
The role of GLUT4 phosphorylation at Ser488 was also investigated by Piper et al. 
(1993b). The substitution of an Ala, while preventing phosphorylation, did not inhibit 
transport or prevent dibutyrykAMP inhibition of transport Furthermore the deletion 
of the last 29 residues from the C terminus prevented the dibutyryl cAMP inhibition of 
transport. These results suggest that the inhibitory effect of dibutyryl cAMP is the 
result of direct nucleotide binding to the transporter at a site within the C terminus.
1.6.2.6 The role of other kinases in insulin stimulated glucose transport
While the complete pathway for the mediation of insulin stimulation is unknown a 
number of potential insulin cascade components have been identified as being activated 
in the presence of insulin. These include raf-1 (Blackshear et a/., 1990), the mitogen 
activated protein (MAP) kinases pp42mapk and pp44mapk (Ray and Sturgill, 1987) and the 
ribosomal S6 protein kinases pp90rsk and pp70s<k (Fingar etc/., 1993) (see figure 1.8).
The role of the MAP kinases in insulin stimulated glucose transport was investigated 
using the myosin light chain kinase inhibitor, ML-9. ML-9 inhibits insulin stimulated 
transport and GLUT4 translocation in 3T3-L1 adipocytes but does not prevent the 
phosphorylation of pp42mapk or pp44mapk although it inhibits their activity. ML-9 also 
inhibits the ribosomal S6 protein kinases. While this does suggests that insulin 
stimulates glucose transport by activating the MAP kinases ML-9 may not be specific 
and may inhibit other kinases (Inoue et a/., 1993).
The role of pp70s6k in insulin stimulated glucose transport in 3T3-L1 adipocytes was 
investigated using rapamycin, a specific pp70s8k inhibitor. While rapamycin did inhibit
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insulin activation of pp70s6k it had no effect on the stimulation of transport or GLUT4 
translocation. Thus pp70l6k is not involved in the insulin stimulation of glucose 
transport (Fingar et a/., 1993). Both pp90rsk and pp44mapk are rapidly activated by 
insulin although the activation of these kinases alone is insufficient to activate glucose 
transport. This suggests that while there is a linear pathway from ras to the MAP 
kinases, each mediator is likely to act as a branch point (Fingar and Birnbaum, 1994a). 
It has been suggested that the activation of the MAP kinases is not sufficient in itself to 
bring about the translocation of GLUT4 in 3T3-L1 adipocytes. Epidermal growth 
factor (EGF), platelet-derived growth factor (PDGF) and insulin were all shown to 
activate the MAP kinases, as detected by a change in electrophoretic mobility. 
However, while insulin also induced a 13-fold increase in cell surface GLUT4, EGF and 
PDGF only induced a 2-fold rise in cell surface GLUT1 (Gould et a/., 1994).
The activation of raf-1 has also been shown to be insufficient to induce the 
translocation of GLUT4. Activated raf-1 was expressed in 3T3-L1 adipocytes. The 
basal transport rate in these cells was 40-fold higher than the parental basal transport 
rate. Insulin increased this higher basal rate by a further 1.2-fold. When the 
distribution of GLUT1 and 4 were examined then the presence of the activated raf-1 
was found to greatly increase both surface and total levels of GLUT1. In contrast 
activated raf-1 had no effect on either the surface or total levels of GLUT4 in the basal 
3T3-L1 adipocytes. GLUT4 was still translocated to the cell surface in the presence of 
insulin, however (Fingar and Birnbaum, 1994b). These results suggests that GLUT1 
and GLUT4 may be regulated by divergent signalling pathways in 3T3-L1 adipocytes.
A kinase known to be involved in the insulin stimulation of glucose transport in 
adipocytes is the insulin receptor tyrosine kinase, see section 1.4.3. The role of 
tyrosine kinases have been investigated in a range of systems with specific kinase 
inhibitors such as genistein, a tyrosine kinase inhibitor which competes with ATP 
(Akiyama et a/., 1987), and erbstatin and a range of compounds termed tryphostins, 
which compete with the kinase substrate, (Yaish eta/., 1988).
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When genistein was added to rat adipocytes it was found to inhibit insulin stimulated 
glucose oxidation and other responses without inhibiting insulin receptor 
autophosphorylation (Alber et a/., 1992). While genistein inhibits the insulin 
stimulated increase in glucose transport it does not inhibit insulin stimulated 
translocation. Genistein does, however, decrease the C-terminal immunocytochemical 
labelling of plasma membrane GLUT4. It was therefore concluded that genistein, 
rather than inhibiting the insulin receptor tyrosine kinase, lowers the intrinsic activity of 
GLUT4 by causing a conformational change at the C terminus (Smith et a/., 1993).
Tyrosine kinases have now been shown to have an effect on a range of kinase- 
independent systems. For example, genistein was found to be an uncoupler of 
oxidative phosphorylation in mitochondria while both genistein and erbstatin inhibited 
H+-lactate co-transport in erythrocytes (Young et a/., 1993).
1.6.3 G-proteins and guanine nucleotides in insulin signalling
1.6.3.1 G-proteins
G-proteins can be divided into two groups but all share the common feature of being 
activated by the binding of GTP and inactivated by the hydrolysis of GTP to GDP 
(Bourne et a/., 1991). Thus the activity of G-proteins can be probed using 
nonhydrolyzable GTP analogues. One group, the classical heterotrimeric G-protein, is 
made up of one GTP binding and hydrolysing a-subunit, one p- and one y-subunit. 
These are mainly involved in the transduction of signals from G-protein coupled 
receptors. When activated by the binding of GTP the a-subunit dissociates from the 
py-subunits (Birnbaumer, 1990). While most of the classical G-protein signalling 
occurs via the a-subunit the py subunits are also active. The Py subunits can activate 
the ras dependent MAP kinase pathway (Crespo et a/., 1994). The second group of G-
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proteins is the small G-proteins. These small G-proteins make up the ras family and are 
thought to be involved in trafficking within cells and secretion (Hall, 1990).
The potential role of some of the heterotrimeric G-proteins in insulin stimulation in rat 
adipocytes was investigated using the bacterial toxins cholera toxin and pertussis toxin. 
Cholera toxin, which inhibits Gs, was found to have only a small effect on glucose 
transport. Pertussis toxin, which acts on G, and Go, was found to affect glucose 
transport by decreasing the binding affinity of insulin and by decreasing the efficiency of 
the signalling process (Ciaraldi and Maisel, 1989). A similar effect was obtained by 
Honnor et al. (1992) who also found that neither toxin had an inhibitory effect at 
supramaximal concentrations of insulin. These results indicate a possible role for 
heterotrimeric G-proteins in insulin stimulated glucose transport in rat adipocytes, 
possibly by directly interacting with the transporter in the plasma membrane and 
modifying its intrinsic activity. Recently a direct effect of insulin on the G,a subunit of a 
heterotrimeric G-protein was detected using an antiserum to the C terminus. Staining 
in the plasma membrane with this antiserum was much stronger in insulin stimulated 
cells than basal rat adipocytes suggesting that insulin causes a conformational change 
within the G,a G-protein subunit (Record eta/., 1993).
The subcellular distribution of G-proteins was analysed in rat adipocytes. The 40-50 
kDa a-subunits of the heterotrimeric G-proteins were detected almost entirely in the 
plasma membrane although specific G,^ and G,^ antibodies also detected a 100 kDa 
band in the low density microsomes. Insulin does not affect the distribution of these G- 
proteins. Small G-proteins were detected in the low density microsomes but they 
were more abundant in the plasma membrane. A different subset of G-proteins was 
found in each fraction. Small G-proteins were detected in vesicles immunoprecipitated 
with a specific GLUT4 antibody. Such an association could allow G-proteins to regulate 
the exocytosis of the GLUT4 containing vesicles (Cormont et a/., 1991).
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The presence and distribution of both the a-subunit of the heterotrimeric G-proteins 
and the small ras-family G-proteins was investigated in 3T3-L1 cells before and after 
differentiation to adipocytes. Differentiation was found to decrease the a,, a o and the 
47 kDa a s G-protein subunits by 10-50 %. The 43 kDa a s however, increased three 
fold. These G-protein were all found to have a plasma membrane location. A similar 
pattern of expression during differentiation was seen with the small G-proteins. Ha-rcs 
decreased by 50 % while rab-1 and other rab isoforms increased by 100 % and 70 % 
respectively following differentiation. The rab G-proteins were detected in both the 
plasma membrane and the low density microsomes. Ha-ros and K-ros were not 
detected in the low density microsomes at all. While insulin caused the translocation 
of GLUT4 to the plasma membrane there was no detectable change in the distribution 
of the G-proteins studied following insulin stimulation (Huppertz et a/., 1993).
Ras is part of the insulin activated MAP kinase pathway. Ras-GTP activates raf, the first 
kinase of the MAP kinase pathway, by localising raf at the plasma membrane (Leevers 
et o/., 1994). Ras itself is activated by Sos, a guanine nucleotide exchange protein 
which exchanges GDP for GTP (Baltensperger et a/., 1993). Sos is active when it is 
bound to the SH3 domain of the adapter molecule GRB2 which in turn is bound to a 
tyrosine phosphorylated IRS-1 via the SH2 domain (Skolnik et a/., 1993). The 
mechanism whereby Sos may be activated by binding to GRB2 is unclear but it may be 
the result of a conformational change in Sos, the phosphorylation of Sos or simply by 
bringing it into association with the plasma membrane bound ras. Insulin stimulation 
causes a rapid increase in the level of active GTP bound ras. The MAP kinases 
activated by ras can also be activated by okadaic acid to a similar level as insulin 
(Porras et o/., 1992). When N-ras61k, an activated mutant, was overexpressed in 3T3- 
L1 adipocytes the transport rate was found to be similar to the insulin stimulated rate 
in non transfected adipocytes. The ras induced transport rate was not additive with 
that of insulin. N-ras<1k was also found to cause the translocation of most of the
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GLUT1 and all the GLUT4 to the cell surface (Kozma et al., 1993). Thus ras appears 
to be part of the insulin signalling pathway for the stimulation of glucose transport.
Several rab proteins have been detected in adipocytes including rab3d. Rab 3d mRNA 
is present in 3T3-L1 fibroblasts and it increases during adipocyte differentiation (Baldini 
et al., 1992). Rab 3d shares a high sequence identity with Rab 3a which is localised to 
synaptic vesicles in the brain and is involved in exocytosis (Mollard et al., 1990). In rat 
adipocytes the highest levels of rab3d were detected in the high density microsomes. 
The distribution of rab3d is unaffected by insulin and was not detected in vesicles 
immunoprecipitated with a GLUT4 antibody (Guerre-Millo eta/., 1993).
Several other rab proteins have been detected in rat adipocytes. Rab3b and rab3c are 
cytosolic and rab4 and rab8 are membrane associated. Only the distribution of rab4 is 
affected by insulin stimulation. In basal adipocytes most of the rab4 is found in the low 
density microsomal fraction as is GLUT4. In insulin stimulated adipocytes rab4 is 
present at the plasma membrane and in the cytosol. Rab4 can also be detected in 
vesicles immunopurified with an antibody to GLUT4. In addition to insulin rab4 
recycling can be stimulated by okadaic acid. This suggests that a phosphorylation event 
is required to activate rab4 (Cormont et al., 1993). Rab4 is therefore a good 
candidate for regulating the translocation of GLUT4 to the plasma membrane.
Inactive GDP bound rab proteins can be detected in the cytoplasm associated with the 
GDP dissociation inhibitor (GDI). The GDI delivers the rab to the donor membrane 
(Araki, et al., 1990) where the rab-GDI interacts with the GDI-dissociation factor 
which releases the rab. Rab is prenylated at the C terminus and this localises the 
protein at the membrane. The membrane bound rab then interacts with the guanine 
nucleotide exchange protein (GEF) which exchanges GDP for GTP (Ullrich et al., 1994; 
Soldati et al., 1994). The GTP bound rab is then incorporated into the vesicles. At 
the acceptor membrane the GTP is hydrolysed and the GDP bound rab is released 
from the membrane by binding to GDI (Araki et al., 1990).
Introduction 48
The precise mechanism of vesicle trafficking, targeting and membrane fusion is unclear. 
Both the vesicle and acceptor membranes contain a SNARE (SNAP receptor). The 
vesicle SNARE (v-SNARE) and target membrane SNARE (t-SNARE) interact in the 
presence of a 20S particle which contains N-ethylmaleimide-sensitive fusion protein 
(NSF) and soluble NSF attachment proteins (SNAPs) (Sollner et a/., 1993). The 
interactions of these components may require the association of GTP bound rab with 
the v-SNARE (Bennett and Scheller, 1993). A VAMP-like (vesicle associated 
membrane protein) v-SNARE has been identified in adipocytes. This protein is found 
in the vesicles which transport GLUT4 to the plasma membrane (Cain et a/., 1992).
1.6.3.2 GTPyS
The nonhydrolyzable GTP analogue GTPyS, like GTP, will activate G-proteins (Gilman, 
1987). In CHO fibroblasts GTPyS inhibits transport through the Golgi stack by 
blocking vesicle attachment and fusion at the acceptor Golgi membrane. This 
suggested that G-proteins may be involved in Golgi transport (Melan^on et a/., 1987).
The effect of GTPyS upon insulin stimulated glucose transport in adipocytes was first 
investigated by Baldini et al. (1991). They first demonstrated that insulin still stimulates 
GLUT4 translocation in a-toxin permeabilized rat adipocytes. They then tested a 
number of GTP analogues. The nonhydrolyzable analogues guanosine 5'-0-(3- 
thiotriphosphate) (GTPyS), guanylyl imidodiphosphate (GMPPNP) or guanylyl p,y- 
methylenediphosphate (GMPPCP) all caused a 3-6 fold increase in the GLUT4 content 
of the plasma membrane of basal rat adipocytes. GTP itself and adenosine 5'-p,y- 
imino)triphosphate had no effect on transport. From these experiments they were 
unable to determine whether GTPyS affects exocytosis or inhibits endocytosis. A 
similar study was carried out in streptolysin-0 permeabilized 3T3-L1 adipocytes by 
Robinson et al. (1992). They found that in the presence of ATP insulin, GTPyS or 
insulin plus GTPyS the level of cell surface GLUT4 was similar to that of insulin
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stimulated intact cells. In the absence of ATP the level of cell surface GLUT4 in the 
presence of GTPyS or insulin was lower. The removal of ATP from unstimulated cells 
increased the level of GLUT4 at the cell surface. GTPyS and insulin together overcame 
the ATP dependency. They suggested that ATP is required for a phosphorylation/ 
dephosphorylation event which excludes GLUT4 from the plasma membrane.
The effect of GTPyS on 3-0-methyl-D-glucose uptake was measured in 
electropermeabilized rat adipocytes. 1.0 mM GTPyS stimulated transport as much as 
insulin. 0.3 mM but not 1.0 mM GTPyS enhanced insulin stimulation. NaF and 
mastoparan, both of which activate G-proteins, stimulated transport (Suzuki et al.,
1992). GTPyS also has an inhibitory effect on hexose transport (Schurmann et al., 
1989). When the transport activity from insulin stimulated rat adipocyte membrane 
fractions was reconstituted into vesicles GTPyS and GTP inhibited glucose transport by 
50 %. They had no inhibitory effect in membrane fractions from basal cells and ATPyS 
and AMP were without effect. The inhibitory effect of GTPyS was lost when the 
transporters were partially purified from G-proteins on a sucrose gradient (Schurmann 
et al., 1992a). GTP binds directly to the C terminus of GLUT4 where it might act as a 
gate for GLUT4 (Studelska et al., 1993). The uptake of 2-deoxy-D-glucose in oocytes 
expressing GLUT1 is inhibited by the injection of GTPyS or GppNHp, indicating a 
decrease in the intrinsic activity of GLUT1 in oocytes by these GTP analogues (Wellner 
et al., 1993). The microinjection of GTPyS into oocytes expressing GLUT4 had no 
effect on the transport rate however the transport rate was unaffected by insulin and 
very little GLUT4 was expressed at the plasma membrane (Thomas et al., 1993).
The addition of GTPyS to 3T3-L1 adipocytes enhances MAP kinase and pp90Rk activity 
to a similar level as insulin although the effects are not additive. Both kinases are part 
of the ras activated protein kinase cascade (Klarlund et al., 1993).
GTPyS will regulate the function of the insulin receptor in adipocytes. GTPyS inhibits 
the binding of insulin to isolated receptors and inhibits autophosphorylation without
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competing with ATP (Davis and McDonald, 1990). Insulin was found to selectively 
stimulate the binding of GTPyS to a 40 kDa plasma membrane protein. This in turn 
inhibited both the binding of insulin to the insulin receptor and the insulin stimulation of 
the receptor kinase. This suggests that there may be a link between insulin signalling 
and a 40 kDa G-protein (Kellerer et al., 1991). Two G-protein binding motifs have 
been identified within the insulin receptor. A peptide representing one of these, 
GPBP1147 1168, (notation o f Ebina et al., 1985) from a sequence within the tyrosine kinase 
domain which contains the three tyrosine phosphorylation sites, was found to bind to a 
67 kDa G-protein from human placenta, and stimulate the binding o f GTPyS to the G- 
protein. It is therefore possible that the insulin receptor might specifically associate 
with and activate G-proteins (Jo et al., 1993).
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Figure 1.8 Schem atic representation of the insulin signalling pathways 
from  IRS-1 and the stimulation of G L U T 4  translocation
Insulin receptor autophosphorylation occurs in the presence of insulin. The insulin receptor tyrosine 
kinase then phosphorylates the IRS-1 (insulin receptor substrate-1) at the SH2 and SH3 binding domains. 
GRB2 links IRS-1 to Sos, the guanine nucleotide exchange factor, which activates ras triggering the serine 
cascade including MAPKK (MAP kinase kinase) and MAPK (MAP kinase). The p 110 subunit of PI3-kinase 
is activated by the association o f p85 with IRS-1. Soluble rab is recycled from the cell surface to the 
microsomal pool of transporter vesicles in association with GDI (guanine dissociation inhibitor). See text 
for details (from Cormont et al., 1993 and W hite and Kahn, 1994).
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1.7 Cultured cell lines
1.7.1 3T3-LI fibroblasts and adipocytes
3T3-L1 fibroblasts were cloned from a mouse embryo fibroblast line by Green and 
Kehinde (1974). The cells can be maintained as fibroblasts while in the growing state 
but on reaching confluence they spontaneously differentiated into adipocytes containing 
triglyceride droplets (Green and Meuth, 1974). The differentiation can be accelerated 
using dexamethasone, isobutylmethylxanthine and insulin (Frost and Lane, 1985). 
Associated with differentiation is a change in the pattern of gene expression with 
changes in over 300 proteins and many changes at the level of mRNA (Sadowski et a/., 
1992). These changes include the expression of a new transporter gene, GLUT4 (de 
Herreros et a/., 1989). Thus while 3T3-L1 fibroblasts express only GLUT1 adipocytes 
express both GLUT1 and GLUT4. The 3T3-L1 transporters were sequenced by 
Kaestner et al. (1989).
3T3-L1 fibroblasts bind and respond to insulin but the number and affinity of the 
binding sites and the response to insulin increases during differentiation to adipocytes 
(Rubin et o/., 1978). Insulin stimulates glucose uptake by 15- to 20-fold in adipocytes 
(Frost and Lane, 1985). The increase in transport is associated with transporter 
translocation from the trans-Golgi reticulum to the plasma membrane (Blok et a/., 
1988; Calderhead and Lienhard, 1988). Quantitative immunoblotting detected
950,000 copies of GLUT1 and 280,000 copies of GLUT4 per adipocyte and found 
that insulin causes a 6-fold increase in surface GLUT1 and a 17-fold increase in surface 
GLUT4 so that there equal levels of both transporter isoforms at the surface of insulin 
stimulated adipocytes (Calderhead et a/., 1990). ATB-BMPA labelling of the total 
transporter pool detects equal levels of both GLUT1 and GLUT4 (Yang et a/., 1992b).
The total number of transporters per 3T3-L1 adipocyte can be moderated by a 
number of factors including chronic insulin stimulation. Chronic insulin treatment, 24 h 
with 500 nM insulin, stimulates transport but results in a different pattern of
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transporter expression and translocation compared with acute insulin stimulation. 
Chronic insulin stimulation causes a 3- to 4-fold rise in surface and total levels of 
GLUT1 (Tordjman et al., 1989; Kozka et al., 1991) but halves the level of surface 
GLUT4 (Kozka et al., 1991). The differential effects of insulin on GLUT1 and 4 were 
studied by Sargeant and Paquet (1993). Without insulin stimulation the half-lives of 
GLUT1 and GLUT4 are 19 h and 50 h respectively. Insulin at 100 nM lowers the half- 
life of both isoforms to 15.5 h while the average half-life of all proteins remains at 55 
h. A 24 h insulin treatment resulted in a 3.5- and 2-fold rise in GLUT1 and GLUT4 
synthesis respectively. After 72 h the rate of GLUT1 synthesis was 2.5-fold higher 
while that of GLUT4 was the same as control levels and the level of GLUT1 mRNA 
was 4.5-fold higher while GLUT4 mRNA was 50 % lower. Thus the levels of GLUT1 
and GLUT4 appear to be regulated independently.
Glucose also regulates transport rates in 3T3-L1 adipocytes. Glucose deprivation 
increases 2-deoxy-D-glucose transport 5-fold in a protein synthesis dependent manner 
(van Putten et al., 1985). During 72 h glucose starvation GLUT1 mRNA increased 
2.4-fold the protein increased 7-fold. Starvation caused a 10-fold decrease in the level 
of GLUT4 mRNA but the protein level remained the same. Glucose starvation 
increases the cell surface levels of both GLUT1 and GLUT4 (Tordjman etal., 1990).
1.7.2 COS-7 and C H O  fibroblasts
COS-7 fibroblasts were derived from CV-1, an established cell line derived from 
African green monkey kidney cells. The COS-7 fibroblasts were created by 
transforming the CV-1 cells with origin defective SV40. These cells support the 
replication of DNA with the SV40 origin and can be used for transient protein 
expression (Gluzman, 1981). CHO cells were derived from the ovary of an adult 
Chinese hamster (Puck et al., 1958). They can be used for the study of gene 
expression and can be stably transfected.
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1.8 Aims
The aim of the work described in this thesis was to investigate the mechanism whereby 
insulin stimulates glucose transport. Several aspects of this were investigated including 
transport kinetics and the insulin signalling mechanism.
Insulin induces a 20-fold increase in the transport rate but only a 5-6-fold increase in 
the level of transporters at the surface of 3T3-L1 adipocytes. This is associated with an 
increase in the ratio of GLUT4 to GLUT1 at the cell surface, suggesting that GLUT1 
and GLUT4 make different contributions to the rate of uptake. Experiments were 
therefore devised to determine their separate contributions to the transport rate.
The signalling pathway whereby insulin increases the glucose transport rate in 
adipocytes is, as yet, unclear. It has been suggested, however, that phosphorylation 
events are involved. This idea was tested by treating adipocytes with okadaic acid, 
which inhibits protein phosphatases, thus increasing serine/threonine phosphorylation, 
and tyrosine kinase inhibitors which decrease tyrosine phosphorylation.
GLUT4, the insulin regulatable glucose transporter, adopts a different subcellular 
distribution to that of GLUT1. In order to investigate whether the distribution of 
GLUT4 is intrinsic to the transporter or is conferred on it by the insulin sensitivity of 
the cell in which it is expressed, GLUT4 was transfected into insulin insensitive 
fibroblasts. The regions of GLUT4 involved in its unique distribution were analysed by 
adding peptides corresponding to different regions of GLUT1 and GLUT4 to 
permeabilized 3T3-L1 adipocytes and observing their effects on the transport rate.
Rab proteins, small G-proteins, are believed to regulate transporter translocation. This 
idea was studied by looking for rab4 in 3T3-L1 adipocytes and by observing what 
effect transfected rab3d had on the distribution of GLUT4. GTPyS was also added to 
permeabilized 3T3-L1 adipocytes to investigate the involvement of G-proteins in the 




Standard laboratory reagents were obtained from Fisons Pic. (Loughborough, UK), 
BDH Laboratory Supplies (Poole, Dorset, UK), Sigma Chemical Co. (Poole, Dorset, 
UK) and Aldrich Chemical Co. Ltd. (Gillingham, Dorset, UK). Radiochemicals were 
obtained from Amersham International pic (Aylesbury, UK). Monocomponent porcine 
insulin was donated by Dr. Ronald Chance, Eli Lilly Corporation. The sources of other 
specific chemicals are given as appropriate.
2.2 Cell culture
2.2.1 Media and buffers 
DMEM-NCS/FCS:
Dulbecco’s modification of Eagle's medium (87 % v/v) (Flow Laboratories, Irvine, UK) 
supplemented with: Penicillin (100 IU/ml)/Streptomycin (100 \\g/rc\)
Glutamine (2 mM)
Newborn Calf Serum (-NCS) 10 % (v/v) 
or Foetal Calf Serum(-FCS) 10 % (v/v) (Gibco, BRL, Paisley, UK)
Serum was heat treated at 56 *C for 30 min before freezing in 50 ml aliquots.
Phosphate Buffered Saline (PBS):
Dulbecco ‘A* Phosphate buffered saline, pH 7.3, autodaved (Oxoid, Unipath Ltd, UK).
Trypsin/E DTA:
Trypsin/EDTA (Gibco BRL):
Trypsin 0.05 % (w /v)
EDTA 0.02 % (w /v)
diluted 10-fold in PBS or Modified Puck’s Saline A (Gibco BRL).
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2.2.2 Storage of 3T3-LI fibroblast stocks
3T3-L1 fibroblasts were obtained from the American Type Culture Collection and the 
number of cells expanded. In order to store the fibroblasts, 0.5 x 106 cells in 0.5 ml 
DMEM-NCS were mixed with 50 % glycerol on ice and then slowly cooled above liquid 
nitrogen for 24 h before immersing into liquid nitrogen for storage.
Frozen 3T3-L1 fibroblasts in 50 % glycerol were removed from liquid nitrogen, rapidly 
thawed at 37 *C, added to warm DMEM-NCS and the cells spun down at 1500 rpm 
for 3 min. The medium was poured off and the cells were resuspended in 2 ml of 
DMEM-NCS using a 21 g needle and syringe. The cells were added to 40 ml DMEM- 
NCS in a 175 cm2 flask (Nunc, InterMed, Denmark) and grown in a 10 % C 02, 37 *C 
incubator. Cell numbers were allowed to expand toward confluence before being 
harvested while still subconfluent
2.2.3 Harvesting a flask
While the cells in a flask were still subconfluent they were washed twice with 10 ml of 
37 *C PBS. Cells were loosened by a 1 min incubation with 4 ml of 37 *C 
trypsin/EDTA per 175 cm2 flask. The flask was knocked to detach the cells. 20 ml of 
37 *C DMEM-NCS medium was added to the flask and then transferred, with the cells, 
to a 30 ml universal tube. The cells were pelleted by centrifuging the tubes at 1500 
rpm for 3 min in a bench top centrifuge. The cell pellet was resuspended in 2 ml of 
DMEM-NCS with a 21 g needle and syringe. Cells were counted by mixing 50 pi of 
suspended cells with 50 pi 0.1 % (w /v) trypan blue stain and counting them with a 
haemocytometer. Cells were plated out in 35 mm dishes (Nunc, InterMed, Denmark) 
at a density of 0.05 x 106 cells in 2 ml of DMEM-NCS per dish or equivalent and 
between 0.1 to 0.2 x 106 cells in 40 ml in a 175 cm2 flask. Cells were passaged up to 
ten times before being discarded.
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2.2.4 3T3-LI adipocyte differentiation and culture
3T3-L1 fibroblasts were grown to confluence in a 37 *C, 10 % C 0 2 incubator 
replacing the DMEM-NCS every 3 days. Three days after the cells had reached 
confluence they were differentiated using the method developed by Frost and Lane 
(1985). The DMEM-NCS was replaced with DMEM-FCS containing 0.25 pM 
dexametasome, 0.5 mM 3-isobutyl-1-methylxanthine and 0.2 pM insulin. After 2 days 
this was replaced with DMEM-FCS and 0.2 pM insulin for a further 2 days. Thereafter 
medium was replaced with 2 ml DMEM-FCS alone every 2 days. Cells were fully 
differentiated and used for experiments 9 to 13 after the initiation of differentiation.
2.2.5 COS-7 fibroblast culture
COS-7 fibroblasts, provided by Dr. A. Wolstenholme (University of Bath), were stored 
in liquid nitrogen and defrosted as for 3T3-L1 fibroblasts. COS-7 fibroblasts were 
maintained in a 175 cm2 flask with 40 ml DMEM-FCS in a 37 *C, 5 % C 0 2 incubator. 
Cells harvested using the 3T3-L1 method were seeded at a density of 2 x 106 cells per 
90 mm dish in 10 ml DMEM-FCS and grown at 37 *C in 5 % C 0 2 (Gluzman, 1981).
2.2.6 C H O  fibroblast culture
CHO fibroblasts, provided by Dr M. Hashiramoto (Kobe University, Japan), were 
stored in liquid nitrogen and defrosted as for 3T3-L1 fibroblasts. Cells were seeded in 
a 175 cm2 flask at a density of 0.1 x 106 cells in 40 ml HAMS-F12-FCS (87 % (v/v) 
HAMS-F12, 10 % (v/v) FCS, 100 lU/ml penicillin, 100 mg/ml streptomycin, 2 mM L- 
glutamine) in a 37 *C, 5 % C 02 incubator. Cells harvested as for 3T3-L1 fibroblasts, 
were seeded at a density of 0.05 x 10* cells per 35 mm dish in 2 ml HAMS-F12-FCS 
and grown at 37 *C in 5 % C 02 (Asano et a/., 1989).
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2.3 Preparation of cells for experiments
2.3.1 Preparation of isolated rat adipocytes
Male Wistar rats weighing 180-200 g were fed ad libitum. They were stunned and 
then killed by cervical dislocation. The epididymal pads were removed and washed in
1.0 % (w /v) albumin in rat KRH buffer (140 mM NaCI, 4.7 mM KCI, 2.5 mM CaCI,
1.25 mM MgS04, 2.5 mM NaH2P04, 10 mM HEPES, pH 7.4). Before use bovine 
serum albumin fraction V was dialysed overnight and sequentially filtered under 
pressure using Whatman filters 41 and 42 and Millipore AAWP 0.8 pm pore size. The 
pH was adjusted to pH 7.6 and the albumin, at a concentration of 10 % (w/v), was 
stored at -20 *C. After washing the two fat pads were transferred to a 20 ml tube 
containing 3.5 ml digestion buffer (3.5 % (w /v) albumin in rat KRH, pH 7.6, 
supplemented with 1.0 mg/ml collagenase (Worthington, Freehold, USA.) and 
0,1 mg/ml glucose) and cut into small pieces with 70 vigorous scissors strokes. The fat 
pads were incubated in a 37 *C shaking water bath until the connective tissue was 
digested and the adipocytes freed. The adipocytes were then filtered through nylon 
gauze to remove undigested cellular material. The cells were washed three times with 
1 % albumin in rat KRH, allowing the cells to float to the surface between washes and 
changing the tubes to remove free lipid. The cytocrit was adjusted to 40 % in 1 % 
albumin in rat KRH (Taylor and Holman, 1981).
2.3.2 Reversal of insulin stimulation in rat adipocytes
Rat adipocytes at a cytocrit of 40 % were insulin stimulated with 10 nM insulin. This 
stimulation was reversed by treating the adipocytes with 2.5 mg/ml collagenase at 
37 * C (Kono et o/., 1981).
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2.3.3 Preparation of 3T3-LI adipocytes
Prior to use 3T3-L1 adipocytes were washed twice with 2 ml PBS at 37 *C and 
incubated for 2 h in a 10 % C 02, 37 *C, incubator in serum-free DMEM supplemented 
with 2 mM L-glutamine, 100 lU/ml penicillin and 100 mg/ml streptomycin. They 
were then washed three times with 2 ml Krebs-Ringer-HEPES (KRH) buffer (136 mM 
NaCI, 4.7 mM KCI, 1.25 mM CaCI2, 1.25 mM MgS04, 10 mM HEPES, pH 7.4).
2.3.4 Chronic insulin stimulation of 3T3-LI adipocytes
Where chronically insulin stimulated 3T3-L1 adipocytes were used then 24 h before 
required, 500 nM insulin was added to the normal DMEM-FCS medium. The 500 nM 
insulin was maintained throughout the further incubations (Kozka et o/., 1991).
2.3.5 Reversal of insulin stimulation in 3T3-LI adipocytes
3T3-L1 adipocytes were stimulated with 100 nM insulin. The stimulation was reversed 
by washing the cells twice with KRM (136 mM NaCI, 4.7 mM KCI, 1.25 mM CaCI2,
1.25 mM MgS04, 10 mM MES, 25 mM glucose, pH 6.0) at 37 *C followed by 
incubation with the KRM at 37 *C. Before assaying transport the cells were washed 
with KRH and incubated for 5 min in KRH (Yang et o/., 1992a).
2.3.6 Permeabilizing 3T3-LI adipocytes
3T3-L1 adipocytes were washed three times with intracellular (IC) buffer (140 mM 
potassium glutamate, 5 mM EGTA, 5 mM MgCI2, 5 mM NaCI, 20 mM HEPES, pH 7.2) 
and then incubated with 0.8 lU/ml streptolysin-0 for 5 min at 37 *C. The dishes 
were then again washed three times with IC buffer. The cells were then incubated in
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incubation intracellular (IIC) buffer, (IC buffer with 1 mg/ml BSA, 10 mM ATP and 
3 mM sodium pyruvate, pH 7.2) with appropriate additions (Robinson etal., 1992).
The effectiveness of the streptolysin-0 in permeabilizing the 3T3-L1 adipocytes was 
confirmed by permeabilizing in the presence of 1 Mg/ml propidium iodide. When 
examined by fluorescence microscopy only the permeabilized cells fluoresce. 
Fluorescence was compared in cells incubated with propidium iodide in the presence 
and absence of streptolysin-O. Stock propidium iodide, 50 pg/ml in 0.1 % (w /v) 
trisodium citrate dihydrate, was stored in a lightproof container at 4 *C where it is 
stable for at least 3 months (Ockleford et a/., 1981).
Streptolysin-O was prepared in double distilled water at a concentration of 20 lU/ml, 
quickly frozen and stored at -70 *C. The streptolysin-O was removed and defrosted 
just before it was required.
2.4 Transport assays
2.4.1 Assaying transport in rat adipocytes
Rat adipocytes with a cytocrit of 40 % were incubated as required in 1 % albumin in 
rat KRH at 37 *C. Typically basal, unstimulated, cells were left without any additions 
for 30 min while insulin stimulated cells were treated with 10 nM insulin for 30 min. 
To assay the rate of 3-O-methyl-D-glucose uptake, a 50 pi sample of cells was taken 
and added to 10 pi of label cocktail for an appropriate length of time, ideally allowing 
the fractional filling to be about a half. Typically basal cells were incubated with the 
label for 120 s and insulin stimulated cells for 3 s. The cocktail, in rat KRH, gave a final 
concentration of 50 pM 3-O-methyl-D-glucose with 0.3 pCi 3-0-methyl-D-[U- 
14C]glucose. After the required time uptake was stopped with 3 ml rat KRH containing 
phloretin at a concentration of 0.1 mg/ml dissolved in ethanol. Silicone oil was layered 
on the KRH and the cells were spun at 3,000 rpm for 45 s in a MSE Centra R bench
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top centrifuge which causes the cells to float up through the oil. The cells were 
scooped off the surface, put in a scintillation vial with 9 ml of Optiphase Safe 
scintillation fluid and the 14C c.p.m. in the vial counted. Generally each condition was 
assayed in triplicate. In order to calculate the fractional filling the capacity of the cells 
was measured by incubated them with the labelled sugar for 9 min, sufficient time for 
the labelled sugar in the extracellular medium to equilibrate in the intracellular water 
space, and the 14C c.p.m. counted (oo). To obtain the level of non-specific, background 
binding of the sugar the stopping buffer was added to the cells before adding the sugar 
cocktail and the 14C c.p.m. counted (bg) (Taylor and Holman, 1981).
Uptake is assumed to be first order, v=k[S], where k is the first order rate constant 
(Carruthers, 1990). The uptake rate constant was calculated from the 14C c.p.m. using 
fractional filling (Rees and Holman, 1981):
2.4.2 Assaying transport in 3T3-LI adipocytes
2.4.2.1 Basic assay for 3-O-methyl-D-glucose uptake
To each 35 mm dish of prepared 3T3-L1 adipocytes was added 400 pi of KRH 
containing any additions. The dish was placed in a 37 *C incubator for the appropriate 
length of time. The typical insulin stimulation was 100 nM for 30 min. Basal cells were 
left without additions for the same length of time. The uptake of 3-O-methyl-D-glucose 
was assayed by the addition of 100 pi of sugar cocktail in KRH to give a final 
concentration of 50 pM 3-O-methyl-D-glucose with 0.3 pCi/dish 3-O-methyl-D- 
[U-14C]glucose. After a suitable length of time transport was stopped by the addition of 
3 ml of stopping buffer, KRH containing phloretin at 0.1 mg/ml (dissolved in ethanol). 
The dishes of cells were then washed four times with stopping buffer to remove non­
transported labelled sugar. Insulin stimulated uptake was assayed over 10 s while basal
Rate constant = ^ where f (fractional filling)
time (s)
(14Cc.p.m. - bgc.p.m.) 
(oocp.m. - bgcp.m.)
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uptake was assayed over 90 s. The infinity uptake was calculated after 15 min, 
sufficient time for the labelled sugar in the extracellular medium to equilibrate in the 
intracellular water space, and the 14C c.p.m. counted (oo). The background non-specific 
labelling was determined by adding the sugar cocktail after the 3 ml stopping buffer 
and the 14C c.p.m. counted (bg). The cells were removed from the dishes by dissolving 
them in 1 ml of 0.1 M NaOH. This was added to a scintillation vial with 9 ml 
Optiphase Safe scintillation fluid and the radioactivity counted in a scintillation counter. 
Transport for each condition was generally carried out in triplicate (duplicate 
background). Uptake was assumed to be first order (Carruthers, 1990) and the rate
constant calculated from the HC c.p.m. using the equation (Rees and Holman, 1981):
-ln(1-f) , . % (14Cc.p.m. - bgc.p.m.)
Rate constant = — -— - where f (fractional filling) =  -------------------- -— ------- .
time (s) (oocp.m. - bgcp.m.)
2.4.2.2 Basic assay for 2-deoxy-D-glucose uptake
3T3-L1 adipocytes in 35 mm dishes were prepared and incubated in 950 pi KRH. The 
cells were stimulated as described in section 2.4.2.1. Transport was assayed over 
5 min following the addition of 50 pi label in KRH to give a final concentration of 
50 pM 2-deoxy-D-glucose and 0.3 pCi/dish 2-deoxy-D-[2,6-3H]glucose. After the 
5 min the cells were rapidly washed 4 times with 3 ml KRH. Cells were dissolved and 
the radioactivity counted. The background count was determined by adding the sugar 
cocktail in the presence of 50 pM cytochalasin B (Kozka et al., 1991). The rate of 
uptake was assumed to be linear over 5 min (Olefsky, 1978) and was determined as 
the pmol taken up in 5 min per 35 mm dish.
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2.4.2.3 Assaying transport in permeabilized 3T3-LI adipocytes
Permeabilized 3T3-L1 adipocytes in 35 mm dishes (section 2.3.6) were stimulated in 
380 pi IIC buffer. The typical insulin stimulation was 100 nM for 30 min and basal for 
30 min. Transport was assayed over 5 min by the addition of 20 pi of sugar cocktail 
to give a final concentration of 50 pM 2-deoxy-D-glucose with 0.12 pCi/dish 2-deoxy- 
D-[2,6-3H]glucose and 50 pM sucrose with 0.024 pCi/dish [U-,4]sucrose. Uptake was 
stopped by rapidly aspirating the buffer followed by one rapid wash with 3 ml IC 
buffer. The cells were dissolved in 1 ml 0.1 M NaOH and added to a scintillation vial 
with 9 ml Optiphase Safe scintillation fluid. A dual counting protocol was used to count 
3H dpm in a narrow window (0.0-12.0 keV) and 14C (12.0-156 keV). Specific 2- 
deoxy-D-glucose uptake was calculated using the following equation, with 14C counts 
being used to calculate the non-specific uptake of 3H counts:
3H SA.
Specific 3H 2-deoxy-D-glucose counts = 3H counts x (14C counts - (—------- L)).
C SA.
The specific 3H counts were used to calculate the pmol of uptake in 5 min per 35 mm 
dish. Uptake was assumed to be linear over the 5 min assay (Olefsky, 1978).
2.4.2.4 Alternative transport assay in permeabilized 3T3-LI adipocytes
Permeabilized 3T3-L1 adipocytes in 35 mm dishes (section 2.3.6) were stimulated in 
380 pi IIC buffer as described above. Transport was assayed over 5 min by the 
addition of the sugar cocktail to give a final concentration of 50 pM 2-deoxy-D-glucose 
and 0.12 pCi/dish 2-deoxy-D-[2,6-3H]glucose. After 5 min uptake was stopped with 2 
ml boiling water. The cells were scraped from the plate and the cell suspension added 
to a DE81 Whatman filter under suction. This was washed three times with 2 ml cold 
double distilled water. The filter paper was added to a vial with Optiphase Safe 
scintillation fluid and the radioactivity associated with the phosphorylated 2-deoxy-D- 
[2,6-3H]glucose bound to the membrane counted (adapted from Rist et a/., 1990).
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2.5 ATB-BMPA photolabelling of glucose transporters
2.5.1 Preparation of ATB-[2-3H]BMPA
2-N-[4-(1-azi-2,2,2-trifIuoroethyl)benzoyl]-1,3-bis-([>mannos-4-yloxy)-2-propylamine 
(ATB-BMPA) at a specific activity of « 10 Ci/mmol was prepared in phosphate buffer 
as previously described (Clark and Holman, 1990).
2.5.2 Photolabelling rat adipocytes
Rat adipocytes in KRH were stimulated as required. To 1 ml of 40 % cytocrit room 
temperature cells in a 35 mm dish without a lid was added 250 pCi ATB-[2-3H]BMPA 
in the dark. They were irradiated with 300 nm UV light from RPR-3000 lamps in a 
Rayonet Photochemical reactor RPR-100 for 1 min. Following irradiation the cells 
were washed 3 times with 1 % albumin in rat KRH at room temperature to remove 
unbound label. After the first and second wash the cells were spun up to 1,000 rpm 
and up to 1,500 rpm for the third wash in a MSE Centra bench top centrifuge. Cells 
were solubilized in 1.2 ml of solubilization buffer (5 mM phosphate buffer pH 7.2, 2 % 
(w /v) Thesit (C12E9) (Boehringer, Mannheim), 1 pg/ml antipain, aprotinin, leupeptin, 
pepstatin A) for 20 min after an initial vortex. This was spun at 20,000 g ^  for 20 min 
in a TLA-100 rotor and the supernatant between the fat and cell debris pellet was 
removed with a needle and syringe for immunoprecipitation (Holman et a/., 1990).
2.5.3 Photolabelling 3T3-LI adipocytes
3T3-L1 adipocytes in 35 mm dishes in KRH were stimulated as required. The 
incubation medium was replaced with 230 pi of KRH at room temperature. In the 
dark 100 pCi of ATB-[2-3H]BMPA in 20 pi was added. The dishes without the lids 
were irradiated with 300 nm UV light from a Rayonet Photochemical reactor for
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1 min. Immediately after photolabelling dishes were washed four times with 3 ml of 
phloretin stopping buffer (phloretin, 10 mg/100 ml in KRH). Cells were solubilized 
and scraped off the dish in 1.2 ml of solubilization buffer (5 mM phosphate buffer 
pH 7.2, 2 % (w /v) Thesit (C12E9), 1 |Jg/ml antipain, aprotinin, leupeptin, pepstatin A) 
and spun at 20,000 rpm, 20,000 g ^  in a Beckman TLA-100 rotor for 20 min. The 
supernatant could then be used for immunoprecipitation.
2.6 Processing of cell samples
2.6.1 Subcellular fractionation of 3T3-LI adipocytes and fibroblasts
Unlabelled 3T3-L1 adipocytes or 3T3-L1 adipocytes after ATB-BMPA labelling but 
before solubilization were washed with 0 *C TES (10 mM Tris, 5 mM EDTA, 250 mM 
sucrose, pH 7.2), scraped from the plate in 3 ml TES and homogenised by 15 hand or 
machine strokes in a 50 ml Potter tissue grinder. The homogenate was spun for 
15 min at 12,500 g^ (15,000 rpm in TLA-100 rotor in a Beckman ultracentrifuge) to 
obtain a crude plasma membrane pellet. This supernatant was then spun for 9 min at
16,000 g^ (17,000 rpm) to obtain the high density microsome pellet and the 
supernatant spun for 17 min at 554,400 g^  (100,000 rpm) to obtain the low density 
microsome pellet. The crude plasma membrane pellet was purified by resuspending it 
in TES and spinning it for 20 min at 104,000 g^ (35,000 rpm, TLS-55 rotor) on a 
38 % sucrose cushion (1.12 M sucrose, 10 mM Tris, 5 mM EDTA). The two layers 
and the plasma membrane at the interface was poured off into a separate tube and 
spun for 9 min at 76,000 g^ (37,000 rpm, TLA-100 rotor). The plasma membrane 
pellet was resuspended in TES and spun for 9 min at 37,000 grm (adapted from 
Weiland et a/., 1990). A diagrammatic representation of the subcellular fractionation 
procedure is given in figure 2.1. All the pellets were resuspended in phosphate buffer 
for protein estimation. The protein could be solubilized in 2 % Thesit and used for 
immunoprecipitation or in sample buffer and run on a thin gel for Western blotting.
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Adipocytes washed with TES and scraped from 2 dishes in TES 
Homogenise: 15 strokes in 50 ml homogeniser
15 min TLA-100
12,500 q'  a  max 15,000 rpm
Pellet
Resuspend pellet in 2 ml TES 





Supernatant and interface 

























Plasma Mem brane Pellet Low Density Microsome Pellet
Figure 2 .1 The subcellular fractionation of 3T3-LI adipocytes
Centrifugation times and speeds are optimised for fractionation with a Beckman bench top 
ultracentrifuge. See text for details.
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2.6.2 Chloroform/methanol protein precipitation
To a sample containing protein (in « 1300 pi TES) was added an equal volume 
(1300 pi) of methanol. This was mixed before the addition of 300 pi of chloroform 
and a further mixing. After spinning at 9,000 g for 2 min in a bench top centrifuge the 
upper phase was aspirated off taking care to leave the protein at the interface. A 
further 600 pi of methanol was added and mixed. A second 2 min 9,000 g spin gave a 
protein pellet. The supernatant was aspirated and the pellet dried with N2 gas (Wessel 
and Flugge, 1984). The protein can be solubilized for further use.
2.6.3 Immunoprecipitation of G LUT I and GLUT4
Protein A-sepharose, 5 mg per sample for GLUT4 and 7 mg per sample for GLUT1 
was swollen by rotating it with phosphate buffer (5 mM phosphate buffer, pH 7.2) at 
4 *C. This was washed twice with phosphate buffer. To the protein A-sepharose was 
added 60 pi of anti-GLUT4 antiserum and 100 pi of anti-GLUT1 antiserum per sample. 
The total volume was made up to 1.3 ml with phosphate buffer and rotated at 4 *C 
for a minimum of 2 h to bind the antibody to the protein A. After washing three times 
with phosphate buffer the solubilized adipocyte supernatant in solubilization buffer was 
added to the protein A-sepharose anti-GLUT1 or 4. These were rotated at 4 'C for 
2 h. The protein A-sepharose was washed three times with 1 % washing buffer (1 % 
(w /v) Thesit (C12E9), 5 mM phosphate buffer pH 7.2, 1 pg/ml antipain, aprotinin, 
leupeptin, pepstatin A) and once with 0.1 % washing buffer (0.1 % (w /v) Thesit 
(C12E9), 5 mM phosphate buffer pH 7.2, 1 |Jg/ml antipain, aprotinin, leupeptin, 
pepstatin A). The immunoprecipitated GLUT1 or GLUT4 was released by the addition 
of sample buffer (6 M urea, 10 % (w /v) SDS, 0.05 % (w /v) 5-bromophenol blue, 10 
% 2-mercaptoethanol) to the protein A-sepharose. This could then be loaded onto a 3 
mm thick SDS-PAGE gel (section 2.6.4).
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2.6.4 SDS-polyacrylamide gel electrophoresis
Resolving gel buffer, pH 8.8
Tris 1.5 M
SDS 0.4 % (w/v)
Stacking gel buffer, pH 6.8:
Tris 0.5 M
SDS 0.4 % (w /v)
Acrylamide stock:
Acrylamide 30 % (w /v)
N's N' methylene bis acrylamide 2.5 % (w /v)
Sucrose 30 % (w /v)
Gel (for 3 x 120 mm resolving gel): 10 % Resolving 12 % Resolving Stacking
Gel buffer (resolving/stacking) 25 ml 25 ml 3.75 ml
Acrylamide stock 25 ml 30 ml 2.0 ml
ddH20 17 ml 12 ml 9.75 ml
Ammonium Persulphate (100 mg/ml) 500 pi 500 Ml 100 Ml
TEMED 40 pi 40 Ml 20 Ml
Electrophoresis running buffer, pH 8.3:
Tris 25 mM
SDS 1 % (w /v)
Glycine 192 mM
SDS-Polyacrylamide gel electrophoresis (SDS-PAGE) was used to separate proteins 
(Laemmli, 1970). Protein samples were solubilized in sample buffer (6 M urea, 10 % 
(w /v) SDS, 0.05 % (w /v) 5-bromophenol blue, 10 % (v/v) mercaptoethanol) for 
15 min before spinning out unsolubilized protein and sepharose beads from an 
immunoprecipitation. This was then loaded into wells in the stacking gel of a 10 % 
acrylamide SDS-polyacrylamide gel. The molecular weight markers, also in sample 
buffer, were carbonic anhydrase, 26 kDa, ovalbumin, 45 kDa, bovine plasma albumin, 
66 kDa, phosphorylase B, 97.4 kDa, p-galactosidase, 116 kDa and myosin 205 kDa. 
Prestained markers (carbonic anhydrase and p-galactosidase) were frequently added to 
the samples. Thick gels (3 mm) were run at a constant current of 25 mA per gel 
overnight or 50 mA during the day. Thin gels (1.5 mm) required half the current.
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2.6.5 Counting ATB-[2-3H]BMPA labelled transporters
Once the proteins had been separated by SDS-PAGE the gel was shaken for 2 h in 
destain (30 % (v/v) acetic acid, 10 % (v/v) methanol, 60 % (v/v) dH20 )  containing a 
small amount of Coomassie blue (« 0.005 % w/v). The gel was cut into lanes and the 
lanes cut into 6.5 mm slices. The slices were placed in vials and dried in an 80 *C 
oven. The dry slices were dissolved in 0.5 ml of 2 % (v/v) NH4OH in 30 % (w /w ) 
H20 2 in the oven. When dissolved 9 ml of Optiphase Safe scintillation fluid was added 
and the radioactivity counted (Clark and Holman, 1990).
2.6.6 Western blotting and l2sl immunoblotting
Proteins separated on a thin, 1.5 mm, gel by SDS-PAGE were transferred to the 
nitrocellulose membrane using the semi-dry method with a Pharmacia LKB Multiphor II 
blotter. The filter paper, nitrocellulose, gel and dialysis membrane were soaked in 
continuous transfer buffer (48 mM Tris, 39 mM glycine, 20 % (v/v) methanol, 
0.0375 % (w /v) SDS, pH 8.8). A current of 0.8 mA/cm2 of the transunit was applied 
for 1-1.5 h. The transferred proteins on the nitrocellulose were stained with 0.1 % 
(w /v) Ponceau S stain in 3 % (w /v) trichloroacetic acid in ddH20 .
All detection, washing and incubation steps were carried out by shaking at room 
temperature. The membrane was blocked for 2 h with 3 % (w /v) BSA in TBS-T 
(10 mM Tris, 0.9 % (w /v) NaCI, pH 7.4, 0.1 % (v/v) Tween 20). The primary 
antibody, diluted 1:100-500 in 3 % (w /v) BSA in TBS-T, was shaken with the 
membrane for 2 h. The membrane was then subjected to six 5 min washes with 
TBS-T. It was then incubated with affinity purified 125l-labelled Protein A at 0.1 pCi/ml 
in TBS-T. The membrane was again washed six times with TBS-T for 5 min, air dried, 
wrapped in cling film and exposed to x-ray film at -70 X .  The protein bands could be 
cut out and counted on a gamma counter or the film analysed by densitometry.
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2.7 Transfection of fibroblasts with GLUT4
2.7.1 Maxi-prep of pRC-CMV-hGLUT4
To a bijou containing 10 ng of the plasmid DNA was added 100 pi of competent 
£. coli. They were left on ice for 10 min and then heat shocked for 1 min in a 42 * C 
water bath. 1 ml of LB medium (1 % tryptone, 0.5 % yeast extract, 0.5 % NaCI) was 
added and the cell incubated at 37 ’ C for 1 h. Aliquots of cells were then plated out 
onto LB plates (LB medium containing 1.5 % agar) containing 5 \.Jg/ml ampicillin and 
incubated overnight at 37 *C. One colony (transformed cells) was taken and added to 
2 I of LB medium containing 5 |Jg/ml ampicillin and left shaking overnight at 37 *C.
The £. coli were collected in a Sorvall GSA rotor at 6,000 rpm (6,000 x g) for 10 min 
at 4 *C. The pellet was resuspended in 1 volume of GTE (50 mM glucose, 25 mM Tris 
pH 8.0, 10 mM EDTA) with a pipette and left on ice for 20 min for cell lysis to occur. 
This was transferred to a 50 ml Sorvall tube with two volumes of NaOH/SDS (0.2 M 
NaOH, 1 % (w /v) SDS) and incubated on ice for 10 min. A 1.25 volume of 3 M 
sodium acetate, pH 4.6 was added and left on ice for a further 20 min. The solution 
was centrifuged in a SS-34 rotor at 15,000 rpm (27,000 x g) for 15 min at 4 *C.
The supernatant was transferred to a fresh tube and extraction carried out twice with 
an equal volume of phenol (pH 8.0)/chloroform/IAA (24:1) and then once with 
chloroform/IAA. Two volumes of ice cold ethanol were then added, followed by 
incubation at 4 *C for at least 30 min. This was then centrifuged at 15,000 rpm for 
15 min and the pellet washed with 70 % ethanol. After the pellet had been air dried it 
was resuspended in 9 ml of TE buffer (10 mM Tris, 1 mM EDTA, pH 8.0). To this was 
added 9 g caesium chloride and 0.6 ml of 10 mg/ml ethidium bromide. This was then 
placed in a Quickseal tube and spun for 40 h (> 24 h) in a Ti70 rotor at 56,000 rpm at 
20 *C in a Beckman ultracentrifuge. An alternative method was to add to the 
supernatant 10.17 g CsCI per 10 ml of supernatant and 125 pi of 10 mg/ml ethidium 
bromide before phenol/chloroform/IAA extraction. This could then be centrifuged.
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The lower, plasmid, band was removed with a 21 g needle. The syringe was then filled 
with a CsCI saturated 1-butanol solution and shaken. This was repeated four times to 
remove all signs of pink from the DNA. The DNA solution was then dialysed in TE 
buffer for 24 h to remove the CsCI. The DNA was then precipitated out by adding to 
the solution a 1 /10  volume of 3 M sodium acetate and 2 volumes of room 
temperature ethanol. After 10 min to allow precipitation, the DNA was spun down in 
a SS-34 rotor at 10,000 rpm (12,000 x g) for 15 min. The dried pellet was 
resuspended in 1 ml sterile ddH20 in a sterile lidded tube.
2.7.2 Determination of D N A  purity
To 1 ml TE buffer was added 10 pi of the DNA solution in a matched quartz cell, TE 
being in the other cell. This was scanned from 320 to 240 nm in a scanning 
spectrophotometer. The absorbance ratio at 260/280 nm indicates the purity of the 
DNA from protein, a value of 2 is pure DNA. One A ^  unit = 50 pg/ml of ds DNA.
2.7.3 Restriction digest mapping of pRC-CMV-hGLUT4
To 0.2 pg DNA was added 2 pi 10 x One Phor All buffer and 17 pi H20 , 0.5 pi 
Hindlll and 0.5 pi Xbal This was left to digest for 1 h at 37 *C.
1 g agarose was dissolved in 100 ml TBE buffer (89.0 mM Tris, 89.0 mM boric acid, 
2.0 mM EDTA (4 ml per I of 0.5 M EDTA, pH 8.0)), 0.5 mg ethidium bromide was 
added and the gel cast. The gel was put in TBE running buffer. The restriction digest 
was loaded onto the gel with 2 pi 10 x loading dye (30 % (w /v) glycerol, 0.25 % 
(w /v) bromophenol blue, 0.25 % (w /v) xylene cyanole FF). Uncut plasmid and the 
lambda Pst size marker were also loaded. A voltage of 100 - 150 V was applied across 






Figure 2.2. Map of the plasmid pR C -C M V -hG LU T4
The total length of the plasmid before the addition o f the hGLUT4 cDNA is 5452 bp. The CMV  
promoter spans bases 209-864. T7 begins at base 865, the pol/linker spans bases 891-995 and the Sp6 
promoter begins at 1019. The BGH poly A  signals spans bases 1020-1251, the M13 origin spans 1260- 
1793, the SV40 promoter spans 1800-2125, the neomycin gene spans 2131-2925 and the SV40 3' and 
poly A span bases 2928-3138. The pUC 19 backbone, origin and beta lactamase gene begin at base 
3236. The hGLUT4 cD NA was spliced into the plasmid at the Hindlll and Xbal sites within the 
polylinker. In the hGLUT4 cD NA the Hindlll site is 29-33 bases upstream of the start codon and the 
Xbal 351 bases beyond the end.
2.7.4 Transfection of 3T 3 -L I fibroblasts w ith pR C -C M V-hG LU T4
The 3T3-L1 fibroblasts were transfected by the calcium phosphate precipitation 
method (Kingston, 1992). A 85 cm2 flask o f confluent 3T3-L1 fibroblasts was split 
1:15 into 90 mm dishes (section 2.2.3) 24 h before transfecting. The medium was 
replaced with 9 ml DMEM-FCS 2-4 h before transfection. Between 10-50 mg of the 
plasmid DNA was sterilised by ethanol precipitated in 1 ml of cold 95 % ethanol and 
1 /2 0  volume o f 3 M sodium acetate, pH 5.2. The DNA precipitate was spun down by
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a high speed spin in a MSE microcentrifuge. When dry it was resuspended in 450 pi 
sterile ddH20 . To this was added 50 pi of filter sterilised 2.5 M calcium chloride 
solution. This was slowly added dropwise to 500 pi of 2x HEPES buffered saline, HBS 
(280 mM NaCI, 50 mM HEPES, 1.7 mM Na2HP04, pH 7.05-7.12) while bubbling air 
through the 2 x HBS with a mechanical pipettor. This was vortexed and allowed to 
stand for 20 min for the precipitate to form. It was then added to the 3T3-L1 
fibroblast medium and mixed. The dishes were incubated for up to 16 h in a 37 *C, 
5 % C 0 2 incubator. The cells were then washed twice with warm PBS, fresh DMEM- 
FCS was added and the cells were grown for 3-5 days as normal in a 10 % C 02 
incubator before being used as required.
2.7.5 Transfection of COS-7 fibroblasts with pRC-CMV-hGLUT4
90 mm dishes were seeded with COS-7 fibroblasts at a cell density of 2 x 106 cells per 
dish. The cells were allowed to grow for 24 h in DMEM-FCS at 37 X  in a 5 % C 02 
incubator. The dishes were then washed twice with 10 ml PBS and once with 10 ml 
TBS-D (25 mM Tris, 138 mM NaCI, 2.6 mM KCI, 0.1 % (w /v) glucose, pH 7.4). The 
cells were incubated with 1.5 ml TBS-D containing 7.5 pg plasmid DNA and 1.5 mg 
DEAE-Dextran per dish. After 1 h the cells were washed once with TBS-D and once 
with PBS. They were incubated with 10 % DMSO in PBS for 1 min, washed once with 
PBS and then grown for 72 h in DMEM-FCS at 37 X  in a 5 % C 02 incubator. COS-7 
fibroblasts were also transfected in 35 mm dishes with the incubation volumes scaled 
down (adapted from Schurmann et a/., 1992b).
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2.8 Purification of the GLUT4 C-terminal peptide
The previously synthesised C-terminal GLUT4 peptide was stored at -20 *C on the 
resin on which it was synthesised. To 300 mg of GLUT4 resin was added a solution of 
90 % (v/v) trifluoroacetic acid, 5 % (v/v) thioanisole, 3 % (v/v) ethanedithiol and 2 % 
(v/v) anisole. This was left for 2-2.5 h to cleave the peptide from the resin. This was 
then washed three times with petroleum ether, the supernatant being discarded. It 
was then washed a further three times with diethyl ether, discarding the supernatant. 
The remaining residue was the crude peptide. The peptide was then reduced with 
20 mg dithioerythritol in 15 ml 5 % acetonitrile, pH 8.3, overnight. The peptide was 
purified by HPLC on an acetonitrile gradient, collecting the appropriate GLUT4 
C-terminal peptide peak. The collected peak was freeze dried and stored at -20 *C.
2.9 Antibody production
The free cysteine groups of the GLUT4 C-terminal and rab4 peptides were tested for 
by the Ellman’s test. A sample of the peptide dissolved in phosphate buffer was diluted 
in 0.1 M phosphate buffer (0.1 M NajHPO^ pH 8.0). To this was added Ellman's 
reagent, 5,5'-dithio-bis(2-nitrobenzoic acid), or 2-nitro-5-thiocyanobenzoic acid at a 
final concentration of 0.36 mg/ml. The number of free cysteines was determined by 
comparing the absorbance at 412 nm against a standard cysteine curve.
8 mg Keyhole Limpet haemocyanin (KLH) was dissolved in 0.5 ml 10 mM phosphate 
buffer, pH 7.2. 1.4 mg 3-maleimidobenzoic acid N-hydroxysuccinimide ester (MBS) 
dissolved in dry DMF was slowly added, stirred for 30 min and passed down a 
Sephadex G-25 column equilibrated with 50 mM phosphate buffer, pH 6.0. Fractions 
were collected, measured at 280 nm and turbid fractions pooled. 9.5 mg of peptide in 
2 ml 10 mM phosphate buffer, pH 7.2, was added to the KLH-MBS and stirred for 3 h, 
to couple the peptide to the KLH-MBS. This was stored at -20 *C (Liu et a/., 1979).
Peptide Amino acids No. of residues Sequence Source
GLUT1 C-terminal 
peptide
480-492 14 C E E L F H P L G A D S Q V
Cys Glu Glu Leu Phe His Pro Leu Gly Ala Asp Ser Gin Val
A. E. Clark
GLUT2 loop peptide 47-60 15 C G V P  L D D R R A T  I N Y D




497-509 15 C G S T F .  L E Y L G P D E N D





2-17 16 P S G F Q Q I  G S E D G E P P Q
Pro Ser Gly Phe Gin Gin lie Gly Ser Glu Asp Gly Glu Pro Pro Gin
A. E. Clark
Rab3a peptide 52-67 16 V S T V G  I D F K V K T  I Y R N
Val Ser Thr Val Gly lie Asp Phe Lys Val Lys Thr lie Tyr Arg Asn
J. F. Clarke
Rab4 peptide 122-132 14 K K D L D A D R E V T G G C
Lys Lys Asp Leu Asp Ala Asp Arg Glu Val Thr Gly Gly Cys
A. E. Clark
Table 2.1 The sequence and source of peptides used for antibody production and transport assays
Methods 75
In order to inoculate sandy half-lop-eared rabbits » 250 |Jg peptide-KLH conjugate was 
diluted to 500 |j| in PBS and diluted with an equal volume of either complete Freund’s 
(by rapid mixing just before injection) or Imject Alum (Pierce, Rockford, USA) (added 
dropwise into the PBS and stirred for 30 min before injection). This was injected into 
four subcutaneous sites. This was repeated one month later with either incomplete 
Freund’s or Imject Alum. Thereafter the rabbits were boosted with the conjugate in 
Imject Alum every month and a 35 ml bleed was taken. The blood was allowed to clot 
and the serum was removed and stored at -70 *C until required when it was 
defrosted, divided into small aliquots and frozen a t-20 *C until required.
2.10 ELISA determination of antibody levels in serum
To multiwell microplate ELISA wells were added 100 pi 50 mM NaHC03, pH 9.6, 
containing 20 ng/well GLUT4 or rab4 peptide or 1 pg/well of protein depleted 
erythrocyte membrane for GLUT1. This was left at 4 *C for 16 h to coat the plates. 
The wells were emptied and blocked with three 10 min washes of blocking buffer (PBS 
with 1 % casein and 0.05 % Tween 20). The antiserum was then serially diluted in 
duplicate from 1/2 0 0  to 1/25 ,600  in blocking buffer. This was added to the wells for 
2 h at 37 *C. The wells were then washed with three 10 min blocking buffer washes. 
The second antibody, goat anti rabbit IgG peroxidase, was diluted 1:5000 in blocking 
buffer and added to the wells for 2 h at 37 *C. This was then washed with four 5 min 
washes of washing buffer (PBS with 0.05 % Tween 20). To each well was then added 
100 pi of substrate (10 ml 0.1 M sodium acetate, 0.1 ml tetramethylbenzidine diluted 
10 mg/ml in DMSO and 1.5 pi H20 2 (30 % v/v)). After 30 min at room temperature 
100 pi of 2 M H2S04 was added to each well and the colour read at 450 nm, filters 3 
and 8 on the Titertek plate reader. The new serum absorbance was compared against 
that of a previously measured serum (from Kenna et al., 1985).
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2 .11 Protein assays
2 .11. 1 BioRad protein assay
The BioRad protein assay is a Coomassie Brilliant Blue G-250 binding assay originally 
developed by Bradford (1976). The protein sample was diluted in phosphate buffer to 
a suitable concentration to fit on the standard curve. The protein standard, bovine 
serum albumin, was diluted in phosphate buffer to give a concentration range between 
0 and 3.0 pg in a final volume of 155 pi in a microplate well. To both sample and 
standard was added 5 pi of 0.1 M NaOH and 40 pi BioRad reagent. After mixing the 
absorbance at 595 nm was read on a Titertek microplate reader using filters 6 and 7.
2 .11.2 Micro BCA protein assay
The BCA protein assay reagent, bicichoninic acid (BCA), chelates Cu+ forming a colour 
complex in the presence of protein. To a microplate well was added 5 pi of sample 
diluted in phosphate buffer. To each well was added a range of 0 to 10 pg/well of the 
standard protein, BSA, in 0.1 M NaOH. All volumes were made up to 10 pi with 0.1 
M NaOH. To each well was added 200 pi of BCA reagent (sodium carbonate, sodium 
bicarbonate, and sodium tartrate in 0.2 M NaOH (MA), 4 % BCA in water (MB), 4 % 
cupric sulphate pentahydrate in water (MC) MA:MB:MC 50:48:2 (Pierce, Rockford, 
USA)). After a 30 min incubation at 37 *C the absorbance was read at 562 nm on a 
Titertek plate reader using filters 6 and 3.
2 .12 Statistical analysis
During the statistical analysis of experimental data each individual sample of a replicate 
was treated as an individual experiment. Where necessary statistical significance was 
determined using the t-test.
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3.0 Results
3.1 Kinetic analysis of G L U T  I and G L U T 4  in 3T3-L I adipocytes
When 3T3-L1 adipocytes are acutely stimulated with 100 nM insulin both the rate of 
glucose uptake and the concentration of glucose transporters in the plasma membrane 
increase. This was demonstrated by assaying the uptake of 3-O-methyl-D-glucose and 
by purifying plasma membrane with ATB-BMPA photolabelled glucose transporters. 
Figure 3.1 shows that 100 nM insulin stimulated transport by 19-fold while the 
concentration o f transporters in the plasma membrane only increased by 5.6-fold.
Figure 3.1. Effect of acute insulin 
stimulation on A TB -B M P A  
photolabelling and transport
3T3-L1 adipocytes in 35 mm dishes were 
incubated at 37 *C in KRH for 30 min in the 
absence (Q )  or presence of 100 nM insulin ( ■ ) .  
The 3-O-methyl-D-glucose transport was assayed 
as described in section 2.4.2.1. The transport 
values are the average of seven experiments.
The increase in the concentration of cell surface 
transporters was assayed by photolabelling two 
dishes per condition with ATB-[2-3H]BMPA at 
50 pCi/dish. After washing the dishes 6 times 
with 3 ml KRH containing phloretin at 10 mg/ml 
the cells were scraped from the dishes and 
homogenised in 1 ml TES with 10 strokes of a 
tight fitting homogeniser. The homogenate was 
spun at 16,000 g ^ , 17,000 rpm for 20 min. The pellet was washed twice with TES, resuspended in 0.5 
ml TES and applied to a discontinuous Ficoll gradient (0 .15 g /m l TES). This was spun at 34 ,000 g ^ ,  
20 ,000  rpm for 70  min. The plasma membrane at the interface was collected with a needle and syringe, 
diluted with TES and spun down at 34,000 rpm for 20  min. The pellet was dissolved in sample buffer, 
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The effect o f insulin on the translocation o f GLUT1 and GLUT4 in 3T3-L1 adipocytes is 
shown in figure 3.2. Basal and insulin stimulated cells were photolabelled with ATB- 
BMPA and solubilized. GLUT1 and GLUT4 were sequentially immunoprecipitated with 
protein A-sepharose linked specific anti-C-terminal peptide antiserum. This has the 
advantage over the purified plasma membrane of reducing non-specific labelling on the 
gel and enables the separate changes in GLUT1 and GLUT4 to be resolved.
G L U T 4  G L U T 1
Figure 3.2. Comparison of the relative levels of G L U T  I and G LU T4 at 
the surface of basal and insulin stim ulated 3 T 3 -L I adipocytes
3TB-L1 adipocytes in 35 mm dishes were incubated at 37 ‘ C for 20  min in KRH in the absence ( □ )  or 
presence of 100 nM insulin ( ■ ) .  Adipocytes were photolabelled with 150 pCi ATB-[2-3H]BMPA per dish 
and transporters immunoprecipitated as in sections 2.5-6. A  representative experiment is shown.
Figure 3.2 shows that the insulin stimulated 20-fold increase in transport is associated 
with a 13-fold increase in GLUT4 and a 4.3-fold increase in GLUT1 at the plasma 
membrane. This suggests that the two transporter isoforms make an unequal
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contribution towards the transport rate. The activity of the two isoforms have been 
investigated separately in, for example, Xenopus oocytes where the two transporters 
do indeed possess different kinetic properties. The presence of two isoforms within 
the same cell means that the kinetics may not be linear, making it difficult to determine 
their separate contributions. This problem was overcome by examining the kinetics 
under conditions with different proportions of GLUT1 and GLUT4 at the cell surface. 
Figure 3.2 shows that the proportion of cell surface GLUT4 to GLUT1 is different in 
basal and insulin stimulated 3T3-L1 adipocytes. A similar proportion of both 
transporters are at the surface of insulin stimulated cells. In basal cells there is nearly
3-fold more GLUT1 than GLUT4 but the low level of transporters at the surface of 
basal adipocytes increases the possibility of errors. Therefore chronically insulin 
stimulated 3T3-L1 adipocytes were used. Chronic insulin treatment, 500 nM insulin 
for 24 h, halves the level of cell surface GLUT4 while increasing the level of GLUT1 by 
about 3.5-fold relative to acute insulin stimulation. The GLUT4 B^, determined from 
ATB-BMPA binding, was 0.17±0.03 pM in acutely insulin stimulated adipocytes and 
0.099±0.017 pM following chronic stimulation. The GLUT1 B ^ was 0.19±0.03 pM 
for acute and 0.7±0.07 |jM for chronic insulin stimulation (Palfreyman et al.f 1992).
The Km and for transport in acute and chronically insulin stimulated 3T3-L1 
adipocytes were calculated from the results shown in figure 3.3. Uptake of 3-0- 
methyl-D-[U-12C]glucose was determined over the range of 0 to 40 mM 3-O-methyl-D- 
glucose. The adipocytes were equilibrated with the appropriate concentration of 
unlabelled 3-O-methyl-D-glucose before the addition of the labelled sugar to ensure that 
transport was measured under conditions of equilibrium exchange. The data in figure
3.3 were plotted as concentration against rate (s) over cell volume (v) (s/v). The cell 
volume was calculated by dividing the uptake of 3-O-methyl-D-glucose at infinity per 
dish by the specific activity per pi. A cell volume of 2.81 ±0.43 pl-dish'1 (SEM) was 
calculated from six experiments. A line fitted to the points of the reciprocal plot of 
figure 3.3 appeared to be curvilinear, indicating a different contribution by GLUT1 and
Results 80
GLUT4 across the concentration range. Fitting the data to the Michaelis-Menten 
equation gave a Km o f 12.3+1.3 mM and a Vmax of 0.52+0.04 mM-s'1 for 3-O-methyl-D- 
glucose in acute insulin treated 3T3-L1 adipocytes. In chronically insulin treated cells 
the Km for 3-O-methyl-D-glucose was 23.0+9.1 mM and the Vmax was 1.24+0.40 mM-s1 
(SEM). Km and Vmax were calculated by least-squares regression, as described by 
Cleland (1979), using the equation 1/v = Km/(1 +  [S] - Vmax). The same experiment was
carried out in basal 3T3-L1 adipocytes, figure 3.4, where the Km for 3-O-methyl-D- 
glucose was 11.5+1.7 mM and the Vmax was 0.028+0.003 mM-s'1 (SEM).
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Figure 3.3. Equilibrium exchange 
uptake of 3-O-methyl-D-glucose in 
stimulated 3 T 3 -L I adipocytes
3T3-L1 adipocytes in 35 mm dishes were treated 
acutely with 100 nM insulin for 30 min ( # )  or 
chronically with 500 nM insulin for 24 h (Y). 
Following the equilibration o f 3-O-methyl-D- 
glucose, uptake was assayed as described in 
section 2 .4 .2 .1 . Values are the average o f four 
triplicate experiments (n=12). The rate in s was 
converted to s /v  (pf.dish.s) by dividing by the 
equilibrium intracellular volume of 2.81 pl/dish. 
Errors are S.E.M. The lines were calculated using 
the combined data in line 5 o f table 3.1
Figure 3.4. Equilibrium exchange 
uptake of 3-O-methyl-D-glucose in 
basal 3T3-L I adipocytes
The uptake of 3-O-methyl-D-glucose was 
determined in basal 3T3-L1 adipocytes in 35 mm 
dishes ( ■ )  after 30 min equilibration.
Following the equilibration of 3-O-methyl-D- 
glucose, uptake was assayed as described in 
section 2.4.2.1. Values are the average of two 
triplicate experiments (n=6). The rate in s was 
converted to s /v  (pl'1.dish.s) by dividing by the 
equilibrium intracellular volume of 2.81 pl/dish. 
Errors are S.E.M. The line was calculated using the 
data in line 6 of table 3.1
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In order to determine the separate affinities of GLUT1 and GLUT4 toward 3-O- 
methyl-D-glucose, acute and chronically insulin treated 3T3-L1 adipocytes were 
photolabelled in the presence o f a range of 3-O-methyl-D-glucose concentrations. The 
photolabelled GLUT1 and GLUT4 were separately immunoprecipitated and subjected 
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Figure 3.5. An example of A T B -[2 -3H ]B M P A  displacement from  G LU T4  
by 3-O-methyl-D-glucose in acutely insulin stim ulated 3T 3 -L I adipocytes
BT3-L1 adipocytes in 35 mm dishes were acutely stimulated with 100 nM insulin for 30 min and then 
photolabelled with 100 pCi ATB-BMPA in the presence of 0 mM ( # ) ,  2 mM ( ■ ) ,  10 mM (A) or 40 mM 
(T) 3-O-methyl-D-glucose. Photolabelling, immunoprecipitation and SDS-PAGE are described in sections 
2.5 and 2.6. The gel profiles for 5 mM and 20 mM are omitted for clarity.
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The radioactivity associated each transporter peak was converted to the ratio A 0/A  
by dividing the ATB-BMPA peak area in the absence of 3-O-methyl-D-glucose (A0) by 
the peak area in the presence o f 3-O-methyl-D-glucose (A). This ratio was plotted 
against the 3-O-methyl-D-glucose concentration used to displace the photolabel in figure 
3.6. Since Km, K, and Ks were all assumed to be the same (Deves and Krupka, 1984) 
the data in figure 3.6 were used to calculate Km values for 3-O-methyl-D-glucose 
displacement of ATB-BMPA using the equation A 0/A  = 1 + S/Km and non-linear
regression analysis with relative error weighting. In the acutely insulin treated cells the 
Km was 7.2±2.0 mM for GLUT4 and 23.4±7.6 mM for GLUT1. In the chronically 












0 10 20 30 40
[3-0-m ethyl-D-glucose](m M ) [3-0-m ethyl-D-glucose](m M )
Figure 3.6. D eterm ination of Km for 3-O-methyl-D-glucose displacement 
of A T B -B M P A  from  G LU T4 and G L U T  I in acute and chronically insulin 
stim ulated 3T 3 -L I adipocytes
3T3-L1 adipocytes in 35 mm dishes were either acutely treated with 100 nM insulin for 30 min (a) or 
chronically treated with 500 nM insulin for 24  h (b). The dishes were photolabelled with 100 pCi of 
ATB-BMPA in the presence of the concentration of 3-O-methyl-D-glucose indicated. G LUT4 ( ♦ )  and 
GLUT1 ( O )  were then immunoprecipitated, subjected to SDS-PAGE, and counted as described in 
sections 2.5 and 2.6. The radioactivity peak in the presence of 3-O-methyl-D-glucose (A ) is shown 
relative to the value in the absence of 3-O-methyl-D-glucose (A 0). Results are the means o f three 
experiments for (a) and two for (b). Errors are the SD(n.ir
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The TK value, the turnover number/Km, of GLUT1 and GLUT4 can be calculated from
the transport and photolabelling data using the following equation where the
transporter concentration is the Bmax value given in table 3.1:
TK1S- [GLUT11 TK4 • S • [GLUT41
(1 + S/Km1) + (1 + S/Km4)
Since A0/A  = 1 + S/Km, the fraction of unoccupied sites can be calculated with the 
ATB-BMPA displacement data or the Km values from figure 3.3. The TK values were 
calculated using least square regression o f the following equation:
v/S = TK1 • x1 + TK4 • x4
where x1 and x4, the concentration of unoccupied sites, are equal to the B ^  
multiplied by either A /A 0 or 1/(1 + S/Km) ,  the reciprocal fraction o f unoccupied sites.
The calculated TK values and the constants used to calculated them are given in table 
3.1. The table also gives a calculated TK for GLUT1 and GLUT4 in basal 3T3-L1 
adipocytes. This uses the combined acute and chronic Km values. The basal Bmax was 
determined using a tracer concentration of ATB-BMPA.
Stimulation data Method
used
B™, B™, Km1 K m TK1 x 1 0 5 
(m M ’-min'1)
TK4 x 10’3 
(mM’-min'1)
Acute insulin O
<<r 0.19 pM 0.17 pM - - 4.90±2.03 7.92±2.86
Chronic insulin




























19.9 mM 7.0 mM 3.58±0.24 11.34+1.06
Basal VO+S/KJ 0.055 pM 0.015 pM 19.9 mM 7.0 mM 1.20±0.36 5.73±2.02
Table 3.1. Calculation of G L U T  I and G L U T 4  T K  values for 3-O-m ethyl- 
D-glucose in 3T 3 -L I adipocytes Errors are the S.E.M.
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3.2 Okadaic acid tre a tm e n t and insulin stimulation of adipocytes
The effect o f okadaic acid on the uptake of 2-deoxy-D-glucose in rat adipocytes was 
investigated by Haystead et al. (1989) and by Lawrence et al. (1990b) who found that 
the 1 pM okadaic acid stimulated transport rate was half that following insulin 
treatment. To determine the effect of okadaic acid on the uptake of 3-O-methyl-D- 
glucose, firstly rat adipocytes were treated with okadaic acid for different lengths of 
time to find the optimum time for okadaic acid stimulation, figure 3.7. Rat adipocytes 
with a 40 % cytocrit were stimulated with 10 nM insulin for 30 min or with 1 pM 
okadaic acid for 5, 10, 15 or 30 min. Uptake was measured over 3 s for both okadaic 
acid and insulin treatment. While insulin treatment stimulated transport by 19.1-fold, a 
15 min incubation with okadaic acid increased the basal transport rate 7.7-fold, about 
40 % o f the insulin response.
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Figure 3.7. D eterm ining the optim um  tim e for the stim ulation o f rat 
adipocyte uptake of 3-O-methyl-D-glucose with 1.0 pM okadaic acid
Rat adipocytes were treated with 1.0 pM okadaic acid for the specified length of time before removing a 
sample to assay the rate of 3-O-methyl-D-glucose uptake. The methods used for preparing rat adipocytes 
and assaying 3-O-methyl-D-glucose uptake are described in sections 2.3.1 and 2.4.1 respectively. Values 
are the means of a single triplicate experiment. Errors are the S.E.M. The transport rate at 0  min is 
equivalent to basal transport. Acute insulin (10 nM) stimulation was 19-fold.
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Figure 3.7 shows that the maximum transport rate in the presence o f 1 pM okadaic 
acid was achieved after about 10 min and longer incubation times gave about the same 
rate. An incubation time of 20 min was used to find the optimum concentration for 
okadaic acid stimulation. Three experiments in triplicate were used to generate the 
concentration curve over the range of 0.05 to 5 pM shown in figure 3.8. The 
optimum okadaic acid concentration was found to be between 0.2 and 1.0 pM. The 
okadaic acid stimulated transport rate at this concentration was only about 40 % of the 
insulin stimulated rate. Thus a maximum increase in 3-O-methyl-D-glucose uptake with 
» 0.5 pM okadaic acid for 20 min was in agreement with the 1 pM okadaic acid for 
20 min used by Lawrence et al. (1990b) for stimulating 2-deoxy-D-glucose transport.
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Figure 3.8. Determ ining the optim um  concentration of okadaic acid for 
the stimulation of ra t adipocyte uptake of 3-O-methyl-D-glucose
Rat adipocytes were stimulated with the specified okadaic acid concentration for 20 min before assaying 
3-O-methyl-D-glucose uptake. The methods for preparing rat adipocytes and assaying 3-O-methyl-D- 
glucose transport are described in sections 2.3.1 and 2.4.1 respectively. Values are the means of one 
(0 .05 and 0.1 pM), two (2 .0  and 5.0 pM) or three (0.2, 0.5 and 1.0 pM) experiments carried out in 
triplicate. Errors are the S.E.M.



















T----------------  1" " ..........











5  5 0 -I
2 5 -
ii f i Cr
Basal
l-------------------------T-------------------------r
Insulin O kad a ic  acid O A  +
Condition
Figure 3.9. The effect of 5.0 |jM (a) and 1.0 pM (b) okadaic acid on basal 
and insulin stimulated transport and transporter distribution in rat 
adipocytes
Rat adipocytes were incubated for 20 min with no additions (basal), with 10 nM insulin, with okadaic acid 
or with 10 nM insulin and okadaic acid (O A +I) before removing 1 ml of cells for photolabelling and using 
the remainder to assay 3-O-methyl-D-glucose uptake. The concentration of okadaic acid used was 5.0 pM 
in (a) and 1.0 pM in (b). The preparation of rat adipocytes, photolabelling and the assaying of 3-O- 
methyl-D-glucose uptake are described in section 2.0.
Data are the means o f two (a) or one (b) experiments. Results are expressed relative to the mean insulin 
value. Transport results (11) are the means of five (a) or three (b) values. GLUT4 ( ^ )  and GLUT1 (JU) 
photolabelling are the means of two (a) or one (b) values. Errors are the S D ^ .
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Figure 3.8 suggests that higher concentrations of okadaic acid, such as 5.0 |jM, 
stimulate transport less than 1.0 pM. Rat adipocytes were therefore stimulated with 
either 10 nM insulin, 5.0 pM okadaic acid or both for 20 min. 3-O-methyl-D-glucose 
uptake was then assayed and cell surface transporters were photolabelled with ATB- 
BMPA. The results are shown in figure 3.9.
Figure 3.9a shows that 5.0 pM okadaic acid caused a 4.5-fold increase in the basal rate 
of 3-O-methyl-D-glucose uptake, similar to that of figure 3.8. Okadaic acid also caused 
a 2.9-fold rise in the level of GLUT4 in the plasma membrane. Its effect on GLUT1, 
however, was to decrease it to only 65% of the basal value. If in rat adipocytes the 
transport capacity of GLUT4 is « 3-fold higher than that of GLUT1 as it is in 3T3-L1 
adipocytes (Palfreyman et al. 1992; section 3.1) then the increase in GLUT4 is 
sufficient to counter the decrease in GLUT1 and still cause a rise in 3-O-methyl-D- 
glucose uptake. A comparison of the transport rates and transporter levels in okadaic 
acid and insulin treated cells, however, does suggest that the intrinsic activity of the 
transporters in the okadaic acid treated cells is about 80 % of that in the insulin treated 
cells. When rat adipocytes were incubated with 5.0 pM okadaic acid and 10 nM 
insulin then again the transport rate increased but only to 35 % of the insulin 
stimulated rate. This depression of the insulin stimulated transport rate was reflected 
in the surface levels of GLUT1 and GLUT4. GLUT1 was 48 % and GLUT4 was 42 % 
of the insulin stimulated level. Thus the effect of 5.0 pM okadaic acid in rat adipocytes 
is to increase the transport rate by causing the translocation of GLUT4 and by 
increasing the intrinsic activity of the basal transporter but not by as much as insulin.
A similar experiment with 1.0 pM okadaic acid is shown in figure 3.9b. At this 
concentration the rate of 3-O-methyl-D-glucose uptake rose 4-fold and the GLUT4 
surface levels rose 2.5-fold while GLUT1 levels remained the same, rather than 
decreasing it as with 5.0 pM okadaic acid. 1.0 pM okadaic acid reduced insulin 
stimulated transport but to a lesser extent than 5.0 pM, reflected in the smaller 
decrease in the GLUT1 and GLUT4 surface levels.
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An alternative way to study the effect o f okadaic acid was to add it to the rat 
adipocytes as the insulin stimulated increase in transport was being reversed, figure 
3.10. Rat adipocytes were stimulated for 30 min with 10 nM insulin. The stimulation 
was reversed by the addition of 0.25 mg/ml collagenase. Insulin stimulation was also 
reversed in the presence of 0.5 pM okadaic acid. Collagenase alone fully reversed the 
insulin stimulation and after about 30 min the rate had returned to the basal transport 
rate. The addition o f okadaic acid, however, prevented transport returning to the 
basal rate. Instead after 30 min the rate had dropped to 50 % o f the insulin stimulated 
rate. This is slightly higher than the 40 % of the insulin stimulated rate for 0.5 pM 
okadaic acid alone for 20 min in figure 3.8. This difference could be the result o f the 
much longer incubation time. The half-time for the reversal in the presence or absence 
of okadaic acid appeared to be about 10 min.
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stimulation of ra t adipocytes
Rat adipocytes were prepared and transport assayed as described in sections 2.3 and 3.4. Cells were left 
unstimulated ( ■ ) ,  or stimulated acutely with 10 nM insulin ( # ) .  After 30 min the insulin stimulation was 
reversed by treating the insulin stimulated adipocytes with 0.25 m g/m l collagenase alone (O )  or with 
0.25 p M /m l collagenase and 0.5 pM okadaic acid (V).
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The effect of 0.5 pM okadaic acid on the reversal of insulin
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Okadaic acid had a similar effect in 3T3-L1 adipocytes as it had in rat adipocytes. 
Figure 3.11 shows the effect of different concentrations of okadaic acid on basal and 
insulin stimulated transport rates. As in rat adipocytes, treating 3T3-L1 adipocytes 
with 0.5 or 1.0 pM okadaic acid increased in transport rate which appeared to plateau 
at « 38 % o f the insulin stimulated rate. There was no significant difference between 
the level o f stimulation with 0.5 or 1.0 pM okadaic acid. W ith 0.05 pM okadaic acid 
the transport rate was higher than the basal rate but it was not significantly higher.
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Figure 3 .1 1. The effect of okadaic acid on the stimulation of transport in 
3T 3 -L I adipocytes
3T3-L1 adipocytes in 35 mm dishes were untreated, basal, ( □ ) ,  acutely stimulated with 100 nM insulin, 
( ■ )  or stimulated with okadaic acid at 0.05 pM ( 0 ) ,  0.5 pM (B8) or 1.0 pM ( S ) -  Cells stimulated with 
okadaic acid were either stimulated with okadaic acid alone for 30 min (O A ), stimulated with okadaic 
acid for 15 min and okadaic acid plus insulin for a further 15 min (O A+I) or stimulated with insulin for 15 
min and then okadaic acid plus insulin for a further 15 min (l+O A ). The preparation of cells and assaying 
of transport in 3T3-L1 adipocytes are described in sections 2.3.3 and 2.4.2.1.
Values are the means of one (0 .05 and 1.0 pM) or two (rest) triplicate experiments. Errors are S.E.M.
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The effect of okadaic acid on the insulin stimulated transport rate is also shown in 
figure 3.11. Either insulin was added to okadaic acid treated 3T3-L1 adipocytes or 
okadaic acid was added to insulin treated cells. Under these conditions okadaic acid 
had no significant effect on the insulin stimulated transport rate except when insulin 
was added to adipocytes previously stimulated with 0.05 pM okadaic acid. Since 
0.05 pM alone caused only a small increase in transport this lower rate might be due 
to incomplete insulin stimulation after 15 min rather than inhibition by okadaic acid.
The effect of 5.0 pM okadaic acid on the level o f transporters in the plasma membrane 
of 3T3-L1 adipocytes is shown in figure 3.12. Okadaic acid caused a 3.9-fold rise in 
GLUT4 and a 1.9-fold rise in GLUT1. Unlike its effect in rat adipocytes okadaic acid 
only depressed the insulin stimulated increase in cell surface transporters by a small 
amount. This agrees with figure 3.11 where okadaic acid had very little effect on the 
insulin stimulated transport rate. In 3T3-L1 adipocytes 5.0 pM okadaic acid increased 
the basal level o f cell surface GLUT1 but okadaic acid reduced it in rat adipocytes.
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Figure 3.12. The effect of 5.0 pM okadaic acid on the levels of G LU T4 and 
G L U T  I at the plasma m em brane of 3 T 3 -L I adipocytes
3T3-L1 adipocytes in 35 mm dishes were either untreated, basal, or treated for 20 min with 100 nM 
insulin, 5.0 pM okadaic acid (O .A .), or 5.0 pM okadaic acid plus 100 nM insulin (O .A .+I). They were 
photolabelled with 150 pCi of ATB-BMPA per dish and processed as described in section 2.0. GLUT4 
( H )  and GLUT1 (H I) are expressed relative to the peak area of insulin for that isoform.
Values are the means of two experiments. Errors are the SD(iv1).
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The effect o f okadaic acid on the reversal of insulin stimulated transport in 3T3-L1 
adipocytes is shown in figure 3.13a. Again the addition o f 1.0 pM okadaic acid to fully 
insulin stimulated adipocytes caused only a slight depression in the insulin stimulated 
transport rate to 96 % of the rate at 30 min and 84 % of the 60 min insulin treatment 
rate. When okadaic acid was added with KRM to insulin stimulated cells the rate after 
30 min was about 5-fold higher than the rate following reversal in the absence of 
okadaic acid and about 2.5-fold higher than the rate with okadaic acid alone.
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Figure 3.13a. The reversal of transport in 3T3 -L I adipocytes in the 
presence of 1.0 pM okadaic acid
The preparation of 3T3-L1 adipocytes in 35 mm dishes and the 3-O-methyl-D-glucose uptake assay is 
described in section 2.0. Basal cells ( □ )  were untreated for either 30 min or 60 min before assaying 
transport. Cells treated with 1.0 pM okadaic acid ( 0 )  were stimulated for 30 min before assaying 
transport. All other dishes of 3T3-L1 adipocytes were stimulated with 100 nM insulin for 30 min. Dishes 
treated with insulin alone ( | )  were stimulated for either 30 min or 60 min. Dishes treated with both 
1.0 pM okadaic acid and 100 nM insulin (E8) were first stimulated with insulin for 30 min and then 
treated with both insulin and okadaic acid for a further 30 min. Insulin stimulation was reversed (M )  by 
incubating the cells with KRM (pH 6.0) for 30 min. Insulin stimulation was also reversed with KRM in the 
presence of 1.0 pM okadaic acid ( 0 ) .
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Figure 3 .13b. A  tim e  course for the reversal of insulin stim ulated  
transport in 3 T 3 -L I adipocytes in the presence of I.O pM okadaic acid
3T3-L1 adipocytes in 35 mm dishes were left untreated, basal, ( ■ )  for either 30 min or 60 min before 
assaying 3-O-methyl-D-glucose uptake. All other dishes were stimulated with 100 nM insulin for 30 min 
when the transport was assayed ( # ) .  The insulin stimulated increase in transport was reversed by 
incubating the cells in KRM at pH 6.0 (O )-  Insulin stimulation was also reversed with KRM in the 
presence o f 1.0 ( jM  okadaic acid (V). The preparation of the 3T3-L1 adipocytes, the reversal of insulin 
stimulation and the assaying of 3-O-methyl-D-glucose uptake are described in section 2.0.
Each point is the mean o f the duplicate from a single experiment. Errors are the SD(B.1}.
In order to see if okadaic acid affected the rate o f change in the transport rate 
following the reversal o f insulin stimulation a time course with more time points was 
undertaken. The time course for the reversal of insulin stimulated transport in the 
presence or absence of okadaic acid is shown in figure 3.13b. Okadaic acid altered the 
half-time for the change to a new transport rate. The t^ for the decrease in the 
transport rate in the absence of okadaic acid was » 4.4 min. When the insulin
stimulation was reversed in the presence o f okadaic acid the t% was « 6.6 min. The 
half-times were calculated using the equation ty2 = ln2 /(Kex + K en) where KeX and Ken
were calculated from % at surface = (Kw + Kenexp(-t(K ex + Ken))/(K ex + Ken) .
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The effect of okadaic acid on the recycling of GLUT4 was also investigated. 3TB-L1 
adipocytes were stimulated with insulin for 30 min and then photolabelled. The insulin 
stimulation was then either maintained for a further 30 min with 100 nM insulin or was 
reversed with KRM in either the absence or presence of 1.0 pM okadaic acid. The 
photolabelled transporters were thus allowed to recycle between the cell surface and 
the intracellular pool under these three different conditions. The cells were then 
homogenised and subjected to subcellular fractionation. The photolabelled GLUT4 
was immunoprecipitated from the purified plasma membrane fraction, run on SDS- 
PAGE and the transporter peak counted (section 2.6).
The levels of photolabelled GLUT4 in the purified plasma membrane after recycling 
were compared. There was about 10 % more GLUT4 at the surface of the cells 
treated with KRM and okadaic acid than in the cells treated with insulin. In the 3T3-L1 
adipocytes treated with KRM alone there was approximately 25 % less GLUT4 at the 
cell surface compared with the level in the presence of insulin. Thus okadaic acid 
appears to reduce the rate of endocytosis and so increase the level of GLUT4 
remaining at the cell surface. The result of this experiment should, however, be 
treated with caution as the level of GLUT4 in the plasma membrane of the cells treated 
with KRM alone was higher than expected. This could be due to incomplete reversal, 
perhaps following cell damage during the UV irradiation. Alternatively it could be the 
result of contamination of the plasma membrane fraction by photolabelled transporters 
from the low density microsomes. However, the experiment does show a higher level 
of GLUT4 in the plasma membrane of photolabelled cells treated with both okadaic 
acid and KRM compared with the cells treated with either insulin or KRM alone.
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3.3 The effect of tyrosine kinase inhibitors on transporters in adipocytes
A set of 10 tyrosine kinase inhibitors (TKI) were provided by Wellcome. The 
structure and IC50 of the inhibitors for the epidermal growth factor receptor tyrosine 
kinase are given in table 3.2. A starting concentration o f 0.68 pM was initially used to 
test the effect of the inhibitors on the insulin stimulation o f glucose transport. This 
concentration was chosen by doubling the average IC50 of all 10 inhibitors for the 
EGFRK. The rat adipocytes were incubated with each TKI for 30 min before 
stimulating the cells with insulin plus the TKI for a further 30 min. This was also 
repeated at the higher concentration of 500 pM. The results are shown in figure 3.14.
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Figure 3.14. The effect of 0.68 pM and 500 pM tyrosine kinase inhibitors 
on the insulin stim ulated rate of 3-O-methyl-D-glucose uptake
Rat adipocytes were prepared and transport assayed as described in sections 2.3.1 and 2.4.1. Cells were 
incubated with the indicated tyrosine kinase inhibitor (TKI) at either 0 .68 pM ( 0 )  or 500 pM (O )  for 30 
min before stimulating with 10 nM insulin in the presence of the TKI for a further 30 min. All TKI were 
tested at both concentrations. A t 0.5 mM 453C 89, 764C 89 and 26C 90 the TKI inhibited transport rate 
was less than the basal rate. Results marked basal and insulin were not treated with TKI.













22 .0  pM Akiyama 
et a/., (1987)
759C 90 Methyl 2,5-dihydroxy-cinnamate 0 .77 pM Umezawa 
eta/., (1990)






1.1 pM Shiraishi 
et a/., (1989)
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0.85 pM Yaish et al., 
(1988)
764C 89 a<yano-3-ethoxy-4-hydroxy-5- 
phenylthiomethyl-cinnamide 
(ST 638)











3.3 pM Isshiki 
eto/., (1987)
408C 90 2-amino-4-(4-hydroxyphenyl)-1,3- 
butadiene-1,1 3-tricarbonitrile
x o V
125 nM Gazit et a/., 
(1989)
839C 90 5-(2,5-d i hyd roxy-benzyl am i no)-2- 
hydroxybenzoic acid hemihydrate
I
43 .0  nM Onoda et al., 
(1989)
567C91 RG 13022
X r c °
4.0  pM Yoneda et al., 
(1991)
Table 3.2 The structure of the tyrosine kinase inhibitors and their 
potency as epidermal growth factor tyrosine kinase (EGFRK) inhibitors
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Figure 3.14 shows that that at the lower concentration of 0.68 pM the inhibitors had 
no significant effect on the insulin stimulated transport rate. A t 500 pM all the 
inhibitors inhibited transport to some extent with several lowering the transport rate 
below the basal rate. As a result of these experiments inhibitor 453C89, a-cyano-3,4- 
dihydroxythiocinnamide was chosen for further experiments.
A more detailed study was carried out with 453C89 to determine the effect of 
different concentrations of the inhibitor on insulin stimulated transport as shown in 
figure 3.15. As seen in the previous figure the lowest concentration o f 50 pM caused a 
slight but not significant rise in the rate of transport while increasing concentrations 
progressively increased the degree of inhibition until at the highest concentration, 
500 pM, the transport rate was less than the basal transport rate.
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Figure 3.15. The  effect of the tyrosine kinase inhibitor 453C89 on insulin 
stim ulated 3-O-methyl-D-glucose uptake in ra t adipocytes
Rat adipocytes were prepared and 3-O-methyl-D-glucose transport assayed as described in sections 2.3.1 
and 2.4.1. Cells were incubated for 30 min with the indicated concentration of the tyrosine kinase 
inhibitor 453C 89 ( ^ )  before stimulating them with 10 nM insulin for a further 30 min in the presence of 
453C 89. Basal ( □ )  and insulin treated cells ( ■ )  were not incubated with TKI 453C 89.
Data are the means o f a single experiment carried out in triplicate. Errors are the S.E.M.
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In the previous experiments the inhibitor was added to the adipocytes before they 
were stimulated with insulin. Figure 3.16 shows the effect o f treating insulin stimulated 
rat adipocytes with 500 pM 453C89 for up to 30 min before assaying 3-O-methyl-D- 
glucose uptake. The data shows that a long incubation period was not required to 
completely inhibit transport. Inhibition by 500 pM 453C89 occurred within one 
minute. Such a rapid drop in the transport rate is unlikely to be due an effect on 
translocation but the inhibitor could be competing with 3-O-methyl-D-glucose at its 
binding site or it could be causing a decrease in the activity o f the transporter.
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Figure 3.16. The inhibitory effect of 500 pM tyrosine kinase inhibitor 
453C89 on insulin stim ulated 3-O-methyl-D-glucose uptake
Rat adipocytes were prepared and 3-O-methyl-D-glucose transport assayed as described in sections 2.3.1 
and 2.4.1. Cells were stimulated with 10 nM insulin for 40 min. After assaying the insulin stimulated 
transport rate at 0 min ( # )  tyrosine kinase inhibitor 453C89 was added at a final concentration of 500  
pM and transport was assayed at the indicated times (A)-
Values are the means of triplicates from two independent experiments. Errors are the S.E.M.
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The effect o f the tyrosine kinase inhibitor 453C89 on insulin stimulated glucose 
transport in 3T3-L1 adipocytes was also investigated. Figure 3.17 shows a 
concentration curve for the inhibition of insulin stimulated transport following a 30 min 
incubation with 453C89. As in rat adipocytes the lowest concentration, 5 pM, 
appeared to further increase the insulin stimulated rise in transport. The insulin 
stimulated transport rate in the presence o f 500 pM 453C89 was a little higher than 
the basal transport rate. The degree of inhibition by 500 pM 453C89 in 3T3-L1 
adipocytes was less than it was in rat adipocytes where the TKI inhibited insulin 
stimulated rate was less than the basal transport rate.
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Figure 3.17. The effect of the tyrosine kinase inhibitor 453C89 on insulin 
stimulated 3-O-methyl-D-glucose uptake in 3 T 3 -L I adipocytes
3T3-L1 adipocytes were prepared and transport was assayed as described in sections 2.3.3 and 2.4.2.1. 
Cells were incubated with the tyrosine kinase inhibitor 453C 89 for 30 min. They were then treated with 
100 mM insulin and 453C 89 for a further 30 min before assaying 3-O-methyl-D-glucose uptake. The 
mean basal and insulin stimulated transport rates are also shown.
Values are the means of triplicates from a single experiment. Errors are the S.E.M.
Results 99
The results shown in figure 3.18 support the idea that at high concentrations 453C89 
inhibits transport rather than having a rapid effect on translocation. When 500 pM 
453C89 was added to the insulin stimulated 3T3-L1 adipocytes in the sugar cocktail 
used to assay 3-O-methyl-D-glucose transport then the insulin stimulated transport rate 
was halved although the rate was still double that for adipocytes incubated with the 
inhibitor before the transport assay. 500 pM 453C89 was also added to adipocytes at 
18 *C one minute before the 3-O-methyl-D-glucose transport assay, sufficient time to 
inhibit transport in figure 3.16. 453C89 still inhibited insulin stimulated transport at 
18*C. This suggests that the inhibitor was not inducing a rapid endocytosis of cell 
surface transporters as the internalisation of cell surface glucose transporters in rat 




Figure 3.18. The  effect of 500 pM tyrosine kinase inhibitor, 453C89 on 
insulin stim ulated 3-O-methyl-D-glucose uptake in 3 T 3 -L I adipocytes
The preparation of 3T3-L1 adipocytes and assaying of 3-O-methyl-D-glucose are described in sections 
2.3 .3 and 2.4.2.1. Basal cells ( □ )  were untreated for 30 min (n=5). Insulin stimulated cells were treated 
with 100 nM for 30 min before assaying transport at either 37 *C  (n=5) or 18 *C  (n=6) ( ■ ) .  0.5 mM 
TKI 453C 89 was added to insulin stimulated cells with the labelled 3-O-methyl-D-glucose (E3) (n=6) or 
was added to insulin stimulated cells at 18 ’ C 1 min before transport was assayed ( 0 )  (n=3).
Values are the means of triplicates or duplicates from one or two experiments. Errors are the S.E.M.
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Figure 3.19 shows the result o f treating 3T3-L1 adipocytes with 5 pM 453C89. This 
was done to try to inhibit the tyrosine kinases with a low concentration o f 453C89 for 
an extended length of time rather than a high concentration for a short time. 3T3-L1 
adipocytes were treated with 5 pM 453C89 for between 1 to 50 hours with the 
inhibitor added to the cell culture medium as required. Although following treatment 
with the inhibitor there was a small drop in the transport rate it did not continue to 
decrease during the course of the experiment and the mean of all the values always lay 
within the S.E.M. o f the individual points Thus prolonged incubation with 5 pM 
453C89 had no significant effect on the rate o f 3-O-methyl-D-glucose transport.
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Figure 3.19. The  effect of prolonged incubation w ith 5.0 pM tyrosine 
kinase inhibitor 453C89 on insulin stim ulated 3-O-methyl-D-glucose 
uptake in 3 T 3 -L I adipocytes
The preparation of 3T3-L1 adipocytes and assaying of 3-O-methyl-D-glucose are described in sections 
2.3.3 and 2 .4 .2 .1 . The 3T3-L1 adipocytes were treated with 5 pM 453C 89 for the required time before 
treating then with 100 nM insulin and 453C89 for 30 min and then assaying 3-O-methyl-D-glucose uptake 
(A). For the longer incubation times 453C89 was first added to the DMEM-FCS medium. The dashed 
line is the mean of all the values. A t 0  h cells were only treated with insulin ( # ) .
Values are the means of triplicates from a single experiment. Errors are the S.E.M.
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3.4 The targeting of transfected G L U T 4  in fibroblasts
The plasmid pRC-CMV-hGLUT4 was provided by Dr Mitsuru Hashiramoto and Dr 
Yoshikazu Tamori, (Kobe University, Japan). The human GLUT4 cDNA was originally 
provided by Dr G. I. Bell. The GLUT4 cDNA was approximately 1900 bp long of 
which 1530 bp were coding region. It was spliced into the plasmid at the Hindlll and 
Xbal sites. The plasmid map is shown in figure 2.2.
A large quantity o f plasmid DNA was prepared using the maxi-prep method described 
in section 2.7.1. To confirm that the correct plasmid had been purified it was 
restriction digest mapped using Hindlll and Xbal (section 2.7.3) which cut at the sites 
used to splice the cDNA into the plasmid. The restriction digest map is shown in figure 
3.20. Two bands were obtained, one « 5000 kb and one » 1900 kb as expected.
Figure 3.20. The restriction mapping of pR C -C M V-hG LU T4
0.2 pg of plasmid D N A  was digested with both Hindlll and Xbal in one Phor all buffer at 37 *C for 1 h. 
This was loaded onto an agarose gel (C) next to uncut plasmid (U ) with A. Pst as a size marker. After 
electrophoresis the gel was viewed under UV light and photographed with Polaroid film, section 2.7.3.
The plasmid was first expressed in 3T3-L1 fibroblasts following transfection by the 
calcium phosphate method, section 2.7.4. When Western blots of the solubilized 
whole cells were immunoblotted with the anti-GLUT4 antiserum then only a weak 
band was detected in cells transfected with pRC-CMV-hGLUT4, figure 3.21. As the 
level o f GLUT4 expression in 3T3-L1 fibroblasts was low the plasmid was transfected 
into COS-7 fibroblasts, figure 3.22.
C U C U XPst
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Figure 3 .2 1. The im m unoblotting of G L U T 4 in 3T 3 -L I fibroblasts 
transfected with pR C -C M V-hG LU T4
3T3-L1 fibroblasts were transfected with pRC-CMV-hGLUT4 by the calcium phosphate method, section 
2.7.4. The fibroblasts were scraped from the dishes in 150 pi SDS-PAGE sample buffer and a third of a 
dish, 50 pi of solubilized cells, per lane was loaded onto a thin 10 % SDS-PAGE gel. The nitrocellulose 
was probed with 1:100 anti-GLUT4 antiserum and 0.1 pC i/m l 125l-protein A, section 2.6.
Lane 1: nontransfected 3T3-L1 fibroblasts, lane 2: 3T3-L1 fibroblasts incubated with calcium phosphate in 
the absence of plasmid, lane 3: fibroblasts transfected with maxi prep pRC-CMV-hGLUT4, lanes 4 and 5: 
fibroblasts transfected with original pRC-CMV-hGLUT4, lane 6: 3T3-L1 adipocytes.
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Figure 3.22. The im m unoblotting of G L U T 4  in CO S-7 fibroblasts 
transfected w ith pR C -C M V-hG LU T4
COS-7 fibroblasts in 90 mm dishes were transfected with pRC-CMV-hGLUT4 using the DEAE-dextran 
method of section 2.7.5. The plasma membrane and low density microsomal fractions were purified as 
described in section 2.6 .1 . Approximately 20 pg protein was loaded per lane of a 10% thin gel. The 
nitrocellulose was probed with 1:200 anti-GLUT4 antiserum and 0.1 pC i/m l 125l protein A, section 2.6. 
Lanes 1 to 4 contain purified plasma membrane while lanes 5 to 8 contain low density microsomes. 
Lanes 1 and 5 are from nontransfected COS-7 fibroblasts. Lanes 2 and 6 are from COS-7 fibroblasts 
incubated with DEAE-dextran in the absence of plasmid. Lanes 3 and 7 are from COS-7 fibroblasts 
transfected with pRC-CMV-hGLUT4. Lanes 4 and 8 are from 3T3-L1 adipocytes.
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Higher levels of GLUT4 were expressed when pRC-CMV-hGLUT4 was transfected into 
COS-7 fibroblasts using the DEAE-dextran method, section 2.7.5. Figure 3.22 shows 
the result of immunoblotting the plasma membrane and low density microsomal 
fractions from transfected and nontransfected COS-7 fibroblasts and 3T3-L1 
adipocytes. GLUT4 was only detected in COS-7 fibroblasts transfected with 
pRC-CMV-hGLUT4 (lanes 3 and 7) where it was detected in both the plasma 
membrane and the low density microsomes. These bands, when compared with those 
of the 3T3-L1 adipocytes (lanes 4 and 8), were much broader and less dense. Volume 
densitometry measurements of the plasma membrane and low density microsome 
bands indicated a 9.8-fold higher level of GLUT4 in the plasma membrane in the 
COS-7 cells and 6.8-fold higher in the 3T3-L1 adipocytes.
Since ATB-BMPA was to be used to calculate what proportion of the GLUT4 
expressed in COS-7 fibroblasts was at the cell surface it was necessary to characterise 
COS-7 fibroblast photolabelling. Figure 3.23 shows the gel profile of
immunoprecipitated photolabelled GLUT1 and GLUT4 in both transfected and 
nontransfected COS-7 cells (solid symbols). To confirm that the immunoprecipitated 
peak was photolabelled transporter the cells were also photolabelled in the presence of 
200 mM glucose to displace ATB-BMPA and prevent it labelling the transporter (open 
symbols). The GLUT4 glucose displaceable transporter peak was only seen in the 
COS-7 fibroblasts transfected with pRC-CMV-hGLUT4. A GLUT1 glucose displaceable 
peak was seen in both the transfected and nontransfected fibroblasts.
The subcellular distribution of GLUT4 expressed in COS-7 fibroblasts transfected with 
pRC-CMV-hGLUT4 was calculated by photolabelling the transporters in the presence 
or absence of 2.5 \ig /m \ digitonin. Digitonin permeabilizes the cells enabling the total 
transporter pool, both surface and intracellular, to be labelled (Yang et al., 1992b). 
The proportion of the total transporter pool at the cell surface was calculated by 
comparing the labelling level in the presence and absence of digitonin. Figure 3.24 
shows the result of three experiments.
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Figure 3.23. The photolabelling of COS-7 fibroblasts transfected with 
pRC-CM V-hGLUT4 in the presence and absence of glucose
COS-7 fibroblasts in 35 mm dishes were transfected with pRC-CMV-hGLUT4 using the DEAE-dextran 
method, section 2.7 .5 . Two dishes per condition were photolabelled with 100 pCi per dish in the 
presence (A.O) or absence (A.#) of 200 mM glucose. Solubilized fibroblasts were 
immunoprecipitated with G LUT4 (A,A )  and GLUT1 (0,0) antiserum, subjected to SDS-PAGE and the 
slices counted as described in section 2.6.
Figures 3.23a and c are from pRC-CMV-hGLUT4 transfected COS-7 fibroblasts while b and d are from  
untransfected fibroblasts.
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Figure 3.24 shows that the proportion of GLUT1 at the cell surface is similar in both 
nontransfected and pRC-CMV-hGLUT4 transfected COS-7 fibroblasts, 56 % in the 
nontransfected and 62.5 % in the transfected cells. The proportion of GLUT4 at the 
surface of the transfected COS-7 cells was » 140 %. Such a percentage is not possible.
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Figure 3.24. The percentage of total photolabelled transporter at the cell 
surface of COS-7 fibroblasts transfected with pRC-CMV-hGLUT4
COS-7 fibroblasts in 35 mm dishes were transfected with pRC-CMV-hGLUT4 using the DEAE-dextran 
method, section 2.7 .5 . Two dishes per condition were photolabelled with 100 pCi per dish in either the 
absence (surface) or presence (total) of 2.5 Mg/ml digitonin. GLUT1 (HD) and G LUT4 ( I I )  were 
immunoprecipitated from solubilized cells and run on SDS-PAGE, section 2.6. The percentage of total 
transporters at the cell surface transporter was calculated by dividing the surface peak area by the total 
peak area. Percentages are given for GLUT1 in nontransfected fibroblasts (N T ) and for GLUT1 and 
G LUT4 in COS-7 fibroblasts transfected with the pRC-CMV-hGLUT4 plasmid (Trans).
Values are the means of three experiments. Errors are the S.E.M.
As an alternative to transient transfection in COS-7 fibroblasts a CHO fibroblast line 
stably transfected with GLUT4, provided by Dr M. Hashiramoto (Kobe University, 
Japan), was used. As with the COS-7 cells the CHO cells were photolabelled in the 
presence and absence o f glucose to confirm the suitability o f ATB-BMPA, figure 3.25.
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As expected a GLUT4 glucose displaceable peak was obtained in the GLUT4 
transfected cell line (a) but not in the wild type cells (b). A GLUT1 glucose 
displaceable peak was detected in both GLUT4 transfected cell lines (c) and the wild 
type (d) but the peak was much larger in the wild type cells.
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Figure 3.25. The photolabelling of C H O  fibroblasts stably transfected 
with G LUT4 in the presence and absence of glucose
35 mm dishes were seeded with 0.05 x 10‘ C H O  fibroblasts and allowed to reach confluence in 4 days. 
Two dishes per condition were photolabelled with 100 pCi per dish in the absence (A.#) or presence 
(A.O) of 200  mM glucose. GLUT4 (A.A) and GLUT1 (# ,0 ) were immunoprecipitated from  
solubilized cells, run on SDS-PAGE and counted as described in section 2.6.
Figures 3.33a and c are from C H O  fibroblasts stably transfected with GLUT4, b and d are from  
nontransfected C H O  fibroblasts.
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The proportion o f GLUT1 and 4 at the surface o f the CHO fibroblasts was determined 
by photolabelling in the presence or absence of digitonin as for the COS-7 cells. A 
protein assay found that the digitonin permeabilized cells had only 85 % of the protein 
of the untreated cells. Although the protein lost might be soluble protein in the light o f 
the anomalous result in the COS-7 fibroblasts the transporter peaks were adjusted to 
account for this protein loss. Figure 3.26 shows that the proportion of GLUT1 at the 
cells surface was lower in the CHO fibroblasts than in the COS-7 cells. In the wild type 
CHO fibroblasts 38 % of the GLUT1 was at the cell surface while only 33 % was at the 
surface o f the cells expressing GLUT4. There was also a difference in the absolute 
amounts o f GLUT1 in the two cells lines. As figure 3.25 shows, there was over 4 
times more GLUT1 in the nontransfected CHO cells than the cells expressing GLUT4. 
The percentage of GLUT4 at the cell surface of the transfected CHO fibroblasts was 
much higher than for GLUT1. About two thirds o f the GLUT4 was at the cell surface.
Figure 3.26. The percentage of tota l 
photolabelled transporter at the  
surface of C H O  fibroblasts stably 
transfected w ith G L U T 4
35 mm dishes were seeded with 0.05 x 10‘ C H O  
fibroblasts and allowed to reach confluence in 4 days. 
Two dishes per condition were photolabelled with 100 
pCi per dish in either the absence (surface) or 
presence (total) of 2.5 (Jg/ml digitonin. GLUT1 ( □ )  
and GLUT4 ( ^ )  were immunoprecipitated from  
solubilized cells, run on SDS-PAGE and counted as 
described in section 2.6. The percentage of the 
transporters at the cell surface was calculated by 
dividing the surface counts by the total counts. 
Percentages are for GLUT1 in wild type fibroblasts 
(N T ) and for GLUT1 and G LU T4 in C H O  fibroblasts 
stably transfected with G LU T4 (Trans). Values are the 
means of five experiments. Errors are the S.E.M.
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3.5 Glucose transporter peptides and the targeting of GLUT4
Peptides corresponding to different regions o f the glucose transporters were 
introduced into permeabilized 3T3-L1 adipocytes. To ensure that the cells were 
effectively permeabilized by a 5 min treatment with 0.8 lU /m l streptolysin-0 (SLO) at 
37 'C  (Robinson et a/., 1992) 1 Mg/ml propidium iodide was added with the SLO. 
The cells were then washed and photographed with either phase or fluorescence 
microscopy as shown in figure 3.27. Fluorescent nuclei were only seen where the cells 
were treated with SLO. Most o f the SLO treated cells were fluorescent. Thus the 
concentration and incubation time was sufficient to permeabilize 3T3-L1 adipocytes.
In order to observe the effect o f the peptides on the permeabilized cells it was 
necessary to develop a transport assay. The problem that had to be overcome was 
the leakage o f labelled sugar from the cells during washing. Two different 2-deoxy-D- 
glucose assays were tested, figure 3.28. In intact 3T3-L1 adipocytes, following the 
addition o f the labelled sugar to the dish, the medium was either (a) rapidly removed, 
the cells washed four times, dissolved and counted or (b) uptake was stopped with 
boiling water which lyses the cells and the cell lysate was passed through a DE81 filter 
which binds phosphorylated 2-deoxy-D-glucose. The filter was washed to remove non- 
phosphorylated, nontransported 2-deoxy-D-glucose and the filter counted. Both 
methods gave a similar level o f insulin stimulation. Both methods were tested in SLO 
permeabilized 3T3-L1 adipocytes but with the following differences. In the non filter 
method (c) permeabilized cells were incubated with 2-deoxy-D-[2,4-3H]glucose and [U- 
14C]sucrose. This was rapidly removed and the cells washed once. The sucrose, which 
cannot be transported, was used to differentiate between specifically and non- 
specifically transported 2-deoxy-D-glucose while the single rapid wash prevented the 
loss o f transported sugar. In permeabilized 3T3-L1 adipocytes the filter assay was 
ineffective (d) as the presence o f cytochalasin B, which blocks transport, did not 
prevent 2-deoxy-D-glucose phosphorylation. Thus phosphorylation cannot be used to 
distinguish between specifically and non-specifically transported 2-deoxy-D-glucose.
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Figure 3.27. Testing the efficacy of streptolysin-O perm eabilization of 
3T3-L I adipocytes w ith propidium iodide
The preparation of 3T3-L1 adipocytes is described in section 2.3.3. The cells were washed twice with IC 
buffer, pH 7.2, and incubated in IC buffer for 5 min at 37 'C  with 1 (Jg/ml propidium iodide in the 
absence (a and b) or presence of 0.8 lU /m l streptolysin-0 (c and d). The cells were then washed 3 times 
with PBS and observed and photographed at x400 magnification with a Nikon microscope with either 
phase (a and c) or fluorescence microscopy (b and d). Permeabilized 3T3-L1 adipocytes have red 
fluorescent nuclei. The bar represents 2.5 pm.
Results 110
The transport assay method shown in figure 3.28 (c) gave an acceptable insulin 
stimulated increase in the transport rate of nearly 4-fold. Using sucrose to calculate 
the background was more successful than trying to reduce it with more washes as this 
reduced the insulin stimulation (results not shown).
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Figure 3.28. The developm ent of a 2-deoxy-D-[2,4-3H]glucose transport 
assay for use in streptolysin-O permeabilized 3T 3 -L I adipocytes
3T3-L1 adipocytes in 35 mm dishes were prepared and permeabilized as required (section 2.3.3 and 6 ). 
Transport was assayed in untreated, basal, cells ( □ ) ,  in basal cells treated with 50 pM cytochalasin B five 
minutes before the assay ( 0 )  or in cells stimulated with 100 nM insulin for 30 min ( ■ ) .
In the washed transport assay (a) 50 pM, 0.12 pCi/dish, 2-deoxy-D-glucose was added for 5 min before 
4 rapid washes with KRH (section 2 .4 .2 .2). In the lysis transport assay (b and d) after 5 min with the 
labelled 2-deoxy-D-glucose uptake was stopped with 2 ml boiling double distilled water containing 200  
pM sodium orthovanadate. The water and scraped cells were put through a DE81 filter which was 
washed 3 times with ice cold double distilled water and then counted (section 2 .4 .2 .4 ). In the 2-deoxy-D- 
glucose uptake assay in permeabilized adipocytes both labelled and unlabelled 2-deoxy-D-glucose (3H) and 
sucrose ( 14C) were added at a ratio of 5:1. Following the 5 min incubation the cells were washed once 
with 3 ml IC buffer (section 2 .4 .2 .3). The 3H dpm were adjusted with the 14C counts. W ith  the 
exception of (c) the values shown are percentages of the insulin stimulated crude dpm counts.
Values are the means of single triplicate (a, c) or duplicate (b, d) experiments. Errors are S D ^ .
(a) (b) (c) id)
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To determine which regions o f GLUT4 are involved in translocation several peptides 
corresponding to the terminal regions of GLUT4 and GLUT1 were added to 
permeabilized 3T3-L1 adipocytes. The GLUT2 loop peptide was used as a control. 
Figure 3.29 shows the effect of adding the peptides to basal adipocytes. The GLUT2 
loop peptide caused a slight decrease in the transport rate and this was considered a 
non-specific peptide effect. The GLUT4 C-terminal peptide caused a slight rise in the 
transport rate but this was not significantly different from the basal rate. The GLUT4 
N-terminal peptide did cause a significant, 1.7-fold, increase in the basal transport rate.
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Figure 3.29. The effect of glucose transporter peptides on basal rate of 2- 
deoxy-D-glucose uptake in streptolysin-O permeabilized 3T3-LI 
adipocytes
3T3-L1 adipocytes grown in 35 mm dishes were prepared, permeabilized and 2-deoxy-D-glucose uptake 
assayed as described in sections 2.3.3, 2.3 .6 and 2.4.2.3 respectively. After permeabilization the 
adipocytes were incubated in IIC buffer at 37 *C for 30 min with no addition, basal ( □ ) ,  with 100 nM 
insulin, ( ■ ) ,  »  100 pM GLUT2 loop peptide (B), 100 pM G LUT4 C-terminal peptide (£3) or 100 pM 
G LUT4 N-terminal peptide, ( B )  before assaying transport. Peptide sequences are given in table 2.1. 
Values are the means of 9 ( □ ,  ■ ,  n=19), 5 (B ,  n=12 ), 3 ( 0 ,  n=9) or 1 ( B .  n=2 ) experiments carried 
out in duplicate or triplicate. Errors are the S.E.M. The transport rate in the cells treated with the 
G LUT4 N-terminal peptide was significantly different (p<0.01) from the basal transport rate.
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The effect o f the two GLUT4 terminal peptides on the insulin stimulated transport rate 
in permeabilized 3T3-L1 adipocytes is shown in figure 3.30. The GLUT4 C-terminal 
peptide caused a slight, but not significant, decrease in the insulin stimulated transport 
rate. The GLUT4 N-terminal peptide caused a significant increase in the transport rate 
o f 1.13-fold in the insulin stimulated transport rate. Thus the GLUT4 N-terminal 
peptide increases both the basal and insulin stimulated transport rates.
Figure 3.30. The effect of GLUT4 terminal peptides on insulin stimulated 
uptake of 2-deoxy-D-glucose in streptolysin-O permeabilized 3T3-LI 
adipocytes
3T3-L1 adipocytes grown in 35 mm dishes were prepared, permeabilized and 2-deoxy-D-glucose uptake 
assayed as described in sections 2.3.3, 2.3.6 and 2.4.2.3 respectively. After permeabilization the 
adipocytes were incubated for 30 min in IIC buffer at 37 'C  with no addition, basal ( □ ) ,  with 100 nM 
insulin, ( ■ ) ,  100 nM insulin and 100 pM GLUT4 C-terminal peptide ( 0 ) .  or 100 nM insulin and 100 pM 
GLUT4 N-terminal peptide, ( 0 )  before assaying transport. Peptide sequences are in table 2.1.
Values are the means of 9 ( □ ,  ■ ,  n=19), 6 ( 0 ,  n=14) or 3 ( S .  n=9) experiments carried out in 
duplicate or triplicate. Errors are the S.E.M. The transport rate with the GLUT4 N-terminal peptide was 
significantly different (p<0 .0 1 ) from the insulin stimulated rate.
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The effect o f incubating the 3T3-L1 adipocytes with the peptides for 15 min before 
treating them with insulin for a further 30 min is shown figure 3.31. Each of the four 
peptides increased the insulin stimulated transport rate. This included an increase in 
the presence o f the GLUT2 loop peptide. The transport rate in the presence of the 
other three peptides was higher than the GLUT2 loop peptide rate but only the rate in 
the presence o f the GLUT4 N-terminal peptide was significantly higher than that with 
the GLUT2 loop peptide, 1.3-fold higher than the rate for insulin alone.
Figure 3.31. The effect of incubating streptolysin-O permeabilized 3T3-LI 
adipocytes with glucose transporter peptides on the insulin stimulated 
uptake of 2-deoxy-D-glucose
3T3-L1 adipocytes grown in 35 mm dishes were prepared, permeabilized and 2-deoxy-D-glucose uptake 
assayed as described in sections 2.3.3, 2.3.6 and 2.4.2.3 respectively. After permeabilization some 
dishes were treated without ( □ )  or with 100 nM insulin, ( ■ )  for 30 min in IIC buffer at 37 *C. The 
remaining dishes were preincubated for 15 min with 100 pM GLUT4 C-terminal peptide ( 0 ) ,  100 pM 
GLUT4 N-terminal peptide (0), 100 pM GLUT1 C-terminal peptide (U). «  100 pM GLUT2 loop 
peptide ( ^ ) ,  or no peptide (E8 ) before a further 30 min incubation with both the peptide and 100 nM 
insulin before assaying transport. Peptide sequences are given in table 2.1.
Values are the means of 9 ( Q  ■  n=18), 6 ( S  n=14), 5 ( 0  n=12 , 0  n=10, M  n = 10 ) or 3 (U, n=6 ) 
experiments carried out in duplicate or triplicate. Errors are the S.E.M. The mean rate with the G LUT4  
N-terminal peptide ( 0 )  was significantly different (p<0.001) from that of the insulin stimulated rate after 
15 min ( ^ )  and from the rate with the GLUT2 loop peptide and insulin (p<0.01) ( ^ ) .
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The effect o f the GLUT4 N-terminal peptide on the insulin stimulated translocation of 
transporters was investigated by photolabelling 3T3-L1 adipocytes after a 30 min 
treatment with both the peptide and insulin, figure 3.32. The plasma membrane from 
these cells was purified before the transporters were immunoprecipitated. When peak 
areas were compared the addition o f the GLUT4 N-terminal peptide increased the 
levels o f both GLUT1 and GLUT4 in the plasma membrane above those for insulin 
alone, the increase in GLUT4 being 1.4-fold higher. Because of the greater error in 
the GLUT1 values, only the increase in the plasma membrane GLUT4 was significant.
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Figure 3.32. The effect of 100 pM GLUT4 N-term inal peptide on surface 
G LU T I and G LU T4 in streptolysin-O permeabilized 3T3-LI adipocytes
3T3-L1 adipocytes grown in 35 mm dishes were prepared and permeabilized as described in sections
2.3.3 and 2.3 .6 . A fter permeabilization 2 dishes of adipocytes per condition were incubated at 37 'C  
for 30 min in IIC buffer with no addition, basal, with 100 nM insulin or with 100 pM G LUT4 N-terminal 
peptide and 100 nM insulin, (G LUT4 N-ter+lns). The cells were photolabelled with 300 pCi ATB-BMPA 
per dish, washed with IC buffer and TES and then subcellular fractionated to obtain purified plasma 
membrane for immunoprecipitating and counting cell surface G LUT4 and GLUT1 as described in section 
2.6. The level of G LU T4 ( ^ )  and GLUT1 (C0) are expressed relative to that for insulin.
Values are the mean of 2 independent experiments. Errors are the SD
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To see if the GLUT4 N-terminal peptide was blocking endocytosis or stimulating 
exocytosis the peptide was added to 3T3-L1 adipocytes that had been stimulated with 
insulin before being permeabilized with streptolysin-O. The effect of the peptide on the 
transport rate is shown in figure 3.33. 40 min after treating the permeabilized cells 









Figure 3.33. The effect of 100 pM GLUT4 N-terminal peptide and insulin 
on 2-deoxy-D-glucose uptake in insulin stimulated streptolysin-O 
permeabilized 3T3-LI adipocytes
BT3-L1 adipocytes grown in 35 mm dishes were prepared as described in section 2.3 .3 . After washing 
with KRH the dishes they were treated with 100 nM insulin at 37 *C for 30 min. The cells were then 
permeabilized with 0.8 I.U ./m l streptolysin-O as described in section 2.3 .6 . Insulin stimulation was then 
maintained in the absence ( # )  or presence of 100 pM GLUT4 N-terminal peptide (A)- The uptake o f 2- 
deoxy-D-glucose (section 2.4 .2 .3 ) was assayed at the indicated times.
Values are the means of 2 independent experiments carried out in duplicate. Errors are the S.E.M. The 
difference between the 2 values at 40 min has a significance of p<0.05.
The experiment shown in figure 3.33 was repeated but the level of transporters in the 
plasma membrane was followed instead. Unlike in the transport assay the addition of 
the peptide had no effect o f the cell surface levels o f GLUT4 or GLUT1 when 
compared with insulin alone. After 40 min with insulin alone about 75 % of the 
labelled transporter remained at the cell surface instead o f the expected 50 %. This 
suggests that either the cells may have been damaged by the UV irradiation or that the 
plasma membrane fraction was contaminated with labelled intracellular transporters.
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Figure 3.34 shows a preliminary experiment to see if the GLUT4 N-terminal peptide 
prevents the departure o f GLUT4 from the low density microsomal fraction. Basal 
3T3-L1 adipocytes, with most of the GLUT4 in the low density microsomes (LDM), 
were permeabilized and photolabelled. They were then treated with either insulin or 
insulin and the GLUT4 N-terminal peptide. The level o f labelled transporters 
remaining in the LDM was assayed. Figure 3.34 shows that the peptide does not 
appear to prevent GLUT4 leaving the LDM with « 50 % of the transporters remaining 
in this fraction under both conditions, as expected for insulin stimulation. This results 
should be treated with caution, however, as the GLUT4 peak was associated with a 
high level o f non-specific, background, labelling and this is a preliminary experiment.
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Figure 3.34. The effect of 100 |jM GLUT4 N-terminal peptide and insulin 
on the level of G LUT4 in the low density microsomes of streptolysin-O 
permeabilized 3T3-LI adipocytes
3T3-L1 adipocytes grown in 35 mm dishes were prepared and permeabilized as described in sections 
2.3.3 and 2.3.6. Immediately after being permeabilized the cells were photolabelled with 300 pCi per 
dish for 1 min with a 1:1 ratio of 300 and 350 nm U V light. The unbound label was washed off and 
dishes o f cells for 0 min were taken. The rest of the dishes of cells were stimulated with either 100 nM 
insulin ( # )  or 100 nM insulin and 100 pM GLUT4 N-terminal peptide (A). A t 0, 10 and 40 min cells 
were homogenised, the low density membrane purified, and G LUT4 immunoprecipitated and counted. 
The values are the mean of two counts from a single experiment. Errors are the SD(n.ir
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3.6 Rab proteins and insulin stimulated transport in adipocytes
The ras-like GTP-binding protein rab4 has been shown to control the function or 
formation o f endosomes involved in recycling by overexpressing the protein in CHO 
fibroblasts (van der Sluijs et al.( 1992).
A peptide whose sequence (see table 2.1) was from a hydrophilic region in the middle 
of rab4 was used to produce antibodies against rab4. The rabbit serum was tested 
with a peptide ELISA to ensure that anti peptide antibody was being produced and that 
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Figure 3.35. The production of antibodies against a rab4 peptide
The rab4 peptide coupled to KLH via MBS in Imject Alum was injected at four subcutaneous sites in a 
sandy half lop rabbit, as described in section 2.9. Anti-rab4 peptide IgG was detected with an ELISA 
(section 2 .10) coated with rab4 peptide. Serum was diluted 1:100 ( # ) ,  1:400 (B ) ,  1:1600 (A) or 
1:6400 (T). The values are the mean of two counts from a single count. Errors are the SD{iv1).
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Figure 3.36. Immunoblotting of 3T3-LI and rat adipocytes with anti-rab4 
antiserum
Adipocytes were subcellular fractionated and Western blotted as described in section 2.6.
(a) (lanes 1-6) is of 3T3-L1 adipocyte plasma membrane, low density microsome (LDM ) and whole cell 
fractions run on a 10 % acrylamide gel and probed with 1:100 anti-rab4 antiserum (lanes 1-3) or 
preimmune (PIM) serum (lanes 4-6) and 0.1 pC i/m l 1J5l-protein A.
(b) (lanes 7-12) is of plasma membrane (PM) and low density microsome (LDM ) fractions of basal and 
insulin stimulated 3T3-L1 and rat adipocytes run on a 12 % acrylamide gel and probed with 1:500 anti- 
rab4 antiserum, with a high (0.2 M) salt wash and 0.1 pC i/m l 125l-protein A.
Lane 1: 3T3-L1 plasma membrane (160  pg) rab4 
Lane 2: 3T3-L1 LDM (380pg) rab4 
Lane 3: 3T3-L1 whole cells (105 pg) rab4 
Lane 4: 3T3-L1 plasma membrane (160  pg) PIM 
Lane 5: 3T3-L1 LDM (380pg) PIM 
Lane 6 : 3T3-L1 whole cells (105 pg) PIM
Lane 7: 3T3-L1 insulin PM (6 6  pg) rab4 
Lane 8 : 3T3-L1 basal PM (6 6  pg) rab4 
Lane 9: 3T3-L1 insulin LDM (33 pg) rab4 
Lane 10: 3T3-L1 basal LDM (33 pg) rab4 
Lane 11: Rat insulin PM rab4 
Lane 12: Rat insulin LDM rab4
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Western blots of rat and 3T3-L1 adipocytes were probed with the anti-rab4 
antiserum. Figure 3.36 shows immunoblots of whole and subcellular fractionated 
3T3-L1 rat adipocytes. The samples from 3T3-L1 adipocytes in figure 3.31a were 
probed with preimmune serum and antiserum against rab4 and GLUT4. GLUT 4 was 
detected in all samples (results not shown).
The 3T3-L1 adipocyte proteins in lanes 1-3 of figure 3.36a were immunoblotted with 
the anti-rab4 antiserum were compared with their respective lanes 4-6 immunoblotted 
with the preimmune serum. There were no specific bands in any of the three lanes 
immunoblotted with anti-rab4 antiserum at the expected size of » 24 kDa. No low 
molecular weight proteins were detected in any of the lanes in figure 3.36b. However, 
a unique band with an apparent mass of « 150 kDa was found. This band was 
detected in all the fractions immunoblotted with the anti-rab4 antiserum, from both 
3T3-L1 and rat adipocytes, but not in those blotted with the preimmune serum. This 
band appears to be stronger in the plasma membrane than in the low density 
microsomes fraction.
Figure 3.37 shows the result of a similar subcellular fractionation of rat adipocytes but 
with the addition of the high density microsomes and the chloroform/methanol 
precipitated proteins remaining in the final supernatant after the removal of the low 
density microsomes. Again the » 150 kDa band was strongly detected in plasma 
membrane and weakly in LDM. It was not detected in either the high density 
microsomes or the supernatant. When all the blots were compared there was found 
to be no consistent difference in the intensities of the band in the basal and insulin 
simulated adipocytes. An additional band was also detected in the supernatant fraction 
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Figure 3.37. Im m unoblotting of subcellular fractionated ra t adipocytes 
with anti-rab4 antiserum
Rat adipocytes were either untreated or were treated with 10 nM insulin for 30 min, section 2.3.1. The 
adipocytes were then subcellular fractionated as described in section 2 .6.1 but with the following 
alterations. The adipocytes were homogenised in TES (containing 150 pM sodium orthovanadate, 
1 pg/m l protease inhibitors and a trace of PMSF) with 10 machine strokes. This homogenate was first 
spun at 1000 rpm in an I EC Centra-3R for 1 min to remove cell debris and fat. The supernatant was 
spun at 18,000 rpm (18 ,000  x gmix) for 20 min to obtain the crude plasma membrane pellet. The high 
density microsome pellet was obtained by a 9 min spin at 30,000 rpm (50 ,000  x g ^ ) . The protein left 
in the supernatant after removing the LDM was precipitated by the chloroform/methanol method, 
section 2.6 .2 . An equal volume of each fraction was loaded onto a 10 % gel. The nitrocellulose was 
probed with a 1:200 diluted anti-rab4 antiserum and 0.1 pC i/m l 125l-protein A.
Lane 1: Insulin stimulated rat adipocyte supernatant
Lane 2: Basal rat adipocyte supernatant
Lane 3: Insulin stimulated rat adipocyte high density microsomes
Lane 4: Basal rat adipocyte high density microsomes
Lane 5: Insulin stimulated rat adipocyte plasma membrane
Lane 6 : Basal rat adipocyte plasma membrane
Lane 7: Insulin stimulated rat adipocyte low density microsomes
Lane 8 : Basal rat adipocyte low density microsomes
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Rab3d has been detected in adipocytes and its mRNA level increases during 3T3-L1 
adipocyte differentiation (Baldini et al., 1992). A rab3d effector domain peptide, 
residues 52-67, (see table 2.1) was used to test for the involvement of this small 
G-protein on insulin stimulated transport. Figure 3.38 shows the effect of the peptide 
on basal and insulin stimulated transport rates in streptolysin-0 permeabilized 3T3-L1 
adipocytes. The addition o f the peptide to basal cells caused only a small rise in the 
rate o f transport. When the peptide was added to insulin stimulated adipocytes there 
was a small decrease in the transport rate to » 90 % o f the rate for insulin alone. 
These effects are not significant, suggesting that the peptide has no effect on transport.
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Figure 3.38 The effect of the rab3d effector domain protein on 2-deoxy- 
D-glucose uptake in streptolysin-O permeabilized 3T3-LI adipocytes
3T3-L1 adipocytes grown in 35 mm dishes were prepared, permeabilized and 2-deoxy-D-glucose uptake 
assayed as described in sections 2.3.3, 2.3.6 and 2.4.2.3 respectively. After permeabilization the 
adipocytes were incubated for 30 min in IIC buffer at 37 ‘ C with no addition, basal ( □ ) ,  with 100 nM 
insulin ( ■ ) ,  with 100 pM rab3d peptide ( 0 ) ,  with 100 pM rab3d peptide and 100 nM insulin ( ^ )  or 
100 pM rab3d peptide and 100 nM insulin after an additional 15 min pretreatment with the peptide ( H )  
before assaying transport. The sequence of the peptide is given in table 2.1.
Values are the means of one or two experiments ( □ ,  ■ ,  0  n=5; E8 n=3; 0  n=2). Errors are S.E.M.
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Figure 3.39. The effect of stably transfected rab3d on the distribution of 
stably transfected G LUT4 in C H O  fibroblasts
35 mm dishes were seeded with 0.05 x 106 C H O  fibroblasts and allowed to reach confluence in 4 days. 
Two dishes per condition were photolabelled with 100 pCi per dish in either the absence (surface) or 
presence (total) of 2.5 pg/m l digitonin. GLUT1 (|U ) and G LUT4 ( H )  were immunoprecipitated from  
solubilized cells and the gel counted as described in section 2.6. (a) The average peak area of the total 
transporter photolabelling, (b) The percentage of cell surface transporter was calculated by dividing the 
surface peak area by the total peak area. Values are given for GLUT1 in wild type fibroblasts and for 
GLUT1 and G LUT4 in the transfected C H O  fibroblasts. W .T .: wild type C H O  fibroblasts; GLUT4: C H O  
transfected with GLUT4; Rab3d W .T .: C H O  transfected with GLUT4 and rab3d; Rab3d 62-7: C H O  
transfected with G LUT4 and Rab3d with a deletion between residues 62 and 67; Rab3d 67-8: C H O  
transfected with GLUT4 and Rab3d with a deletion between residues 62 and 6 8 .
Values are the means of three experiments. Errors are the S.E.M.
The effect o f rab3d on transporter translocation was investigated in CHO fibroblasts 
transfected with both rab3d and GLUT4, provided by Dr M. Hashiramoto (Kobe 
University, Japan). Figure 3.39 shows that neither the wild type or the mutant rab3d 
lacking an effector domain had a significant effect on the distribution of GLUT4 with 
« 70 % at the cell surface. The transfected rab3d had a greater effect on the 
distribution o f GLUT1. In the CHO cells cotransfected with both GLUT4 and the wild 
type rab3d there was a significant increase in the proportion of the GLUT1 at the cell 
surface to » 75 %. The level o f GLUT1 at the surface o f cells expressing the deletion 
mutant rab3d was « 40 %. This percentage is higher than that in cells expressing 
GLUT4 alone but is similar to level of GLUT1 at the surface of the nontransfected 
CHO fibroblasts.
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3.7 The effect of GTPyS on glucose transport in 3T3-LI adipocytes
GTPyS, because it cannot be hydrolysed, will constitutively activate G-proteins when it 
is exchanged for GDP. The effect o f GTPyS on insulin stimulated glucose transport was 
therefore tested in streptolysin-0 permeabilized 3T3-L1 adipocytes. Figure 3.40 shows 
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Figure 3.40. The effect of 0.2 mM GTPyS on 2-deoxy-D-glucose uptake in 
streptolysin-O permeabilized 3T3-LI adipocytes.
3T3-L1 adipocytes grown on 35 mm dishes were prepared, permeabilized and 2-deoxy-D-glucose uptake 
assayed as described in section 2.3 and 2.4.2.3. After permeabilization the adipocytes were incubated 
for 30 min in IIC buffer at 37 'C  with no addition, basal ( □ ) ,  with 100 nM insulin, ( ■ )  or with 0.2 mM 
GTPyS ( 0 )  before assaying 2-deoxy-D-glucose.
Values are the means o f 6 experiments generally carried out in duplicate (n=13). Errors are the S.E.M.
Insulin caused a 3.6-fold increase in the rate o f 2-deoxy-D-glucose uptake. GTPyS also 
caused a rise in the rate of uptake of 2-deoxy-D-glucose but it was only about two 
thirds o f the insulin stimulated rate, a 2.3-fold rise over basal. To get a clearer idea o f 
how GTPyS stimulates transport in streptolysin-0 permeabilized 3T3-L1 adipocytes the 














50 - - U ,
X i i
Basal Insulin G T P 7 S
Figure 3.41. The effect of 0.2 mM GTPyS on the level of G LUT4 and 
G LU T I at the surface of streptolysin-O permeabilized 3T3-LI adipocytes
3T3-L1 adipocytes grown in 35 mm dishes were prepared and permeabilized as described in sections
2.3.3 and 2.3 .6 . After permeabilization 2 dishes of adipocytes per condition were incubated at 37 *C  
for 30 min in IIC buffer with no addition, basal, with 100 nM insulin or with 0.2 mM GTPyS. The cells 
were photolabelled with 300 pCi ATB-BMPA per dish, washed with IC buffer and TES and then 
subcellular fractionated to obtain purified plasma membrane for the immunoprecipitation and counting of 
G LUT4 and GLUT1 as described in section 2.6. The peak area for G LU T4 ( H )  and GLUT1 (E3) are 
expressed relative to that for insulin.
Values are the means of 2 independent experiments. Errors are the SD{[>-1).
Figure 3.41 shows the level GLUT1 and GLUT4 in purified plasma membrane. Insulin 
caused a 2.5-fold increase in GLUT4 and a 1.7-fold rise in GLUT1. Using the TK 
values o f table 3.1 this would result in a 2-fold rise in the transport rate. The 
proposed 2-fold increase in intrinsic activity following insulin stimulation would give the 
transport rate shown in figure 3.40. GTPyS caused a 5.2-fold in GLUT4, twice that o f 
insulin and a 1.7-fold rise in GLUT1, the same as for insulin. The over 200 % increase 
in cell surface level GLUT4 relative to the insulin stimulated level suggests that most of 
the total cellular GLUT4 was purified with the plasma membrane. The increase in the 
level o f cell surface transporters is more than is required for the transport rate shown 
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Figure 3.42. The effect of 0.2 mM GTPyS on insulin stimulated 2-deoxy-D- 
glucose uptake in streptolysin-O permeabilized 3T3-LI adipocytes
3T3-L1 adipocytes grown on 35 mm dishes were prepared, permeabilized and 2-deoxy-D-glucose uptake 
assayed as described in section 2.3 and 2.4.2.3. After permeabilization the adipocytes were incubated 
for 30 min in IIC buffer at 37 *C with no addition, basal ( □ ) ,  with 100 nM insulin, ( ■ ) ,  with 0.2 mM 
GTPyS (E2) or with 0.2 mM GTPyS and 100 nM insulin (E8) before assaying transport.
Values are the means of 2 experiments (n=5). Errors are the S.E.M.
The effect o f GTPyS on basal transport and insulin stimulated transport is shown in 
figure 3.42. While both insulin and GTPyS separately stimulated transport when 
3T3-L1 adipocytes were treated with insulin and GTPyS the effect o f the two was not 
additive and the transport rate was no more than insulin alone. Indeed there was a 
slight drop in the rate of insulin stimulated transport in the presence o f GTPyS. A 
similarly small effect was seen when insulin was added to cells that had been incubated 
GTPyS first (results not shown).
These results show that while both GTPyS and insulin stimulate glucose transport their 
effects are not additive. The effect of GTPyS appears to cause the translocation of 
GLUT4 to the cell surface but the level o f cell surface transporters is more than is 
required for the GTPyS stimulated transport rate.
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4.0 Discussion
4.1 Kinetic analysis of G LUT I and GLUT4 in 3T3-LI adipocytes
Insulin stimulation causes the rate of glucose uptake to increase about 20-fold in the 
highly insulin responsive cell line, 3T3-L1 adipocytes. The major mechanism whereby 
insulin achieves this stimulation is the translocation of transporters from an intracellular 
poo! to the cell surface. However, translocation, as assessed by subcellular 
fractionation, results in only a 5-6-fold increase in the concentration of transporters at 
the cell surface. Thus this increase on its own is not sufficient to explain the increase in 
the transport rate. 3T3-L1 adipocytes possess two transporter isoforms, GLUT1 and 
GLUT4. Insulin, as well as increasing the total number of cell surface transporters also 
alters the ratio of the two isoforms there. Under basal conditions the ratio of GLUT1 
to GLUT4 at the cell surface is 5:1 while insulin stimulation increases the proportion of 
GLUT4 to give a ratio of 1:1. This suggests that GLUT1 and GLUT4 may be making 
different contributions toward the transport rate.
Because the transport rate is contributed to by two different transporter isoforms the 
kinetic parameters for the individual isoform cannot be calculated directly from 
transport data as the kinetics of transport are a combination of two Km and two Vmax 
values. In order analyse the separate contributions of the two transporter isoforms, 
therefore, the separate affinities of GLUT1 and GLUT4 were determined for 3-0- 
methyl-D-glucose. This was achieved by measuring the displacement of the photolabel 
ATB-BMPA by a range of 3-0-methyl-D-glucose concentrations. This was used to 
calculate the specificity or transport constant, TK, for GLUT1 and GLUT4. TK 
incorporates both the Km and of the transporter as the TK is equal to the turnover 
number divided by the Km and the turnover number is equal to the Vmax divided by the 
concentration of transporters. The TK can therefore be defined thus:
TK = (equation 4.1).
[GLUT1 or 4] v  ^ '
The TK value can therefore be used to determine the transport capacity of the
Discussion 127
transporter isoforms at low substrate concentrations, the capacity being governed by 
both the turnover of the transporter and its affinity for the substrate.
As there are two transporter isoforms involved in the uptake of sugar by the 3T3-L1 
adipocytes the rate of uptake is defined by the sum of two Michaelis-Menten equations:
, ,   M nax.1  ^ / ^ m 1  , M n a x .4  ^ / ^ m 4  f    a(equation 4.2).
Using equation 4.1, TK can be substituted into equation 4.2 in place of Vmax:
TK1-S4GLUT11 TK4-S-IGLUT41
"  J t f c )  *  ( T , «  <«*»<». « , .
Since A0/A  = (1 + S/Km)  the reciprocal of the fraction of the unoccupied sites in 
equation 4.3, 1/(1 + S/Km) ,  can be determined from the displacement of ATB-BMPA by
3-O-methyl-D-glucose by dividing the radioactivity associated with transporters 
photolabelled with ATB-BMPA in the presence of 3-O-methyl-D-glucose (A) by the 
radioactivity associated with transporters in the absence of 3-O-methyl-D-glucose (A0). 
This equation can also be used to calculate the Km of GLUT1 and of GLUT4. These 
ratios (A 0/A )  are given in figure 3.6. The values used for the concentration of either
GLUT1 or 4 are taken from Palfreyman et al. (1992) and are the Bmax values given in 
table 3.1. The transport rate (v) from figure 3.3 at a particular concentration of 3-O- 
methyl-D-glucose (S) can be used to calculate the TK values for GLUT1 and GLUT4 
using least square regression of the equation:
v/S = TK1-x1 + TK4-x4 (equation 4.4)
where x1 and x4, the concentration of unoccupied sites, are equal to the Bmax 
multiplied by either A /A0 or 1/(1 + S/Km) ,  the reciprocal fraction of unoccupied sites.
By using the Km values previously calculated from figure 3.6 the error in calculating the 
TK values is reduced. The use of acute and chronically insulin stimulated adipocytes, 
which have different concentrations of surface GLUT1 and GLUT4, aids the analysis.
The results of the analysis, given in table 3.1, show that the TK values of GLUT1 and 
GLUT4 are similar in both acute and chronically insulin stimulated 3T3-L1 adipocytes. 
Therefore the best estimate is given when these two sets of data are combined. This
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gives TK1 as 3.6 x 10'3 mM'1-mm1 and TK4 as 11.3 x 10'3 mM'1-min1. Thus the 
transport capacity of GLUT4 is « 3-fold higher than that of GLUT1. When the 
average Km are used to calculate the turnover number (Km1 = 19.9 mM and = 7.0 
mM) then the turnover number is 7.2 x 104 min1 for GLUT1 and 7.9 x 104 min*1 for 
GLUT4. Since these are very similar the difference in the transport capacity is due to 
the low affinity of GLUT1 for 3-O-methyl-D-glucose. Thus at low sugar concentrations 
more of the uptake occurs via GLUT4 than via GLUT1 due to the lower Km of GLUT4.
In the basal 3T3-L1 adipocytes the TK values and turnover numbers for both GLUT1 
and GLUT4 were « 2-fold lower than the equivalent value in the insulin stimulated 
adipocytes. These values are less reliable than those in the insulin stimulated 
adipocytes as the low concentration of transporters and transport rate makes accurate 
measurement difficult. However, while not too much emphasis should be placed on 
this « 2-fold difference in the activity of GLUT1 and GLUT4 in basal and insulin 
stimulated 3T3-L1 adipocytes it does suggest that, in addition to affecting transporter 
translocation, insulin also increases the intrinsic activity of the transporters. This insulin 
induced 1.5-2-fold increase in transporter activity has been reported by others, for 
example by Holman et al. (1990) in rat adipocytes.
During the analysis of the transport capacities of GLUT1 and GLUT4 several 
assumptions have been made. It was assumed that both GLUT1 and GLUT4 bind 
ATB-BMPA with equal efficiency even though their affinity for glucose is different. The 
Kd for both transporters for ATB-BMPA has been shown to be « 150 jjM (Palfreyman 
et o/., 1992). This is similar to the affinity of liver membrane GLUT2 toward ATB- 
BMPA where the Kd was reported to be « 200 pM (Jordan and Holman, 1992). If the 
affinities of GLUT1 and GLUT4 were different then this would have the effect of 
increasing the TK and so the turnover number of one transporter isoform relative to 
the other one. Another factor associated with labelling is the efficiency of both 
labelling and immunoprecipitation. If a significant proportion of the cell surface 
transporters were either not photolabelled or immunoprecipitated then this would
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result in an over estimation of the transporter turnover numbers. If one isoform was 
immunoprecipitated more efficiently than the other then this would have the same 
effect as if the two isoforms had different affinities for ATB-BMPA. In fact after 
immunoprecipitation there is less than 20 % of the radioactivity running in the same 
region as the transporters on SDS-PAGE still remaining in the solubilized cell 
supernatant (Palfreyman et a/., 1992). This percentage is similar to that for rat 
adipocytes (Holman et a/., 1990). A further problem in using ATB-BMPA to determine 
the concentrations of transporters at the cell surface is that ATB-BMPA may be able to 
photolabel transporters that are present at the plasma membrane but which are not 
yet involved in transport. These transporters were described by Satoh et al. (1993) as 
being in partially occluded vesicles. They used this state to explain the lag between the 
insulin stimulated increase in cell surface ATB-BMPA labelling and the increase in the 
transport rate. If transporters in such vesicles were included in the concentration of 
cell surface transporters then this would lead to an under estimation of the turnover 
numbers.
The Km and turnover number of GLUT1 alone for 3-O-methyl-D-glucose have been 
relatively easy to measure because it is abundantly available in human erythrocytes 
where it is the only isoform. Here measurements made at 20 *C generally give a Km of 
» 25 mM and a turnover of 2.0 to 4.0 x 104 min'1 (Carruthers, 1990). Holman et al. 
(1981), for example, calculated a Km of 20.0 mM and a turnover of 4.3 x 104 min'1. 
These parameters have also been calculated in Xenopus oocytes expressing GLUT1. 
Keller et al. (1989) measured a Km of 21 mM and a turnover of 13.2 x 104 min'1 for 
human GLUT1 at 22 'C. Gould et a/., at 18 *C, measured a Km of 20 mM and aw w m
turnover of 1 x 104 min'1 for rat GLUT1 (Gould et al., 1989) and a Km of 17.6 mM for 
human GLUT1 (Gould et al., 1991). More recently Nishmura et al. (1993) have 
measured the kinetics of rat GLUT1 at 20 *C and obtained a Km of 26.2 mM and a 
turnover of 2.7 x 104 min’1 at 20 *C. Thus the K of 20 mM and turnover number ofm
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7.2 x 104 min'1 measured here for the mouse transporter in 3T3-L1 adipocytes are 
similar to the findings of others.
The measurement of the kinetics of GLUT4 transport activity is less easy as there are 
no cells expressing exclusively GLUT4. In insulin stimulated adipocytes, where GLUT4 
is by far the predominant species, the average Km for 3-O-methyl-D-glucose is » 5 mM 
(Birnbaum, 1992) at 37 *C. Taylor and Holman (1981) calculated a Km of 4.5 mM 
while Simpson etal. (1983) calculated a turnover of 5.6 x 104 min'1 for rat adipocytes. 
In Xenopus oocytes at 22 *C Nishmura et al. (1993) calculated a Km of 4.3 mM and a 
turnover of 1.7 x 104 min'1 for rat GLUT4 at 22 *C. These values are a little lower 
than the turnover number of 7.9 x 104 min'1 and K of « 7 mM calculated here. Such am
difference could be due in part to a low efficiency of photolabelling and 
immunoprecipitation.
All the measurements of the Km of GLUT1 for 3-O-methyl-D-glucose agree on a value 
around 20 mM. The range of calculated turnover number for GLUT1 is greater. 
While the value obtained by Nishmura et al. (1993) in Xenopus oocytes is within the 
range for erythrocytes the value for GLUT1 in 3T3-L1 adipocytes is higher but within 
the same order of magnitude. The calculated values for Km GLUT4 are also fairly 
comparable and are several fold lower than the Km for GLUT1. AH the GLUT4 
turnover numbers are of the same order of magnitude although the turnover for 
GLUT4 in Xenopus oocytes (Nishmura et o/., 1993) is lower than that for GLUT4 in 
either rat or 3T3-L1 adipocytes. Despite the difference in the absolute GLUT1 and 
GLUT4 turnover numbers in the 3T3-L1 adipocytes and the oocytes of Nishmura the 
turnover numbers for GLUT1 and GLUT4 are similar in both studies. Thus both 
studies, where the K and the turnover number for GLUT4 and GLUT1 have been 
calculated at the same time, show that at high concentrations of 3-O-methyl-D-glucose 
the activity of both transporters would be the same and the greater activity of GLUT4 
at lower concentrations is due to its lower K .m
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The difference in the absolute values between these two studies highlights the inherent 
dangers in measuring kinetic parameters in either system. There are several factors 
which could potentially affect the calculation of kinetic parameters in Xenopus oocytes. 
The transport measurements in both human erythrocytes and Xenopus oocytes were 
made at around 20 *C rather than at the more physiological temperature of 37 *C. 
This may cause a decrease in the turnover number and so result in a lower TK, which 
would explain the slightly lower turnover numbers that were calculated in Xenopus 
oocytes. Substitutions at Asn45, the N-glycosylation site, have been shown to reduce 
the affinity of GLUT1 for glucose (Asano et a/., 1991). Since Xenopus oocytes are not 
mammalian cells they may be unable to correctly N-glycosylate the transporters which 
may affect the transport rate. The activity of GLUT1 and GLUT4 appears to be lower 
in basal than in insulin stimulated adipocytes. As oocytes are insulin insensitive it is not 
possible to tell which of these two states in adipocytes is comparable to the activity 
measured in the oocytes. One further difference is that the oocytes were transfected 
with rat transporters while 3T3-L1 are a mouse cell line.
In summary, these experiments have shown that ATB-BMPA and 3T3-L1 adipocytes 
can be used to estimate the separate kinetic activities of both GLUT1 and GLUT4 in an 
insulin sensitive cell line which expresses both transporter isoforms. The results have 
shown that the turnover numbers of GLUT1 and GLUT4 for 3-O-methyl-D-glucose are 
similar and that the difference in activity of the two isoforms at low sugar 
concentrations is due to their different K values. Thus the result of insulin stimulationm
is to increase the transport rate by increasing the total amount of transporter at the 
cell surface and to increase the proportion of surface GLUT4. A further effect of acute 
insulin stimulation appears to be to increase the intrinsic activity of the transporters 
relative to that in the basal adipocytes. Chronic insulin stimulation does not appear to 
further alter the activity of the transporters but instead, as with rat adipocytes (Kozka 
et a/., 1993), chronic insulin stimulation depresses the levels of GLUT4 reaching the cell 
surface while increasing the surface and total levels of GLUT1.
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4.2 Okadaic acid and insulin stimulation in adipocytes
Okadaic acid is an inhibitor of the serine/threonine protein phosphatases PP1 and 
PP2A. It has been used to investigate the mechanism whereby insulin stimulates 
glucose transport. When okadaic acid is added to cells it causes an increase in the level 
of phosphorylated proteins by inhibiting their dephosphorylation (Cohen et cL, 1990). 
Okadaic acid has previously been shown to increase the basal rate of glucose transport 
and to decrease the insulin stimulated rate with a similar effect on the concentration of 
cell surface transporters (Lawrence et al., 1990b). This led to the suggestion that a 
serine/threonine phosphorylation event may be involved in the insulin induced 
increase in the transport rate. These observations were made using 2-deoxy-D-glucose 
uptake assays and Western blotting in rat adipocytes.
In this study the effect of okadaic acid on hexose transport in both rat and 3T3-L1 
adipocytes was assayed with a 3-O-methyl-D-glucose transport assay. The use of this 
sugar analogue to assay transport activity allows any effect of okadaic acid on the 
phosphorylation of 2-deoxy-D-glucose to be discounted. The level of GLUT1 and 
GLUT4 at the cell surface was determined by photolabelling, a more accurate and 
easily quantifiable method for determining the effects of okadaic acid on the level of 
cell surface transporters than Western blotting.
In basal rat adipocytes the optimum okadaic acid concentration for the stimulation of 
3-O-methyl-D-glucose uptake was found to be between 0.2 to 1.0 pM. This is within 
the okadaic acid concentration range of 0.05 to 1.0 pM which Haystead et al. (1989) 
found stimulated the uptake of 2-deoxy-D-glucose in rat adipocytes. This is also 
consistent with the concentration of 1.0 (jM used by Lawrence et al. (1990b). 
Haystead et al. (1989) found that okadaic acid stimulated the uptake of 2-deoxy-D- 
glucose but with a 5 min lag. When Lawrence looked more closely at this they found 
that okadaic acid stimulated the transport rate by only about 50 % of the insulin 
stimulated rate. This is fairly similar to the 40 % stimulation shown in figure 3.8.
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The same okadaic acid concentration range had a similar effect in 3T3-L1 adipocytes. 
Here, however, the maximal stimulation in the rate of 3-O-methyl-D-glucose uptake 
with 0.5 to 1.0 pM okadaic acid alone was only 35 % of the insulin stimulated 
transport rate, a little less than the rate for rat adipocytes. In both basal and insulin 
stimulated rat adipocytes GLUT4 is the dominant transporter isoform at the cell 
surface. In the plasma membrane of basal 3T3-L1 adipocytes there is much more 
GLUT1 than GLUT4 so that in these cells more of the 3-O-methyl-D-glucose uptake 
occurs via GLUT1 than in rat adipocytes. Thus if okadaic acid has a greater effect on 
GLUT4 than GLUT1 then the effect of the inhibitor will be less in 3T3-L1 adipocytes.
When ATB-BMPA was used to detect GLUT1 and GLUT4 in the plasma membrane 
then the small okadaic acid induced increase in the transport rate was found to be 
associated with a small increase in the concentration of transporters at the cell surface. 
In both rat and 3T3-L1 adipocytes the increased rate of uptake following okadaic acid 
stimulation could be accounted for by the increase in cell surface transporters if the 
intrinsic activities of GLUT1 and GLUT4 were more like those in insulin stimulated cells 
rather than basal ones. This finding is in agreement with that of Corvera et al. (1991) 
who also found that the submaximal stimulation of transport by okadaic acid was 
associated with only a small increase in cell surface GLUT4. They also reported that 
the intrinsic activity of GLUT4 following okadaic acid treatment was lower than would 
be expected for GLUT4 in insulin stimulated adipocytes. This difference may partially 
be explained by the observed decrease in the concentration of plasma membrane 
GLUT1 in rat adipocytes, figure 3.9.
Okadaic acid was found to have an inhibitory effect on the insulin stimulated uptake of 
3-O-methyl-D-glucose transport (Lawrence et al., 1990b; Corvera et al., 1991). Since 
the stimulatory effects of okadaic acid and insulin are not additive this suggests that the 
stimulatory pathways of insulin and okadaic acid share at least one common 
component. The inhibition of insulin stimulation by okadaic acid was greater in the rat 
adipocytes than in the 3T3-L1 adipocytes. In rat adipocytes the rate of uptake
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following insulin stimulation in the presence of 0.5 pM okadaic acid was only 30-40 % 
of the rate with insulin alone. This is similar to the inhibition of 2-deoxy-D-glucose 
uptake obtained by both Lawrence et al. (1990b) and Corvera et al. (1991). In the 
3T3-L1 adipocytes the inhibitory effect of okadaic acid on insulin stimulated transport 
was much less than in the rat adipocytes. Here the transport rate following insulin 
stimulation in the presence of 1.0 pM okadaic acid was only a little less than for insulin 
stimulation alone. The effect of okadaic acid on insulin stimulation was similar whether 
the adipocytes were pretreated with insulin or okadaic acid before the addition of 
either okadaic acid or insulin respectively although pretreatment with okadaic acid 
generally had the greater inhibitory effect.
When the effect of okadaic acid on the insulin stimulated translocation of GLUT1 and 
GLUT4 to the cell surface was studied then it was found that there was a lower 
concentration of both transporters isoforms at the plasma membrane with okadaic acid 
and insulin than with insulin alone. This is consistent with the inhibitory effect of 
okadaic acid on the insulin stimulated transport rate. Thus it appears that the major 
effect of okadaic acid on transport is to modulate translocation rather than to simply 
reduce the intrinsic activity of the transporters already at the cell surface. Insulin has 
been shown by Lawrence et al. (1990b) to reduce the phosphorylation of GLUT4. 
Okadaic acid increases the level of GLUT4 phosphorylation, as expected from a 
phosphatase inhibitor. They suggested that GLUT4 phosphorylation acts as a signal for 
the internalisation of the transporter. The results presented here support the idea that 
the major effect of okadaic acid is to alter transporter translocation. A more recent 
study by Reusch et al. (1993) on GLUT4 phosphorylation and its effect on activity 
suggested that in plasma membrane vesicles the phosphorylated GLUT4 was 35 % less 
active than the dephosphorylated transporter. In order to test if okadaic acid was also 
causing a decrease in the intrinsic activity of the transporters the actual transport rate 
in okadaic acid stimulated rat adipocytes was compared with the potential rate of 
transport from the same number of transporters in insulin stimulated adipocytes. In
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doing this the assumption was made that GLUT4 has an « 3-fold higher transport 
capacity than GLUT1, as has been shown in 3T3-L1 adipocytes (Palfreyman et a/., 
1992) and in Xenopus oocytes expressing rat transporters (Nishmura et a/., 1993). If 
this assumption is valid for rat adipocytes then the transport and photolabelling results 
given in figures 3.9a and b suggest that the transport rate in okadaic acid treated cells is 
between about 80 and 85 % of what would expected for the same number of 
transporters in insulin stimulated rat adipocytes. This therefore provides circumstantial 
evidence that okadaic acid and perhaps therefore phosphorylation does cause a 
decrease in the intrinsic activity of the transporters relative to insulin stimulation. 
However, because no measure was made of the degree of GLUT4 phosphorylation it 
is not possible to be certain whether this effect on the transport activity correlates with 
the phosphorylation of GLUT4 rather than with another conformational change.
The effect of okadaic acid on translocation was investigated by looking at the effect of
okadaic acid on insulin reversal. Adipocytes which had been stimulated with insulin had
this stimulation removed in either the presence or absence of okadaic acid. In the rat
adipocytes (figure 3.10) the presence of okadaic acid did not prevent treatment with
collagenase from causing the transport rate to decrease from the initial insulin
stimulated rate. The rate decreased to a level similar to that for okadaic acid alone.
The lack of sufficient time points in this experiment prevented the calculation of a t,A.
In 3T3-L1 adipocytes (figure 3.13) okadaic acid also failed to prevent the insulin
reversal treatment causing the transport rate to decrease. In figure 3.13a the
transport rate after 30 min reversal in the presence of okadaic acid is higher than the
rate for 30 min okadaic acid treatment of basal adipocytes. Several factors could
contribute to this difference including the longer incubation period and possibly
incomplete reversal. A time course for the reversal of the insulin stimulated transport
rate in 3T3-L1 adipocytes in the presence and absence of okadaic acid is shown in
figure 3.13b. The points were used to calculate the half-time for reversal in the 
presence or absence of okadaic acid using the equation ty2 = ln2/(Kex +K en) , and
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Kw being calculated from % at surface = (Kex + K^expf-^K,* +K en))/(Kex + Ken) since 
a change in the transport rate is governed by the translocation of transporters to and 
from the cell surface. The calculated half time for the reversal of insulin stimulation in 
the absence of okadaic acid was » 4.4 min and » 6.5 min in the presence of okadaic 
acid. The tM for insulin reversal in the absence of okadaic acid is similar to that 
obtained by Yang et al. (1992a). The presence of okadaic acid increases the t% of 
reversal. This slower half time of reversal could be due to a decrease in the rate of 
transporter exocytosis or a decrease in the rate of endocytosis. Altering either of 
these parameters would result in an okadaic acid induced decrease in the reversal half 
time. If okadaic acid regulated translocation at both of these steps then it could inhibit 
the insulin stimulated increase in the transport rate by inhibiting the insulin induced 
increase in exocytosis and increase the basal transport rate by decreasing endocytosis.
The ability of okadaic acid to alter the rate of translocation is also suggested by the 
recycling of ATB-BMPA photolabelled transporters from the plasma membrane. Three 
conditions were compared; continued insulin stimulation, the reversal of insulin 
stimulation and reversal in the presence of okadaic acid. After 30 min the condition 
with the highest concentration of labelled transporter in the plasma membrane was 
that of reversal in the presence of okadaic acid. As figures 3.13a and b show that the 
reversal of insulin stimulated transport in the presence of okadaic acid results in a 
decrease in the insulin stimulated transport rate, the result of the transporter recycling 
must be taken as an indication of a low rate of transporter endocytosis and exocytosis 
when compared with insulin stimulation. Thus the plasma membrane pool of labelled 
transporters is diluted more slowly in the okadaic acid treated adipocytes than in the 
insulin treated cells. Unfortunately the translocation of GLUT4 from the plasma 
membrane was not complete for the reversal of insulin stimulation in the absence of 
okadaic acid. This suggests that the cells may have been damaged during the UV 
irradiation so this result can only be taken as a indication of the okadaic acid effect and 
is not entirely reliable.
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Taken together these experiments indicate that okadaic acid has two separate effects 
on glucose transport in adipocytes affecting phosphorylation at two different sites. The 
first effect is at the level of the transporter itself. Okadaic acid either causes an 
increase the degree of GLUT4 phosphorylation or prevents the insulin induced 
dephosphorylation of GLUT4. This results in a small drop in the intrinsic activity of 
GLUT4. The second effect is at the level of the translocation mechanism. Here 
okadaic acid prevents the insulin stimulated increase in the rate of exocytosis and 
lowers basal endocytosis rate. Such effects are in agreement with the findings of 
Reusch et al. (1993) who reported that the phosphorylation of GLUT4 decreased its 
intrinsic activity but did not alter the distribution of insulin stimulated translocation of 
GLUT4 when phosphorylated by parathyroid hormone treatment. Since, therefore, 
the phosphorylation of GLUT4 does not appear to alter its distribution the effect of 
okadaic acid on GLUT4 translocation must be at another step in the mechanism. 
Cormont et al. (1993) have observed that both insulin and okadaic acid cause the 
cycling of GLUT4 and rab4. They have proposed that rab4 may be a component in 
the GLUT4 translocation mechanism of both insulin and okadaic acid. Insulin 
treatment also induces the phosphorylation of Rab4 (Cormont et al., 1994).
Okadaic acid, at the concentrations of » 1.0 pM required to have an effect in whole 
cells, will inhibit both PP1 and PP2A. There are however reports that insulin regulates 
these two phosphatases differently. The activated insulin receptor has been shown to 
phosphorylate protein phosphatase-2A at Tyr307. Phosphorylation at this site 
deactivates the phosphatase (Chen et al., 1992). Insulin has the opposite effect on 
protein phosphatase-1. Insulin, via the C terminus of the insulin receptor, has been 
shown to activate PP1 (Begum e ta i,  1993b). Therefore if both of these phosphatases 
are involved in the insulin signalling pathway for stimulating glucose transport then 
okadaic acid could be having an insulin like effect on PP2A while inhibiting the effect of 
insulin on PP1. Hence okadaic acid could partially stimulate transport on its own while 
inhibiting insulin stimulated transport.
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4.3 The effect of tyrosine kinase inhibitors on transport in adipocytes
Tyrosine kinase inhibitors, mostly based on tyrphostins, have been shown to inhibit the 
epidermal growth factor tyrosine kinase. Ten such tyrosine kinase inhibitors were 
provided by the Wellcome Research Laboratories and were used to investigate the 
involvement of tyrosine kinases in the insulin signalling pathway for the stimulation of 
glucose transport. Rat adipocytes were incubated with each of the ten inhibitors at a 
concentration of 0.68 [jM before stimulating the adipocytes with insulin in the 
continued presence of the inhibitor. This concentration was chosen as it is double the 
average published IC50 for the inhibition of the epidermal growth factor receptor kinase 
by the ten inhibitors (table 3.2). It was expected that at this concentration at least 
some of the inhibitors would inhibit the insulin receptor tyrosine kinase (IRTK) and so 
prevent the insulin stimulated increase in the rate of 3-O-methyl-D-glucose uptake. At 
0.68 pM not one of the inhibitors inhibited insulin stimulated 3-O-methyl-D-glucose 
uptake. Indeed in the presence of some of the inhibitors the transport rate was slightly 
but not significantly higher than with insulin alone. At the » 1000-fold higher 
concentration of 0.5 mM all the inhibitors had some inhibitory effect on the insulin 
stimulated transport rate and several completely abolished transport, a result not 
obtained with the 0.1 % DMSO or ethanol in which the inhibitors were dissolved. The 
tyrosine kinase inhibitor 453C89, a-cyano-3,4-dihydroxythiocinnamide, had no 
significant effect at a concentration of 0.68 pM but virtually abolished insulin stimulated 
transport at 0.5 mM. This inhibitor was used for the further experiments.
The effect of 5 to 500 pM 453C89 on insulin stimulated 3-O-methyl-D-glucose uptake 
is the same in both rat and 3T3-L1 adipocytes (figures 3.15 and 3.17). At the lowest 
concentration of 5 (jM 435C89 had a slight stimulatory effect on the insulin stimulated 
rate of uptake in both rat and 3T3-L1 adipocytes. In rat adipocytes the insulin 
stimulated rate in the presence of 500 |jM 453C89 was less than the basal transport 
rate. In the 3T3-L1 adipocytes, however, the rate of insulin stimulated 3-O-methyl-D- 
glucose uptake in the presence of 500 pM 453C89 was not quite as low as the basal
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rate. This may be a reflection of the higher proportion of surface GLUT1 relative to 
GLUT4 in the 3T3-L1 adipocytes and suggests that 453C89 has a greater effect on 
GLUT4 than on GLUT1.
Several experiments were carried out which suggested that the inhibition of insulin 
stimulated transport by 453C89 was unlikely to be due to the inhibition of the insulin 
receptor tyrosine kinase. A time course for the inhibition 3-O-methyl-D-glucose uptake 
in insulin stimulated rat adipocytes by 0.5 mM 453C89 showed total inhibition within 
one minute. Such a rapid inhibition suggests that 453C89 is not acting at the insulin 
receptor tyrosine kinase and is unlikely to be affecting the translocation of 
transporters. A lack of an effect by 453C89 on the translocation mechanism is further 
suggested by the significant inhibition of transport by 500 pM 453C89 in insulin 
stimulated 3T3-L1 adipocytes at 18 ’C. The internalisation of transporters is 
temperature sensitive and is significantly inhibited at 18 *C (Clark et al., 1991). As 
453C89 still inhibits insulin stimulated transport at 18 *C, inhibition is unlikely to be 
due to a rapid translocation of transporters from the cell surface.
Further support for the idea that 453C89 acts at the level of the transporter rather 
than at the insulin receptor tyrosine kinase was provided by the observation that when 
0.5 mM 453C89 and 3-O-methyl-D-glucose were simultaneously added to insulin 
stimulated 3T3-L1 adipocytes then the rate of transport is only 60 % of the insulin 
stimulated rate. This inhibition occurred within the 10 sec of the transport assay with 
both the inhibitor and the labelled sugar present at the same time.
In an attempt to determine if 453C89 could inhibit insulin stimulated glucose transport 
at the level of a tyrosine kinase 3T3-L1 adipocytes were incubated with a low 
concentration of the inhibitor for an extended period of time before stimulating the 
adipocytes with insulin and assaying transport. At 5 pM, a concentration high enough 
to inhibit the epidermal growth factor receptor tyrosine kinase (Yaish et al., 1988) but 
which does not inhibit insulin stimulated transport after a short period of incubation,
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453C89 did not inhibit insulin stimulated 3-O-methyl-D-glucose transport even after 
several hours incubation. This again suggests that 453C89 has not inhibited any 
tyrosine kinase involved in the insulin signalling pathway for the stimulation of glucose 
uptake.
The absence of inhibition of the insulin receptor tyrosine kinase by these tyrosine 
kinase inhibitors has been reported by others. Young et al. (1993) have found that in 
rat adipocytes both 690C88 and 453C89 inhibit both the basal and insulin stimulated 
rates of fatty acid synthesis from glucose. Neither inhibitor, however, significantly 
reduced the magnitude of the insulin effect. 453C89 was also found to inhibit 
aldehyde dehydrogenase, suggesting that this, and other inhibitors are not specific for 
tyrosine kinases (Young et a/., 1993). Alber et al. (1992) have reported that genistein 
(76W79) inhibits insulin stimulated glucose oxidation but does not inhibit insulin 
receptor autophosphorylation or the activity of the insulin receptor tyrosine kinase. 
Smith et al. (1993) have also shown that while genistein does not inhibit the insulin 
induced redistribution of GLUT4 to the plasma membrane it does inhibit both basal 
and insulin stimulated 3-O-methyl-D-glucose uptake.
The results of others and those reported here suggest that the inhibitory effect of 
453C89, as with genistein, occurs at the level of the transporter itself and that it does 
not inhibit the insulin receptor tyrosine kinase. There are two possible mechanisms 
whereby 453C89 could inhibit transport. One is competitive inhibition with the 
inhibitor competing with the 3-O-methyl-D-glucose for the sugar binding site of the 
transporter. The second is non competitive inhibition with perhaps the inhibitor 
inducing a conformational change in the transporter that greatly reduces its activity. If 
453C89 were simply competing with the sugar then 0.5 mM 453C89 would be 
expected to produce a similar level of inhibition of the uptake of 50 pM 3-O-methyl-D- 
glucose transport whether the cells were pretreated with the inhibitor or both the 
sugar and inhibitor were added together. Since the degree of inhibition was less when 
sugar and inhibitor were added together than when the sugar was added after a pre­
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treatment with the inhibitor then non competitive inhibition seems more likely than 
competitive inhibition.
The difference between the degree of inhibition by 500 pM 453C89 in rat and 3T3-L1 
adipocytes suggests that the inhibitor preferentially inhibits GLUT4, the higher 
proportion of GLUT1 in the 3T3-L1 adipocytes lessening the degree of inhibition. 
Such a difference between GLUT1 and GLUT4 might be less likely if the inhibitor was 
simply blocking transport. Thus it seems likely that 453C89 is inhibiting transport 
perhaps by inducing a conformational change reducing the intrinsic activity of the 
transporters. Furthermore the greater inhibitory effect appears to be on GLUT4 
rather than on GLUT1. Such a conclusion is supported by the findings of Smith et al. 
(1993) who reported that while genistein did not alter the translocation of GLUT4 in 
rat adipocytes it did decrease the intrinsic activity of GLUT4 by inducing a 
conformational change at the C terminus. They were able to demonstrate that while 
insulin caused an increase in the level of immunocytochemical labelling at the C 
terminus of GLUT4, genistein induced a conformational change which decreased 
C-terminal labelling without affecting labelling at the N terminus. Thus they concluded 
that conformational changes at the C terminus of GLUT4 alter its intrinsic activity and 
that this results in a reduced rate of 3-O-methyl-D-glucose uptake.
In summary, the tyrosine kinase inhibitor 453C89, a-cyano-3,4- 
dihydroxythiocinnamide, does not appear to inhibit any tyrosine kinase involved in the 
insulin induced translocation of GLUT4 and indeed does not appear to be a specific 
tyrosine kinase inhibitor. It does, however, inhibit the uptake of 3-O-methyl-D-glucose 
at the level of the transporter itself with a preference for GLUT4. The inhibitory effect 
is possibly the result of a conformational change in the transporter which alters its 
intrinsic activity.
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4.4 The targeting of transfected GLUT4 in fibroblasts
The facilitative glucose transporter GLUT1 occurs in many cell types and tissues 
including both insulin sensitive and insensitive cells. Much of the GLUT1 is expressed at 
the cell surface. GLUT4 expression is limited to the insulin sensitive adipose and 
muscle tissue. These cells express both GLUT1 and GLUT4. A greater proportion of 
the total GLUT1 is at the cell surface of basal adipocytes than GLUT4. However, 
following insulin stimulation a greater proportion of GLUT4 is translocated to the cell 
surface. The aim of these experiments was to determine if the differential distribution 
of GLUT1 and GLUT4 within adipocytes is a property of the GLUT4 protein itself or 
whether it is conferred on it by the insulin sensitivity of the cell in which it is expressed. 
In order to determine whether GLUT4 is intrinsically a plasma membrane protein or 
an intracellular protein it was expressed in insulin insensitive cells which do not 
normally express GLUT4.
It is not only in insulin sensitive cells that transporters are sequestered in intracellular 
pools. GLUT1 has been shown to be internally sequestered in many cells. These 
include BHK cells (Widnell et a/., 1990) and murine fibroblasts (Haspel et al., 1986). 
The redistribution of GLUT1 to the cell surface has been shown to occur in these cells 
in response to stresses such as heat shock and glucose starvation. Yang et al. (1992b) 
have reported that in 3TB-L1 fibroblasts over 75 % of the GLUT1 can be sequestered 
to intracellular stores.
Attempts to transfect 3T3-L1 fibroblasts with the plasmid pRC-CMV-hGLUT4 and 
express GLUT4 proved not to be very successful as the level of expression, although 
detectable, was too low and the transfection was not reliable. There are two potential 
reasons for that this. One reason may be associated with the calcium phosphate 
precipitation method which may not have been reliable or may not have induced a high 
enough level of transfection. A second reason may be that the plasmid, pRC-CMV- 
hGLUT4, was designed specifically for transfection into COS-7 fibroblasts.
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When COS-7 fibroblasts, an insulin insensitive cell line, were transfected with pRC- 
CMV-hGLUT4 by the DEAE-dextran method the level of transfection and expression 
was much higher. When the plasma membrane and low density microsomal fractions 
of the COS-7 fibroblasts were immunoblotted, figure 3.22, transfected GLUT4 was 
detected in both fractions. Most of the transfected GLUT4 appeared as a broad band 
in the plasma membrane fraction. A similar experiment by Schurmann et ai. (1992b) 
also showed that the subceilular fraction of COS-7 with the greatest proportion of the 
total GLUT4 was the plasma membrane fraction. They also had a much broader 
GLUT4 band in COS-7 cells than in 3T3-L1 adipocytes which they suggested was due 
to heterogeneous glycosylation.
To better quantify the proportion of the total GLUT4 at the cell surface of both COS-7 
and CHO fibroblasts the cells were photolabelled with ATB-BMPA. In order to 
determine the suitability of ATB-BMPA for the labelling of GLUT1 and GLUT4 in these 
cell lines transporters at the surface of COS-7 and CHO fibroblasts transfected with 
GLUT4 were photolabelled in either the presence or absence of glucose. A single 
glucose displaceable peak was obtained following either immunoprecipitation with 
GLUT1 or GLUT4 which confirmed that the label was still sufficiently specific and 
therefore suitable for quantifying the levels of GLUT4 and GLUT1 in these cells.
Surface and total photolabelling of transporters in nontransfected COS-7 fibroblasts 
and fibroblasts expressing GLUT4 was used to determine the percentage of the 
transporters at the cell surface. In both transfected and nontransfected cells the 
proportion of total GLUT1 at the cell surface was 55-60 %, a similar proportion to 
that reported by Schurmann et al. (1992b) who found » 55 % of the GLUT1 at the 
surface of nontransfected cells as detected by counting Western blots. They also found 
» 45 % of the transfected GLUT4 at the cell surface. Using ATB-BMPA, however, the 
photolabelling of fibroblasts transfected with GLUT4 appeared to indicate that 140 % 
of the total GLUT4 was at the cell surface! While such a value is obviously not 
possible it does suggest that most of the GLUT4 was at the surface of these cells. Such
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a high calculated percentage of GLUT4 at the cell surface could be simply due to 
different levels of transfection and expression of the GLUT4 between the dishes of cells 
used for surface and total transporter photolabelling. An alternative explanation is that 
the digitonin treatment, used to permeabilize the fibroblasts and allow both the surface 
and intracellular pools of transporters to be photolabelled, resulted in the loss of a 
large proportion of the labelled GLUT4 from these dishes. This would give the 
appearance of a high proportion of the total GLUT4 at the cell surface. There was a 
loss of protein following the digitonin treatment of the CHO fibroblasts. The digitonin 
treated CHO fibroblasts had only 85 % of the protein of the intact cells. If the same 
protein loss occurred in the COS-7 fibroblasts then in addition to lowering the 
percentage of GLUT4 at the cell surface there would also be likely to be a lower 
percentage of GLUT1 at the cell surface.
In order to ensure the same level of GLUT4 expression between the different dishes of 
fibroblasts used for the photolabelling of surface and total transporter pools, CHO 
fibroblasts stably transfected with GLUT4 were used. In order to adjust for the loss of 
photolabelled transporters from the digitonin treated dishes of fibroblasts used to 
determine the total cellular transporter pool the results of a protein assay was used. In 
the nontransfected CHO fibroblasts only 40 % of the GLUT1 was at the cell surface. 
This percentage was a little lower in the cells expressing GLUT4. The total amount of 
GLUT1 in the cells expressing GLUT4 was also lower than in the nontransfected 
fibroblasts. This suggests that the expression of GLUT1 had been down regulated in 
response to the expression of GLUT4. Thus it appears that these fibroblasts may 
regulate GLUT1 expression according to their metabolic requirements, as suggested by 
Sargeant and Paquet (1993).
The photolabelling of transporters in insulin insensitive CHO fibroblasts stably 
transfected with GLUT4 showed that about two thirds of the total GLUT4 was at the 
surface of these cells with the remaining third sequestered within the cells. This is a 
higher proportion of the GLUT4 in the plasma membrane than the 55 % at the cell
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surface of the COS-7 fibroblasts of Schurmann et al. (1992b) and is much higher than 
the less than 20 % at the cell surface of the CHO fibroblasts of Piper et al. (1993a) and 
Asano et al. (1992b). When Hudson et al. (1993) expressed GLUT4 in the 
neuroendocrine cell line PC12 the/ found that GLUT4 was localised in the large 
density core vesicles with very little being detected at the plasma membrane. GLUT4 
has also been expressed in Xenopus oocytes by Thomas et al. (1993) who found that 
over 70 % of the GLUT4 was located in intracellular membranes. These differences in 
GLUT4 localisation between cell types could be due to differences in N-glycosylation. 
Asano et al. (1993) have shown that non N-glycosylated GLUT1 is targeted to the cell 
interior rather than the cell surface. Alternatively the differences could be due to the 
different ways that different cell types have of sorting proteins or to the method used 
to transfect and express GLUT4 in the different cells.
There are several reasons why the surface labelling of GLUT4 might be so high in the 
CHO fibroblasts. One is the low level of GLUT4 and native GLUT1 expression. The 
GLUT1 peak area in the non transfected CHO fibroblasts is about 5-fold larger than 
that of the fibroblasts transfected with GLUT4. The GLUT4 peak area in the 
transfected cells in more than 5-fold smaller than the GLUT1 peak in these cells. Thus 
the relatively high proportion of GLUT4 at the cell surface may be necessary to 
compensate for the lower GLUT1 levels. Alternatively, as suggested for the COS-7 
fibroblasts, the digitonin treatment may result in a significant loss of labelled GLUT4 
from the dishes used to calculate the total transporter pool. If this were the case then 
the use of digitonin to determine the total transporter pool must be carefully tested on 
a particular cell line before it is used.
While it is difficult to confirm the essentially intracellular localisation of GLUT4 in these 
experiments they do suggest that the apparent localisation of GLUT4 may be affected 
by the method used for expressing GLUT4 in cells and the method used to detect its 
location. The results do show that the subcellular distribution of GLUT1 and GLUT4 is 
different even within non insulin sensitive cell lines.
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4.5 Glucose transporter peptides and the targeting of GLUT4
GLUT4 and GLUT1 are differentially sorted and have a distinct distribution between 
intracellular membranes and the cell surface of insulin sensitive adipocytes. A large 
proportion of GLUT1 is in the plasma membrane (James et al., 1993). GLUT4 is 
selectively excluded from the surface of unstimulated cells and is instead sequestered in 
a specific GLUT4 vesicle population within the tubulo-vesicular elements. The 
differential sorting of GLUT4 is believed to be intrinsic to the GLUT4 protein itself. 
Several groups have tried to identify specific regions within GLUT4 that are responsible 
for the isoform specific distribution of transporters. This was done by making 
GLUT1/GLUT4 chimeras and expressing them in fibroblasts including CHO and COS- 
7 fibroblasts. This has resulted in the implicating of three different regions of GLUT4 
in its specific sorting. These are the GLUT4 N terminus (Piper et a/., 1992) a domain 
around helices 7 and 8 (Asano et a/., 1992b) and the C terminus (Czech et a/., 1993; 
Verhey etc/., 1993).
An alternative approach to determine which regions of GLUT4 are involved in its 
sorting and targeting was taken using peptides corresponding to different regions of the 
glucose transporters. The advantage of this approach is that the targeting of GLUT4 is 
investigated in 3T3-L1 adipocytes, an insulin sensitive cell line which expresses both 
GLUT1 and GLUT4. Furthermore it does not involve the construction and expression 
of transporter chimeras. Both the construct and the level of expression could affect 
the distribution. Very few regions of either GLUT1 or GLUT4 penetrate far beyond 
the phospholipid head groups of the membrane because the inter helical loops are too 
short. The regions that are exposed to the cytoplasm include the N- and C-terminal 
regions and the loop between helices 6 and 7. The peptides used in this study came 
from sequences within the N and C terminus of GLUT4 and the C terminus of GLUT1. 
A peptide with a sequence from within the first extracellular exofacial loop of GLUT2 
was also included so that the specific effect of a peptide could be distinguished from a
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non-specific effect resulting merely from the addition of a peptide. The sequences of all 
the peptides used in these experiments are given in table 2.1.
The effect of the peptides on the rate of uptake of 2-deoxy-D-glucose peptides in 
streptolysin-0 permeabilized 3T3-L1 adipocytes was first tested, figures 3.29 to 3.31. 
The peptides were added to basal 3T3-L1 adipocytes and to insulin stimulated 
adipocytes either at the same time as the insulin or 15 minutes before the cells were 
stimulated with insulin in the presence of the peptide. The only one of the three 
peptides that consistently caused a significant difference in the transport rate relative to 
the rate either in the absence of peptide or in the presence of the GLUT2 loop peptide 
was the GLUT4 N-terminal peptide. In insulin stimulated, insulin stimulated after pre­
treatment with the peptide and basal streptolysin-0 permeabilized 3T3-L1 adipocytes 
the N-terminal peptide caused an increase in the rate of 2-deoxy-D-glucose uptake. 
There was a 2-fold increase in the basal rate, a 10 % increase in the insulin stimulated 
rate when added with insulin and a 30 % increase in insulin stimulated transport 
following a 15 min pre-treatment with the peptide. It is interesting to note that the 
N-terminal region of GLUT4 is 14 residues longer than that of GLUT1 and the N- 
terminal peptide sequence is from within this region.
In order to confirm that the N-terminal peptide was increasing the transport rate by 
altering transporter translocation, the transporters were photolabelled with 
ATB-BMPA. Streptolysin-0 permeabilized 3T3-L1 adipocytes were stimulated with 
insulin in the presence of the GLUT4 N-terminal peptide. They were then 
photolabelled with ATB-BMPA and the plasma membrane purified. The cells simulated 
with insulin in the presence of the peptide were found to have a significantly higher 
concentration of GLUT4 at the plasma membrane compared to those stimulated with 
insulin alone. The level of cell surface GLUT1 was also increased in the presence of the 
peptide but to a lesser extent. However, due to the greater error in the GLUT1 
measurement this difference was not significant. The influence of the N-terminal 
peptide on the distribution of GLUT1 as well as GLUT4 may be, as suggested by
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Calderhead et al. (1990), an indication of poor sorting of the two isoforms in 3T3-L1 
adipocytes which express much higher levels of GLUT1 than do primary adipocytes.
The results with the peptides do indicate an important role for the N-terminal region 
of GLUT4 in its translocation. The peptide induced increase in the concentration of 
GLUT4 in the plasma membrane could be due either to an increase in endocytosis or a 
decrease in exocytosis. In an attempt to resolve these alternatives the GLUT4 
N-terminal peptide was added to 3T3-L1 adipocytes that had been stimulated with 
insulin prior to being permeabilized with streptolysin-O, figure 3.33. After 40 min the 
transport rate in the presence of the N-terminal peptide and insulin was » 50 % higher 
than the rate in the presence of insulin alone. Such an increase suggests that the 
peptide is preventing GLUT4 from leaving the plasma membrane. An equivalent effect 
was not observed when the recycling of photolabelled GLUT1 and GLUT4 was 
followed. The level of photolabelled GLUT4 and GLUT1 remaining in the plasma 
membrane was the same whether the transporters were recycled in either the 
presence or absence of the GLUT4 N-terminal peptide. However, since after 40 min 
of recycling in the presence of insulin alone there was still 80 % of the labelled GLUT4 
in the plasma membrane rather than the expected 40 to 50 %, this result probably 
demonstrates the effect of cell damage following UV irradiated and streptolysin-0 
permeabilization rather than the effect of the peptide.
An alternative approach to studying the effect of the GLUT4 N-terminal peptide on 
transporter recycling was to photolabel all the transporters in permeabilized basal cells. 
In basal adipocytes most of the GLUT4 would be in the intracellular pool and insulin 
stimulation and recycling would follow the departure of the labelled transporters from 
the low density microsomal fraction which is easier to purify than the plasma 
membrane fraction. Unfortunately this did not give a clear result as the 
immunoprecipitated GLUT4 gel peak was much broader than for simple cell surface 
photolabelling. However the preliminary experiment does show that after 40 min with 
insulin alone « 55 % of the photolabelled GLUT4 was in the low density microsome
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fraction while in the presence of insulin and the GLUT4 N-terminal peptide *  51 % of 
the GLUT4 remained in the low density microsomal fraction. Such a difference in the 
presence of the peptide could be due either to a rate of exocytosis higher than that for 
insulin alone or, more likely in the light of the earlier observations, due to a decreased 
rate of endocytosis. It certainly suggests that the GLUT4 N-terminal peptide does not 
inhibit the departure of GLUT4 from the low density microsomal pool. This method 
of following the recycling of glucose transporters has the advantage of labelling a larger 
proportion of the transporters in one location and it is easier to obtain a purified low 
density microsome fraction than a pure plasma membrane fraction. The broad 
indistinct peak following SDS-PAGE is presumably due to the non-specific labelling of 
proteins by ATB-BMPA within the permeabilized 3T3-L1 adipocytes. This makes the 
results unreliable.
Overall these results show that there is a role for the N-terminal region of GLUT4 in 
the translocation of this protein. They also suggest that it may be involved in the 
sequestration of GLUT4 from the plasma membrane. Presumably the peptide, at a 
500-fold higher concentration, competes with the N terminus of GLUT4 for the 
endocytosis machinery thus causing GLUT4 to build up in the plasma membrane. This 
conclusion agrees with the findings of James’ group who transfected CHO fibroblasts 
with chimeras of GLUT1 and GLUT4. They found that when the GLUT4 N-terminal 
sequence PSGFQQI, residues 2-8 (contained within the N-terminal peptide), was 
incorporated into the N terminus of either GLUT1 or the transferrin receptor then 
both of these proteins adopted a GLUT4-like distribution. This substitution, however, 
had no effect on the rate of recycling of these proteins to the plasma membrane (Piper 
et ai. 1992, 1993a; Garippa et a/., 1994). When the N terminus of GLUT4 was 
replaced with that of GLUT1 then a higher proportion of the chimera was at the cell 
surface compared to the wild type GLUT4 (Piper et a/., 1992, 1993a). Further 
mutational analysis of the N-terminal region led to the proposal that Phe5 is an 
important part of the intracellular sequestration motif as substitution at this site causes
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GLUT4 to accumulate in the plasma membrane (Piper et al., 1993a). A similar 
phenylalanine/tyrosine based internalisation motif is found within other internalized 
proteins such as surface glycoproteins (Ktistakis et al., 1990) and the mannose-6- 
phosphate/IGF II receptor (Jadot et al., 1992). Garippa et al. (1994) demonstrated 
that the GLUT4 N-terminal motif is responsible only for the internalisation of GLUT4 
and not for the retention of the transporter in the intracellular pool. This is also 
suggested by figure 3.34. Another sequence may therefore be required to maintain 
the intracellular localisation of GLUT4 in basal adipocytes.
The N terminus of GLUT4 is not the only region that has been implicated in the 
localisation of GLUT4. Asano et al. (1992b) have found evidence for the involvement 
of a domain between transmembrane helix 7 and the N-terminal half of the loop 
between helix 7 and 8 rather than the N terminus. Several groups have also 
implicated the C-terminal region (Czech et al., 1993; Verhey et al., 1993). This 
suggests that more than one region may be involved in GLUT4 targeting with perhaps 
the N terminus acting as a recognition sequence for internalisation and the C terminal 
motif retaining the transporter within the intracellular pool. Czech et al. (1993) 
identified within the GLUT4 cytoplasmic C-terminal region a dileucine motif at residues 
489-490 which is involved in the targeting and sorting of GLUT4 and is similar to 
sequences involved in the targeting and sorting of other plasma membrane proteins.
The results obtained from the peptides and permeabilized 3T3-L1 adipocytes do 
support the idea that a phenylalanine based motif in the N terminus of GLUT4 is 
involved in the intracellular sequestration of the protein in an insulin sensitive cell line 
which expresses GLUT4. The lack of effect of the GLUT4 C-terminal peptide on 
transporter translocation in permeabilized 3T3-L1 adipocytes does not rule out a role 
for this region as a whole but does suggest that the last 14 residues of the transporter 
are not involved. As the dileucine motif is not within these last 14 residues the 
C-terminal peptide would not be expected to have an effect if this motif in addition to 
the N-terminal region of GLUT4 is involved in the sorting of GLUT4.
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4.6 Rab proteins and insulin stimulated transport in adipocytes
Rab proteins are members of the large family of small GTP binding proteins. They 
have been shown to be involved in the regulation of membrane trafficking. One 
specific member of the rab family, rab4, has been shown to be associated with early 
endosomes and other vesicles that are involved in the recycling of the transferrin 
receptor in a number of cells types including CHO, HeLa, MDCK and NRK cell lines 
(van der Sluijs et a/., 1991). It was suggested that rab4 might be involved in the 
regulation of the receptor recycling pathway.
In order to probe adipocytes for the presence of rab4 an anti-rab4 antiserum was 
raised against a peptide whose sequence came from the middle of the protein 
(Zahraoui et al., 1989). This serum was used to probe Western blots of membrane 
fractions from both rat and 3T3-L1 adipocytes in order to try and detect rab4 in these 
cells. No protein with the expected molecular weight of 23 to 25 kDa was detected in 
either the plasma membrane or low density microsome fractions of either rat or 
3T3-L1 adipocytes. However, there was a strong band at the higher Mr of « 150,000. 
This band appeared to be stronger in the plasma membrane fraction than in the low 
density microsomes. Densitometry of the « 150 kDa band in both the plasma 
membrane and the low density microsomal fractions did not appear to show a 
difference in band intensity following insulin stimulation.
The cytoplasm was then probed with the antiserum. The protein in the supernatant 
remaining after the removal of the low density microsomal fraction was precipitated 
using chloroform/methanol and Western blotted. This fraction gave a different 
pattern of bands. The « 150 kDa band was not detected in this subcellular fraction. 
Instead an » 25 kDa band was detected. This band was of about the correct molecular 
weight to be rab4. The detection of rab4 in the cytosol is in agreement with the 
findings of van der Sluijs et al. (1991) who, in addition to detecting rab4 in endosomes, 
also detected the protein in the cytosol although at a four-fold lower concentration.
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The identification of the higher Mr band is unclear. It could simply be due to the 
antiserum cross reacting with a different protein. A similar high molecular weight band 
was also detected in low density microsomes using an antibody against a small G- 
protein by Cormont et al. (1991). Alternatively this » 150 kDa band could represent 
rab4 in very close association with another protein or proteins forming a complex. 
Such a complex could contain part of the machinery of membrane trafficking such as a 
guanine nucleotide exchange factor. If this band did prove to be a complex containing 
rab4 then it could be part of the mechanism of rab4 regulated translocation of vesicles 
from intracellular membranes to the plasma membrane with rab4 either being free and 
inactive in the cytosol or a part of the 150 kDa complex.
Such a sequence with rab4 cycling between being free in the cytosol and membrane 
bound has been partially described by Cormont et al. (1993). They detected rab4 in 
rat adipocytes. In basal adipocytes most of the protein was detected in the low and 
high density microsome fractions. Only a faint signal was detected in the cytosol and 
plasma membrane fraction of basal adipocytes. Both insulin and okadaic acid were 
shown to induce the redistribution of rab4 from the microsomal fraction to the 
cytosol. This change in the distribution of rab4 was also associated with the 
translocation of GLUT4 to the plasma membrane. They were also able to 
immunoprecipitate GLUT4 vesicles containing rab4. They reported that rab4 in the 
microsomal fraction was rapidly degraded even in the presence of protease inhibitors. 
The instability of rab4 could explain why free rab4 was not detected in the membrane 
fractions of the rat adipocytes in figure 3.37 even though it was detected in the cytosol. 
The w 25 kDa band on this blot was stronger in the lane containing the supernatant of 
the insulin stimulated cells than the basal cells. The propensity of membrane associated 
rab4 to degrade may provide an alternative explanation to a strong complex for the 
inability to detect the « 25 kDa band in the membrane fractions.
Rab3 is another small G-protein that has been shown to be associated with vesicles. In 
endocrine and neuronal cells it is associated with synaptic vesicles (Mollard et al.,
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1990). Rab3d, a rab3 isotype, has been detected in mouse adipocytes and has been 
shown to increase during the differentiation of 3T3-L1 fibroblasts into adipocytes 
(Baldini et al., 1992). The potential role of rab3d in the insulin stimulation of glucose 
transport in 3T3-L1 adipocytes was therefore investigated. Within rab proteins are 
effector domains through which rab may interact with effector proteins and the 
GTPase activating protein, GAP (Bourne et al., 1991). Peptides from the effector 
domain of rab3a can in themselves activate rab3a regulated processes and have been 
shown to stimulate exocytosis in pancreatic acini (Padfield et al., 1992) and mast cells 
(Oberhauser et al., 1992). When the equivalent peptide from the effector domain of 
rab3d (amino acids 52-67) was added to permeabilized 3T3-L1 adipocytes no 
significant effect on either basal or insulin stimulated glucose transport was observed.
The effect of rab3d on the subcellular localisation of GLUT4 was also tested in CHO 
fibroblasts stably transfected with both GLUT4 and either wild type rab3d or mutant 
rab3d lacking either residues 62-67 or 62-68, part of the effector domain used in the 
peptides. There was no significant effect on the proportion of the total GLUT4 at the 
plasma membrane of the CHO fibroblasts transfected with either the wild type or a 
mutant rab3d. However, in the cells expressing the wild type rab3d there was a slight 
increase in the proportion of GLUT4 at the cell surface while in the cells expressing the 
deletion mutant 62-7 there was a slight decrease in the surface GLUT4. A much 
bigger effect was seen in the distribution of GLUT1. In the CHO fibroblasts expressing 
the wild type rab3d and GLUT4 there was a 2-fold increase in the level of GLUT1 at 
the cell surface. In cells expressing the mutant rab3d and GLUT4 the proportion of 
GLUT1 at the surface was similar to that of the nontransfected CHO cells. Providing 
that the CHO fibroblasts contain the necessary translocation machinery for rab3d to 
interact with then these results suggest that rab3d is not involved in the regulation of 
cell surface GLUT4. However, the result may be affected by digitonin treatment, as 
described in section 4.4. Whether rab3d is involved in the regulation of GLUT1 at the 
cell surface is less clear. The CHO fibroblasts transfected with either GLUT4 or
Discussion 154
GLUT4 and rab3d expressed lower levels of GLUT1. The expression of GLUT4 was 
not the same in all the four cell lines either as the cells expressing rab3d expressed 
higher levels of GLUT4 than the cell line expressing GLUT4 alone. Thus it is possible 
that the differences in GLUT1 may merely be the result of different levels of GLUT4 
expression rather than a direct effect of rab3d on GLUT1. The results do, however 
suggest a role for rab3d in the translocation of GLUT1 to the cell surface in CHO 
fibroblasts.
The absence of a significant effect on the distribution of GLUT4 or the transport rate 
with rab 3d in CHO fibroblasts or the effector peptide in permeabilized 3T3-L1 
adipocytes respectively is in agreement with the findings of Guerre-Millo et al. (1993) 
who were unable to detect rab3d in GLUT4 immunoprecipitated vesicles.
In summary, rab4 can be detected in the cytosol of adipocytes and may be involved in 
the translocation of GLUT4 in adipocytes. Rab3d does not appear to have a role in 
the translocation of GLUT4 although it may be involved in the redistribution of GLUT1 
to the plasma membrane.
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4.7 GTPyS and insulin stimulation in 3T3-LI adipocytes
G-proteins are activated by the exchange of GDP for GTP. The proteins then remain 
active until the GTP is hydrolysed. One way to study the involvement of G-proteins in 
the insulin signalling pathway for the stimulation of glucose transport is to add the 
hydrolysis-resistant GTP analogue GTPyS to adipocytes. Because the GTPyS cannot be 
hydrolysed, once the G-protein has exchanged its GDP for GTPyS it remain active.
Baldini et al. (1991) looked at the effect of GTPyS on the subcellular localisation of 
GLUT4 in a-toxin permeabilized rat adipocytes. They found that 0.2 mM GTPyS 
induced an insulin-like translocation of GLUT4 to the plasma membrane.
When 0.2 mM GTPyS was added to basal 3T3-L1 adipocytes permeabilized with 
streptolysin-0 it caused a rise in the rate of 2-deoxy-D-glucose uptake to a rate which 
was » 60 % of the insulin stimulated rate. The GTPyS induced rise in 2-deoxy-D- 
glucose uptake was not additive with the insulin stimulated increase in transport. 
Indeed GTPyS may have a slight inhibitory effect on the insulin stimulated transport 
rate. The « 3.5-fold increase in 2-deoxy-D-glucose uptake following insulin stimulation 
of the streptolysin-0 permeabilized 3T3-L1 adipocytes and the increase in the basal 
transport rate in the presence of 0.2 mM GTPyS are similar to those of Suzuki et al. 
(1992) who measured 3-O-methyl-D-glucose uptake in electroporated rat adipocytes.
The effect of 0.2 mM GTPyS on the distribution of glucose transporters, as detected by 
ATB-BMPA photolabelling, was more pronounced than its effect on transport. In basal 
streptolysin-0 permeabilized 3T3-L1 adipocytes GTPyS caused an increase in cell 
surface GLUT1 which was equivalent to that induced by insulin. The effect of GTPyS 
on the distribution of GLUT4 was greater. The concentration of cell surface GLUT4 in 
the adipocytes incubated with GTPyS was 2.5-fold higher concentration than the 
concentration of GLUT4 in the plasma membrane of insulin stimulated cells. This 
suggests that in the 3T3-L1 adipocytes exposed to 0.2 mM GTPyS virtually the entire 
GLUT4 pool was photolabelled and purified with the plasma membrane. Taken
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together, the transport and photolabelling results suggest that while GTPyS increases 
the level of cell surface GLUT4 by either stimulating exocytosis and or inhibiting 
endocytosis GTPyS also lowers the intrinsic activity of GLUT4. Experiments in which 
the recycling of photolabelled GLUT4 was followed in the presence of either insulin or 
GTPyS, although unreliable, did indicate that GTPyS may inhibit endocytosis which 
would result in a large increase in level of GLUT4 in the plasma membrane.
Both Baldini et al. (1991) in rat adipocytes and Robinson et al. (1992) in 3T3-L1 
adipocytes found that GTPyS caused the translocation of GLUT4 to the cell surface. 
However the amount of cell surface GLUT4 which they observed was similar to that 
obtained with insulin. This difference in the proportion of GLUT4 at the cell surface 
following treatment with GTPyS could be due to a difference in the method used to 
determine the distribution of GLUT4. Baldini et al. (1991) used a-toxin permeabilized 
rat adipocytes and detected the distribution of GLUT4 by Western blotting the 
subcellular fractions. Robinson et al. (1992) measured the level of GLUT4 at the 
plasma membrane of streptolysin-0 3T3-L1 adipocytes by immunolabelling plasma 
membrane lawns. In this study ATB-BMPA photolabelling and immunoprecipitation 
from purified plasma membrane was used to quantify the level of cell surface GLUT4. 
ATB-BMPA photolabelling is normally an accurate way of quantifying the level of 
transporters in the plasma membrane because it is impermeant and so only labels the 
cell surface transporters. Here, however, permeabilized 3T3-L1 adipocytes were 
photolabelled and so the entire pool of transporters was labelled, both surface and 
intracellular transporters. Thus the determination of the proportion of the 
transporters at the cell surface requires an effective purification of the photolabelled 
transporters in the plasma membrane from those in the low density microsomes by 
subcellular fractionation. The contamination of the plasma membrane fraction with 
microsomal transporters would reduce the difference between the basal and insulin 
stimulated levels of transporters at the plasma membrane. However, the level of 
GLUT4 in the plasma membrane following incubation with GTPyS, even allowing for
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contamination of the plasma membrane fraction with labelled transporters from the 
microsomal fraction, was still about 2-fold higher than the insulin stimulated level and 
was higher than expected from the transport results. Thus an additional explanation of 
the high labelling results is required.
One explanation could be related to the ability of ATB-BMPA to photoiabel glucose 
transporters in partially occluded vesicles (Satoh et o/., 1993). While such transporters 
can be photolabelled they cannot transport glucose. Thus while they would be 
detected by photolabelling they would have no effect on the rate of uptake of 2-deoxy- 
D-glucose. If these partially occluded transporters at the plasma membrane of 3T3-L1 
adipocytes were lost from the plasma membrane while making the plasma membrane 
lawns by sonication but were retained with the plasma membrane by the subcellular 
fractionation procedure used here then this would account for the higher levels of 
GLUT4 at the cell surface. If a large proportion of the transporters were in such 
vesicles then this could also explain why the rate of transport which was lower than 
that expected from the photolabelling results.
It is possible that GTPyS may result in a large proportion of GLUT4 in partially 
occluded vesicles at the cell surface. In a cell-free system GTPyS was shown to inhibit 
transport between successive Golgi cisternae by preventing vesicles which had budded 
from the donor compartment from fusing with the acceptor compartment thus causing 
the vesicles to accumulate (Melan^on et a/., 1987). GTPyS has also been shown to 
prevent budding from the donor compartment in yeast cells. In these cells when sarlp, 
a small protein with GTPase activity, was preloaded with GTPyS vesicles were unable 
to bud from the endoplasmic reticulum. This inhibition was proposed as being either 
due to GTPyS preventing interaction with the transport machinery or, more likely, 
because GTP hydrolysis is required for vesicle budding (Barlowe et a/., 1993). GTPyS 
has been shown initially to stimulate vesicle fusion but to ultimately to inhibit vesicular 
trafficking (Rexach and Schekman, 1991). Such an effect might result in the 
accumulation of GLUT4 in the plasma membrane. GTPyS is believed to have this effect
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by preventing the recycling between the acceptor and donor membranes of the 
components required for vesicular transport, such as the rab proteins. The recycling of 
rab requires the GTP bound to rab to be hydrolysed at the acceptor membrane so 
that the rab GDP can be recycled back to the donor membrane in association with 
GDI (GDP-dissociation inhibitor). This association occurs only when the rab is in the 
GDP bound form (Araki et a/., 1990). Rab proteins have being implicated in the 
movement of vesicles to and from the plasma membrane with rab4 involved in the 
translocation of vesicles to the plasma membrane of rat adipocytes (Cormont et al., 
1993) and rab5 implicated in the movement of vesicles from the plasma membrane 
(Ullrich et al., 1994). Therefore GTPyS, by any of the above mechanisms, could result 
in an increase of partially occluded GLUT4 at the plasma membrane. If the partially 
occluded GLUT4 is in vesicles that are either unable to correctly fuse with or bud from 
the plasma membrane then they may be lost from the plasma membrane fraction 
during certain fraction procedures such as sonication.
An alternative mechanism whereby GTPyS may have an insulin-like effect is via a ras 
type G-protein involved in the insulin signalling pathway. The insulin receptor activates 
ras proteins via Sos (the product of the son of sevenless gene), a guanine-nudeotide 
dissociation stimulator protein. Sos itself is activated following its association with 
GRB2 (growth factor receptor-bound protein 2) when GRB2 is associated with the 
tyrosine phosphorylated IRS-1. GRB2 interacts with the SH2 domain of IRS-1 while 
Sos binds to the SH3 domain of GRB2 (Skolnik et al., 1993). The IRS-1-GRB2-Sos 
complex then activates ras by exchanging GDP for GTP (Baltensperger et al., 1993). 
The activated ras can then activate the effector proteins which include, either directly 
or indirectly the ERK or MAP kinases leading to a serine/threonine phosphorylation 
cascade (Thomas et al., 1992). It has been suggested that ras proteins may be involved 
in the translocation of glucose transport proteins in 3T3-L1 adipocytes. When N- 
ras61K, a activated mutant, was transfected into 3T3-L1 adipocytes then the transport 
rate was similar to the insulin stimulated rate in nontransfected adipocytes. In the
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transfected cells insulin had no effect on the transport rate. In the adipocytes, 
transfection with N-ras61K resulted in an « 1.5-fold increase in the amount of GLUT1 in 
the plasma membrane. The transfected cells had a much reduced total amount of 
GLUT4 but virtually all the GLUT4 was detected in the plasma membrane. Insulin had 
no effect on the distribution of GLUT1 and GLUT4 in the transfected cells (Kozma et 
a/., 1993). The insulin/ras activated MAP kinases have been shown to phosphorylate 
rab4 and this event might regulate the translocation of GLUT4 (Cormont et a/., 1994).
The effect of N-ras61K on the distribution of GLUT1 and GLUT4 is similar to that for 
GTPyS in the streptolysin-0 permeabilized 3T3-L1 adipocytes. This suggests that ras 
proteins are indeed intermediates in the insulin signalling pathway and that GTPyS 
interacts with the pathway at this point. The two effects are not directly comparable, 
however, because of the low level of GLUT4 expression in the 3T3-L1 adipocytes 
expressing N-ras61K. Another difference between the results is the effect on the 
transport rate, although these too are not comparable for the same reason. GTPyS, 
unlike N-ras61\  did not stimulate transport to the same degree as insulin or to a level 
expected from the photolabelling data. GTPyS did not, however, inhibit the insulin 
stimulated rate of transport. This suggests therefore that either the ras-like effect of 
GTPyS is insufficient on its own to fully activate the insulin signalling pathway or that 
GTPyS is also having an inhibitory effect at other places in the pathway and 
translocation mechanism.
GTPyS, in addition to its effect on G-proteins, may have a more direct effect on 
GLUT4 itself. Baldini et al. (1991) reported that they were unable to detect all the 
GLUT4 in the presence of GTPyS. This, they suggested, was due to a GTPyS induced 
conformational change in GLUT4. This change may help to explain the lower 
percentage of GLUT4 at the cells surface as detected by Western blotting in their 
study compared to the present study using ATB-BMPA photolabelling and 
immunoprecipitation. Such a conformational change may cause a decrease in the 
transport capacity of GLUT4 in the presence of GTPyS.
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This inhibitory effect of GTPyS on GLUT4 has been reported by others. When 
Schurmann et al. (1989; 1992a) added GTPyS and GTP to insulin stimulated vesicles 
they found a 50 % inhibition in the rate of transport, an effect that was lost in vesicles 
from basal adipocytes or when vesicles were partially purified from G-proteins. GTPyS 
has also been reported to bind to GLUT4 itself (Studelska et al., 1993). It was 
suggested that GTPyS might act as a gate and lower the intrinsic activity of GLUT4 or 
maintain it at the basal level. GTP analogues have also been reported to lower the rate 
of uptake of 2-deoxy-D-glucose in Xenopus oocytes expressing GLUT1 (Wellner et al., 
1993), although this was suggested as being due to the inhibition of hexokinase activity 
which would also result in a decreased rate of uptake in the 3T3-L1 adipocytes. Thus 
GTPyS may be inhibiting the activity of GLUT4 and the binding of GTP to the 
transporter may therefore be a mechanism for lowering the intrinsic activity of 
transporters in basal adipocytes.
It is not possible to determine from these results the effect of GTPyS on the transport 
rate in insulin stimulated 3T3-L1 adipocytes. The rate of 2-deoxy-D-glucose uptake 
with adipocytes stimulated with insulin in the presence of GTPyS was similar to that of 
insulin alone and was higher than the rate in the presence of GTPyS alone. This could 
be the result of an insulin induced reversal in the inhibitory effect of GTPyS on 
transporter activity thus causing a rise in the intrinsic activity of the transporters. A 
second explanation could be due to a resumption in the translocation of transporters 
to and from the plasma membrane.
The results from both the rab proteins and GTPyS do suggest a role for G-proteins, 
although perhaps not rab3d, in the translocation of transporters to and from the 
plasma membrane of 3T3-L1 adipocytes. The effect of GTPyS on adipocytes could be 
a broad one. It may be stimulating and then inhibiting the translocation mechanism 
while at the same time activating the G-proteins involved in the insulin signalling 
pathway and lowering the intrinsic activity of the transporters themselves, maintaining 
this at basal levels.
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4.8 Conclusions
The aim of this project was to investigate the action of insulin on glucose transport in 
adipocytes. It has, however, been difficult to draw specific conclusions from some of 
the results presented here because of the level of errors in the data. One reason why 
experiments were not repeated to a higher degree of statistical significance is that 
during the course of the experiments results were published in the same area.
The use of an ATB-BMPA displacement method enabled the resolution of the separate 
kinetic properties of the glucose transporters GLUT1 and GLUT4 in 3T3-L1 
adipocytes. The half maximal displacement by 3-O-methyl-D-glucose occurred at 20 
mM for GLUT1 and 7.0 mM for GLUT4. The calculated transport capacities (turnover 
number/KJ were 0.36 x 10* mM’1-min*1 for GLUT1 and 1.13 x 104 mM*1-min*1 for 
GLUT4. The turnover numbers were, however, similar, 7.2 x 104 min*1 for GLUT1 
and 7.9 x 104 min*1 for GLUT4. Thus the « 3-fold higher transport capacity of GLUT4 
at low glucose concentrations is mainly due to the higher Km of GLUT1, an effect also 
observed in Xenopus oocytes expressing either GLUT1 or 4 (Nishimura et al., 1993).
Okadaic acid, a phosphatase inhibitor, has the effect of increasing general levels of 
cellular phosphorylation. Adipocytes were treated with okadaic acid to investigate the 
potential role of phosphorylation in the insulin signalling pathway to the glucose 
transporter. It was found to increase both 3-O-methyl-D-glucose uptake and the level 
of cell surface GLUT4 photolabelling in unstimulated adipocytes. In insulin stimulated 
rat adipocytes okadaic acid reduced the transport rate and the level of cell surface 
transporter photolabelling. Okadaic acid appears to alter both the intrinsic activity and 
translocation of transporters. The broad effects of okadaic acid, however, make it 
difficult to be certain what the specific effects of okadaic acid are on insulin stimulated 
glucose transport. The tyrosine kinase inhibitor a-cyano-3,4-dihydroxythiocinnamide 
(453C89) was used to examine the role of tyrosine kinases in the insulin induced 
increase in glucose transport. The inhibitor appeared not to inhibit the insulin receptor
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tyrosine kinase but to inhibit 3-O-methyl-D-glucose uptake, perhaps by reducing the 
intrinsic activity of GLUT4. These findings and those of others (Smith et al., 1993; 
Young et a/., 1993) suggest that the tyrosine kinase inhibitors may not be specific and 
care should be taken in the interpretation of results.
By expressing GLUT4 in the insulin insensitive fibroblast cell lines COS-7 and CHO, 
GLUT1 and GLUT4 were shown to adopt a different distribution between the cell 
surface and the intracellular pools. This suggests that the subcellular distribution of 
GLUT4, rather than being imposed upon it by the cell in which it expressed, is intrinsic 
to the protein, as has also been shown by others (e.g. Schurmann et a/., 1992b; Piper 
et o/., 1993a). The addition of peptides corresponding to different regions of GLUT1 
and GLUT4 to streptolysin-0 permeabilized 3T3-L1 adipocytes implicated the N- 
terminal region of GLUT4 in transporter recognition. The addition of a peptide 
corresponding to the N terminus of GLUT4 increased the transport rate and the level 
of cell surface GLUT4. This suggests that the N terminus of GLUT4 may be involved in 
the sequestration of GLUT4 from the plasma membrane.
Both rab4 and rab3d have been implicated in the trafficking of GLUT4 containing 
vesicles. Rab4 was detected in the supernatant of rat adipocytes using an anti-rab4 
antiserum. Rab4 has also been shown to recycle in response to insulin and to be 
associated with GLUT4 containing vesicles (Cormont et a/., 1993). The expression of 
Rab3d in CHO fibroblasts expressing GLUT4 appeared not to affect the subcellular 
distribution of GLUT4 but may have affected the distribution of GLUT1. The 
nonhydrolyzable GTP analogue, GTPyS, was found to cause a small increase in basal 2- 
deoxy-D-glucose uptake but had little effect on the insulin stimulated transport rate in 
streptolysin-0 permeabilized 3T3-L1 adipocytes. It also appears to cause the 
accumulation of inactive GLUT4 at the cell surface. Thus G proteins may be involved 
in insulin signalling and glucose transporter translocation. However the wide ranging 
effects of GTPyS make a specific interpretation of the results difficult.
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In summary, the results presented here demonstrate that the translocation of GLUT4 
is the major mechanism whereby insulin increases the rate of glucose uptake in 
adipocytes and that the N terminus of GLUT4 may be involved in the targeting and 
recycling of this insulin responsive glucose transporter. The findings also suggest a role 
for phosphorylation events and G-proteins in the insulin signalling pathway and the 
translocation pathway. They also, however, highlight the danger of using compounds 
whose effects are not or may not be specific to investigate specific events.
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Kinetic resolution of the separate GLUT1 and GLUT4 glucose 
transport activities in 3T3-L1 cells
Robin W. PALFR EYM AN ,* Avril E. C LAR K,* Richard M. D ENTO N,t Geoffrey D. H O LM AN * 
and Izabela J. KO ZKA*
*D epartm ent o f Biochemistry, University of Bath, Claverton Down, Bath BA2 7AY, U.K., 
and fD epartm en t o f Biochemistry, University o f Bristol, University W alk, Bristol BS8 1TD, U .K.
A bis-mannose-photolabel-displacem ent method has been developed for resolving the separate kinetic properties o f the 
glucose transporters GLUT1 and G LU T4, which are both present in 3T3-L1 cells. We have quantified the cell-surface 
transporter abundance (2?max) for the two isoforms by displacing radiolabelled 2-Af-[4-(l-azi-2,2,2-trifluoroethyl)benzoyl]- 
l,3-bis-(D-mannos-4-yloxy)-2-propylamine (ATB-BM PA) by non-labelled ATB-BMPA. In cells acutely treated with 
insulin, the GLUT1 5 max was 0.19 /<m and the G LU T4 fimax was 0.17 /im. In cells which were chronically treated 
with insulin, the GLUT1 7?max was increased by ~  4-fold to 0.7 / im , whereas the G LU T4 was decreased by ~  50%  
(2?max =  0.1 fiM). However, this large increase in total concentrations o f cell-surface transporters (the sum o f GLU T1 and 
G LU T 4 concentrations) was not reflected in a large increase in 3-O-methyl-D-glucose transport, suggesting that GLUT1 
makes a smaller contribution to transport than does G LU T4. In acutely insulin-treated cells at 37 °C, the apparent kinetic 
param eters for 3-0-methyl-D-glucose transport were F ^ apx =  0.52 m \ r s _1 and K™p- =  12.3 mM. In chronically insulin- 
treated cells the k%ppx =  1.24 m M  - s '1 and A^pp =  23.0 mM. We have measured the displacement o f ATB-BM PA by 
different concentrations o f 3-0-methyl-D-glucose to resolve the separate affinity constants o f GLUT1 and G LU T4 for this 
transported ligand. In acute- and chronic-insulin-treated cells the GLUT1 for 3-0-methyl-D-glucose was ~  20 mM, 
and the G LU T 4 Km for 3-O-methyl-D-glucose was ~  7 mM. An analysis o f these data and the 3-0-methyl-D-glucose 
transport rates was carried out to calculate transport capacity (TK values) for the two isoforms at 37 °C. In acute- and 
chronic-insulin-treated cells the TK  values were 0.36 x 104 mM-1 m i n 1 for GLUT1 and 1.13 x 104 m M 1 m i n 1 for 
G LU T4. Thus GLUT1 has an ~  3-fold lower transport capacity than G LU T4 at low concentrations of transported sugar. 
The lower GLUT1 transport capacity was shown to be mainly due to the high K m o f G LU T1. The calculated turnover 
numbers were 7.2 x 104 min 1 for GLUT1 and 7.9 x 104 m i n 1 for GLUT4.
INTRODUCTION
Five m ajor mam malian glucose transporter isoforms appear 
to show some markedly specific tissue distributions. It has been 
suggested [1-3] that the abundance o f a distinct isoform in a 
particular tissue is related to its transport kinetic properties and 
therefore its function in tha t tissue. Cultured cells have been 
shown to contain high concentrations o f the GLUT1 isoform. 
Cell transform ation with oncogenes [4,5], growth factors [6,7], 
cytokines [8,9] and starvation [10-12] have been shown to increase 
markedly the concentration o f this transporter, with a consequent 
increase in glucose transport activity. It has been proposed that 
G LU T2 has a high Km for D-glucose so that it can function to 
export rapidly a large range o f  glucose concentrations from a 
liver which is undergoing rapid glycogenolysis [13]. The G LU T3 
isoform has been detected in many cell and tissue types, including 
brain and foetal muscle [14]. The G LU T4 isoform has a relatively 
low K m, and the translocation o f  this isoform to the cell surface 
of adipose cells and muscle [15-19] is stim ulated by insulin. The 
G LU T5 isoform is found in intestinal enterocytes and kidney
[20]. Tissue specialized metabolic requirem ents and kinetic 
dem ands for glucose can thus be regulated by expression o f 
tissue-specific transporter isoforms which have distinct transport 
kinetic properties.
Cultured 3T3-L1 cells also contain high levels o f the GLUT1 
isoform, but can be differentiated in a regime involving insulin, 
dexam ethasone and isobutylm ethylxanthine treatm ent to give 
high levels o f the acutely insulin-sensitive isoform G LU T4.
Calderhead et al. [21] and Kozka et al. [12] have shown that the 
acute insulin treatm ent increases the cell-surface availability o f 
both G LU T4 and G LU T 1, so that both are present a t the surface 
in equal amounts. Tordjm an et al. [22] and K ozka et al. [12] have 
shown, however, that a 24 h chronic insulin treatm ent increases 
GLUT1 by 4-5-fold. We have shown [12], by cell-surface 
labelling, that G LU T4 is down-regulated by 50% . T hus there is 
a marked change in the isoform type (the GLUT1 :G L U T 4 ratio 
increases to 10:1) and a large change in the total concentration 
o f transporter, but these changes are associated with an only 
~  40 % increase in transport activity, as measured by the uptake 
o f 2-deoxy-D-glucose at tracer concentrations. These findings sug­
gest that G LU T4 and GLUT1 make unequal contributions to 
the transport rate. To analyse this possibility further, a method 
for resolving the separate param eters o f GLUT1 and G LU T4 
kinetic contributions to transport activity is thus required.
Further analysis o f the kinetic differences between the GLUT1 
and G LU T4 isoforms that are present in 3T3-L1 cells has 
necessitated the use o f the non-m etabolized analogue 3-0-m ethyl- 
D-glucose in transport kinetic measurements. Because transport 
measurements alone cannot be easily used to calculate K m and 
Knax. f° r each transporter (four param eters), we have determined 
the separate affinities o f the two isoforms for 3-O m ethyl-D - 
glucose by measuring the displacement o f the bis-mannose 
photolabel 2-A-[4-( 1 -azi-2,2,2-trifluoroethyl)benzoyl]-1,3-bis-(D- 
mannos-4-yloxy)-2-propylamine (ATB-BM PA) by a range of 
concentrations o f 3-O-methyl-D-glucose. By m easuring the bind­
ing o f the photolabel at a range o f ATB-BMPA concentrations,
Abbreviations used: ATB-BMPA, 2-7V-[4-( 1 -azi-2,2,2-trifluoroethyl)benzoyl]-1,3-bis-(D-mannos-4-yloxy)-2-propylamine; DM EM , Dulbecco’s 
modified Eagle’s medium; C 12E9, nona(ethylene glycol) dodecyl ether.
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we have determined the concentrations o f GLUT1 and G LU T4 
at the cell surface. We show how the use o f da ta  on transporter 
concentration and affinity for 3-O-methyl-D-glucose can be used 
to  simplify the analysis of transport data  to resolve just two 
param eters (the T K  values for GLUT1 and G LU T4). Since the 
TK  is the turnover num ber divided by K m (or Vm„  / K m divided 
by transporter concentration), we have used this param eter to 
calculate the transporter turnover num ber for each isoform. The 
T K  is formally equivalent to an association constant [23,24]. The 
T K  thus represents the maximum permeability (or transport 
capacity) o f each transporter. A low transporter capacity (TK) is 
thus due to a low association with substrate because o f either a 
low turnover or a low affinity. We have also examined the issue 
o f photolabelling efficiency.
MATERIALS AND METHODS  
Materials
A TB -B M PA  and  A TB -[2-3H ]B M PA  (sp. rad ioac tiv ity  
~  10 C i/m m ol) were prepared as described previously [25,26]. 3- 
0-M ethyl-D -[U -14C]glucose was from  A mersham International. 
Dulbecco’s modified Eagle’s medium (DM  EM) was from Flow 
Laboratories. Foetal-bovine serum was from Gibco. M ono­
com ponent pig insulin was a gift from Dr. R onald Chance, Eli 
Lilly Corp. Dexam ethasone, isobutylmethylxanthine, phloretin, 
3-O-methyl-D-glucose and Protein A -Sepharose were from 
Sigma. C 12E 9 [nona(ethylene glycol) dodecyl ether] was from 
Boehringer.
Cell culture
3T3-L1 fibroblasts were obtained from American Type Culture 
Collection and were cultured in D M EM  and differentiated to 
adipocytes by treatm ent with insulin, dexamethasone and 
isobutylm ethylxanthine as described previously [12,21,27]. Before 
use in 3-O-methyl-D-glucose transport assays or in cell-surface 
labelling experiments, the cells were subjected to a standard 
washing procedure. Cells were washed with phosphate-buffered 
saline (154mM -NaCl, 12.5 mM-sodium phosphate, pH  7.4) and 
were then incubated for 2 h in serum-free medium containing 
25 mM-D-glucose. This was followed by three washes in K rebs- 
R inger-H epes (K R H ) buffer (136mM -NaCl, 4.7 mM-KCl,
1.25 mM-CaCl2, 1.25 mM -M gS04, 10mM-Hepes, pH  7.4). Cells 
were then m aintained at 37 °C with or w ithout 100 nM pig 
m onocom ponent insulin for 30 min in 1 ml o f K R H  buffer. In 
chronic-insulin treatm ent, fully differentiated cells were incubated 
for 24 h in D M EM  with 25 mM-glucose and 500 nM insulin.
3-O-Methyl-D-glucose transport assays
3T3-L1 cell monolayers in 35 mm-diam. dishes, treated as 
described above, were equilibrated with 0-40 mM-3-O-methyl-D- 
glucose in 0.5 ml o f K R H  buffer for 30 min a t 37 °C. The cells 
were then incubated with 0.5 ml o f K R H  containing the equi­
librium concentrations o f 3-O-methyl-D-glucose and 0.3 ^wCi of 
3-0-methyl-D-[U-14C]glucose. A t 10 s for insulin-treated cells 
and a t 120-160 s for basal cells, 1 ml o f ice-cold K R H  containing 
0.3 mM-phloretin was added to arrest transport. The dishes were 
rapidly washed three times in the stopping solution. The cell- 
associated radioactivity was then extracted and counted. The 
radioactivity associated with the cells a t zero time was determined 
by adding stopping solution before the radioactive 3-O-methyl- 
D-glucose. The radioactivity associated with the cells a t equi­
librium was determ ined by incubating insulin-treated cells with 
3-O-methyl-D-glucose for 15 min. The total cell volume per 
35 mm dish was calculated from the equilibrated 3-O-methyl-D- 
glucose and was found to be 2.81 +0 .43  /d /d ish  (from six 
experim ents; two experiments acute-insulin, three experiments
chronic-insulin, one experiment basal). Equilibrium exchange 
uptake rate constants (k ) were then calculated from the equation 
k — n (l — f ) / t ,  where t is the uptake time and / i s  the fractional 
filling [28,29]. In experiments used to estimate the half-maximal 
inhibition constant (AT,) for ATP-BM PA, the inhibitor was added 
with 5 0 /iM-3-0-methyl-D-glucose as substrate. The extent of 
irreversible inhibition o f transport produced by photo­
incorporation o f ATB-BM PA was determined by irradiating 
cells in 35 mm dishes (for 1 min in a Rayonet photochemical 
reactor [12]) in the presence o f 0.5-2 mM-ATB-BMPA in 500 /d 
o f K RH . The dishes were then washed three times in KRH to 
remove non-incorporated ATB-BMPA and then assayed for 
residual transport o f 50 //M-3-0-methyl-D-glucose as described 
above.
ATB-BMPA photolabelling
Differentiated cells in 35 mm dishes were washed in KRH 
buffer a t 37 °C and were irradiated for 1 min in the presence of 
100 /iC i o f ATB-[2-3H]BMPA as described previously [12], To 
determine the binding kinetic param eters, the specific radio­
activity o f the label was decreased by addition o f non-radioactive 
ATB-BM PA at the concentrations indicated in the Figures. 
Bound ATB-BM PA (mol) was calculated from the d.p.m. 
recovered after im m unoprecipitation and gel electrophoresis of 
the photolabelled GLUT1 or G LU T4. The free ATB-BMPA was 
assumed to be equal to the combined concentration of the non­
radioactive and radioactive ligand, and was not corrected for the 
small am ount o f ATB-BM PA bound to the cells.
Immunoprecipitation and electrophoresis
The irradiated cells were washed three times in K RH  buffer 
and solubilized in 1.5 ml o f detergent buffer, containing 2%  
C 12E9, 5 mM-sodium phosphate and 5 mM EDTA, pH 7.2, and 
with the proteinase inhibitors antipain, aprotinin, pepstatin and 
leupeptin, each a t 1 /tg/m l. A fter centrifugation a t 20000 £ max 
for 20 min, the supernatants were subjected to sequential 
im m unoprecipitation with 20 /tl o f  Protein A -Sepharose coupled 
to 100 /d o f either an ti-G L U T l or anti-G LU T4 antiserum. These 
antisera were raised against C-terminal peptides as described 
previously [23,26]. A fter incubation for 1.5-2 h at 0-4  °C and 
washing o f the im m unoprecipitates three times with 1.0%  and 
once with 0.1 % C 12E9 detergent buffer, the labelled glucose 
transporters were released from the antibody complexes with 
electrophoresis sample buffer (10%  SD S/6 M -urea/10%  
m ercaptoethanol) and then subjected to electrophoresis on 10 %- 
acrylamide gels. The radioactivity on the gel was measured by 
cutting and counting gel slices. The radioactivity in transporter 
peaks was corrected for a background which was based on the 
average radioactivity o f the slices on either side o f the peak [21]. 
We have determined that, after im m unoprecipitation with anti- 
G L U T l and anti-G LU T 4 antibodies, the am ount o f photo­
labelled transporter remaining in the supernatants is <  20 % of 
the unprecipitated to tal o f labelled transporters.
RESULTS
3-O-MethyI-D-glucose transport
The exchange uptake o f 3-O-methyl-D-glucose was studied. 
This transport protocol was equivalent to that used in the 
photolabel-displacem ent experiments described below. Thus the 
cells were pre-equilibrated with non-radioactive 3-O-methyl-D- 
glucose, and then the influx o f radioactive 3-O-methyl-D-glucose 
was measured. When a single transporter isoform is present, the 
concentration o f 3-O-methyl-D-glucose at which the rate constant 
is decreased by half is formally equivalent to the equilibrium 
binding constant between 3-O-methyl-D-glucose and the trans-
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Fig. 1. Equilibrium exchange uptake of 3-O-methyl-D-glucose in 3T3-L1 
cells
3T3-L1 cells in 35 mm dishes were either acutely treated with 
100 nM-insulin for 30 min ( # )  or chronically treated with 500 nM- 
insulin for 24 h (O ), and uptake o f 3-O-methyl-D-glucose was 
determined as described in the Materials and methods section, s/v, 
the reciprocal of the uptake rate constant, was plotted against the 3- 
O-methyl-D-glucose concentration. The values shown were means 
from four experiments each with triplicate estimates of uptake rate 
constants. The inner s.e.m. bars were calculated with n =  12 (com­
bining the replicate values), and the outer s.e.m. bars were calculated 
with n =  4 (by using the mean of the replicates from each independent 
experiment), except the value indicated by *, where the inner bar is 
the s.e.m. (n =  4) and the outer bar is the s.e.m. (m =  12). To convert 
the s/v values from /d_ 1 dish s into s, the plotted values were 
divided by the equilibrium intracellular volume of 2.81 /d/dish. The 
lines for both acute and chronic insulin treatments were derived 
from a single set of calculated TK values of 3.58 x 103 and
11.34x 103 m M "1 min-1 for GLUT1 and GLUT4 respectively and 
by using the 5 max and Km values listed in row 5 of Table 1.
porter (the equilibrium exchange K m). This has been shown to 
equal the concentration of 3-O-methyl-D-glucose tha t displaces 
the binding of tracer concentrations o f another ligand such as 
cytochalasin B or ATB-BM PA [30].
When two isoforms are present, the relationship between the 
reciprocal o f the exchange rate constant and the 3-O-methyl-D- 
glucose concentration may be curvilinear. The reciprocal plots 
shown in Fig. 1 are slightly curved, and this is likely to be due to 
the varying contributions of the two isoforms as the 3-O-methyl- 
D-glucose concentration is varied. The lines in Fig. 1 were 
therefore derived from the analysis o f the separate GLUT1 and 
G LU T4 contributions to transport as described in the Discussion 
section. F itting the data  to the M ichaelis-M enten equation, 
however, revealed an apparent Km for 3-O-methyl-D-glucose of 
12.3±1.3m M  and V — 0.52 +  0.04 mM-s-1 in acute-insulin- 
treated cells (derived from the mean values o f the rate constants 
from four experiments). These estimates are similar to  those 
determined by Clancy et al. [31], who have also measured the 
kinetic param eters for 3-O-methyl-D-glucose transport in insulin- 
stimulated 3T3-L1 cells. They report values o f K m =  10.9 mM 
and Fmax =  2.76 pm ol/m in  per 106 cells. Calculations using their 
estimate o f cell volume o f 5 .6 /d /lO 6 cells gave a Vmax o f 
0.46 m M -s'1. However, we note that the cell volume in our 
experiments was ~  2-3-fold smaller than that estim ated by 
Clancy et al. [31].
In chronically-insulin treated cells we have found that the 
apparent K m and Vmax were increased to 23.0 ±9.1  m M  and 
1.24±0.40 mM-s 1 respectively (determined from m ean values of 
the rate constants obtained from four experiments). The large 
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Fig. 2. Equilibrium exchange uptake of 3-O-methyl-D-glucose in basal 
3T3-L1 cells
The uptake of 3-O-methyl-D-glucose into basal cells was determined 
as described in the Materials and methods section, s/v, the reciprocal 
o f the uptake rate constant ( # ) ,  was plotted against 3-O-methyl-D- 
glucose concentration, and the values are means ±  s.e.m. (« =  6 from 
two experiments with triplicate estimates of the uptake rate 
constants). Additional experiments were carried out at 50 //M-3-0- 
methyl-D-glucose to estimate the range of variation of basal activity 
between experiments. In basal cells the s/v value was 
144.9±  18.1 /d-1 dish-s (« = 1 1 , mean + s.E.M. of 11 experiments 
each with triplicate estimates of the rate constants). In this series of 
experiments, acute insulin treatment decreased the s/v value 15-fold, 
to 9.57 ±  1.64 /i\ 1 • dish • s (« =  11, mean ±  s.e.m. from 11 experiments 
each with triplicate estimates of the rate constant). To convert the 
s/v values from //T 1 • dish ■ s into s, the plotted values were divided by 
the equilibrium intracellular volume of 2.81 //,1/dish. The line 
was deri’
Table 1.
kinetic plot, rather than the between-experiment variations in the 
kinetic param eters. The chronic-insulin treatm ent altered the 
GLUT1 :G L U T 4 ratio  from 1:1 to 10:1 (see below). Thus the 
high apparent Km for 3-O-methyl-D-glucose transport found in 
this condition is likely to reflect a high GLUT1 K m for this 
substrate.
The apparent K m and Vmstx for 3-O-methyl-D-glucose transport 
in basal cells obtained by fitting o f the M ichaelis-M enten 
equation were 11.5±  1.7 m M  and 0.028±0.003 m M - s 1 respect­
ively (determined from mean values o f the rate constants obtained 
in two experiments) (Fig. 2).
We have also determined the for the bis-mannose 
photolabel, ATB-BM PA, as an inhibitor o f 3-O-methyl-D-glucose 
uptake (Fig. 3). We have used a 3-O-methyl-D-glucose substrate 
concentration o f 50 / /M , which is low in com parison with the 
affinity o f either GLUT1 or G LU T 4 for 3-O-methyl-D-glucose. 
U nder these conditions the can be calculated from the equation 
v j v  — 1 + I / K V where v j v  is the fractional inhibition and /  is the 
inhibitor concentration [29]. The calculated K. was 263 ±  30 /im 
in the acute-insulin treatm ent, which was not significantly 
different from the determined in chronically insulin-treated 
cells, which gave K, =  200 ±  53 /zM (one experiment).
We have examined the efficiency o f irreversible inactivation of 
the transport rate owing to photoincorporation o f ATB-BMPA. 
We have found that, after irradiation o f 3T3-L1 cells in the 
presence o f 0.5 m M -, 1 m M - and 2 mM-ATB-BMPA and removal 
o f unbound ligand by washing, 2-deoxy-D-glucose transport was 
inhibited by 48% , 54%  and 68%  respectively com pared with 
untreated samples. Since at these concentrations of ATB-BM PA 
33% , 20%  and 12% o f the sites are unoccupied (assuming a Ka 
for ATB-BM PA o f 250 / z m ) , it can be calculated that, when all 
the sites are occupied, ~  75 %  o f the sites would have been 
irreversibly inactivated (results from  two experiments).
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Fig. 3. Inhibition of 3-O-methyl-D-glucose uptake by ATB-BMPA
3T3-L1 cells in 35 mm dishes were either acutely ( # )  or chronically 
(O ) treated with insulin, and the ratio of the rate constant for 
uptake of 50 //,M-3-0-methyl-D-glucose in the absence and presence 
of ATB-BMPA {v jv )  was plotted against the ATB-BMPA con­
centration (/). The results are from a single experiment with triplicate 
determinations of the rate constant. The line was derived by fitting 
the equation v0/v  =  1 + I / K i by using non-linear regression analysis 
weighted for relative error. This gave Ki values of 263 +  30 /m  
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Fig. 4. Displacement of radiolabelled ATB-BMPA from GLUT4 by non­
labelled ligand
3T3-L1 cells in 35 mm dishes were acutely treated with insulin and 
then photolabeled with 4 0 /<m-ATB-[2-3H]BMPA (100 / id )  either 
alone (■ )  or with additional non-labelled ATB-BMPA at 50 /m  
(A ). 100//M  (O ), 150//M ( # )  or 300 /im  (A)- GLUT4 was 
immunoprecipitated with anti-C-terminal-peptide antibody and 
subjected to electrophoresis. The radioactivity was measured by 
cutting and counting the gel slices. The data were used to calculate 
the concentration of ATB-BMPA bound. The position of the 
45 kDa marker protein (ovalbumin) is shown
ATB-BMPA photolabelling
We have shown from results obtained by im munoprecipitating 
glucose transporters with antibodies against GLUT1 and G LU T4 
C-terminal peptide tha t GLUT1 is the predom inant isoform 
present in the cell m em brane in the basal cells and that this is 
increased by ~  3-5-fold after insulin treatm ent. Only low levels 
o f G LU T4 were detected at the cell surface in the basal state, but 
an ~  10-15-fold increase was observed after insulin treatm ent 
[12,21], We have extended these observations here by measuring 
the binding o f ATB-BM PA at a range o f concentrations and 
calculated the Ka and apparent Z?max for GLUT1 and G LU T4. 
Fig. 4 shows the displacement o f ATB-[2-3H]BM PA by a range 
o f concentrations o f non-labelled ATB-BM PA from G LU T4 in 
acutely insulin-treated cells. F rom  these data  the am ount o f 
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Fig. 5. Determination of the Bmax values for ATB-BMPA binding to 
GLUT1 and GLUT4 glucose transporters in 3T3-L1 cells
3T3-L1 cells in 35 mm dishes were in (a) acutely treated with 100 nM- 
insulin for 30 min and in (6) chronically treated with 500 nM-insulin 
for 24 h and then described in the legend to Fig. 4, except that the 
data show the binding in immunoprecipitated GLUT4 (■ )  and 
GLUT1 (□ ). The results shown are from a single experiment. To 
convert the bound ATB-BMPA from pm ol^-dish into //M, the 
values were divided by the equilibrium cell volume of 2.81 /tl/dish.
In acutely insulin-treated cells the GLUT1 Bmax was 0.19 +  0.03 //M 
and the GLUT4 Bmax was 0.17 +  0.03 /m  (from three experi­
ments). In chronically insulin-treated cells the GLUT1 Bmax was
0.7 +  0.07 fiu , whereas the GLUT4 Bmax was 0.099 +  0.017 /im  (from 
three experiments).
calculate Bmax and Kd values by non-linear regression analysis of 
bound versus free ATB-BM PA concentration. Reciprocal plots 
are shown in Figs. 5(a) and 5(b). Fig. 5(a) shows that in acutely 
insulin-treated cells GLUT1 and G LU T4 have Kd values which 
were not significantly different and were ~  150 fiM. Thus binding 
o f the photolabel at the high specific radioactivity o f 10 Ci/mmol 
and low tracer concentrations o f 40 /iM  (the present study) and 
80 fiM [12] is proportional to the num ber o f GLUT1 and GLUT4 
binding sites and is not dependent on an affinity difference 
between the two isoforms. We have previously shown that a 
chronic insulin treatm ent increases the tracer labelling of GLUT1 
by 4-5-fold com pared with the acute treatm ent. In Fig. 5(6) this 
is confirmed not to be due to an affinity change. The plots in Figs. 
5(a) and 5(6) show bound ligand as pmol bound per 35 mm dish 
and are from one experiment. The Bmax values were obtained 
from these data  by dividing by the 3-O-methyl-D-glucose equi­
librium space o f 2.81 /tl/dish, which gave transporter concen­
trations in /tmol/1 o f intracellular water o r / iu .  In acutely insulin- 
treated cells the GLUT1 5 max was 0.19 +  0.03 f iu  and the GLUT4
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Fig. 6. Determination of the Km values for 3-O-methyl-D-glucose dis­
placement of ATB-BMPA from GLUT1 and GLUT4 glucose 
transporters in 3T3-L1 cells
3T3-L1 cells in 35 mm dishes were in (a) acutely treated with 100 nM- 
insulin for 30 min and in (b) chronically treated with 500 nM-insulin 
for 24 h and then photolabelled with 100 /iC i of ATB-BMPA at the 
indicated concentrations of 3-O-methyl-D-glucose. Photolabelled 
GLUT1 (O ) and GLUT4 ( # )  were then immunoprecipitated with 
anti-C-terminal-peptide antibodies and subjected to electrophoresis. 
Radioactivity was determined by cutting and counting gel slices. The 
ratio of the radioactivity associated with the peaks obtained in the 
absence (A0) and presence (A) of competing ligand were then 
determined. The results shown are the mean values from three 
experiments (acute treatment) and two experiments (chronic treat­
ment). The Km values were obtained by fitting the equation A0/A  =
1 +  s/Km by using non-linear regression analysis weighted for relative 
error. In the acute treatment the GLUT1 K m was 23.4 +  7.6 mM and 
the GLUT4 K m was 7.2 +  2.0 mM. In the chronic treatment the 
GLUT1 Km was 16.4 +  2.9 mM and the GLUT4 K m was 
6.85+1.5 mM.
2?max was 0.17 +  0.03 / i m  (from three experiments). The GLUT1 
BnvAx for ATB-BMPA in chronically insulin-treated cells was 
0.70 ± 0 .07  fiM. The G LU T 4 fimax in these cells was decreased to 
0.099 +  0.017 /tM  (from three experiments).
A similar photolabel-displacem ent m ethodology was used to 
measure the separate affinity constants o f GLUT1 and G LU T4 
for 3-O-methyl-D-glucose. C oncentrations o f 3-O-methyl-D- 
glucose o f 0-20 m M  were incubated with the photolabel in either 
acutely or chronically insulin-treated 3T3-L1 cells. Fig. 6(a) 
shows tha t in acutely insulin-treated cells the Km for 3-O-methyl- 
D-glucose displacement was 23.4 +  7.6 m M , which was ~  3-fold 
higher than the G LU T4 Km, which was 7 .2+  2.0 m M  (from three 
experiments). In chronically insulin-treated cells (Fig. 6b) the 
GLUT1 K m for 3-O-methyl-D-glucose was 16.4 +  2.9 mM and 
was ~  3-fold higher than the G LU T4 K m, which was 6.8 ± 1 .5  m M  
(from two experiments). The results o f the 3-O-methyl-D-glucose 
displacement were used in conjunction with the Bm&x values to 
calculate T K  values for GLUT1 and G LU T4 as described in the 
Discussion section. Table 1 shows tha t the T K  value for G LU T4 
was ~  3-fold higher than for G LU T1.
In the basal state, the GLUT1 and G LU T4 K m values for 3-O- 
methyl-D-glucose and their Kd values for the photolabel could 
not be examined directly by using the ATB-BM PA displacement 
methodology, because the radioactive ATB-BM PA incorporated 
was very low and any displacement by ligand would decrease the 
recovered radiolabel even further. However, we have shown, in 
basal ra t adipocytes and 3T3-L1 cells, that the ATB-BM PA 
concentration required for half-maximal inhibition o f transport 
is not significantly different from that required for half-maximal 
inhibition of transport in insulin-treated cells [21,23]. In view of 
the limited applicability o f the photolabel-displacem ent m eth­
odology to the basal state, we have determined GLUT1 and
G LU T4 levels from the photolabelling of basal cells with tracer 
concentrations (80 /iM) o f ATB-BM PA. We have then calculated 
the concentrations o f unoccupied sites (x l and x4 in eqn. 4 in the 
Discussion section), using the assum ption that the KA for ATB- 
BMPA and the K m for 3-O-methyl-D-glucose were the same as in 
the insulin-stim ulated cells. This analysis method (Table 1) 
showed that the calculated GLUT1 and G LU T4 TK  values in 
basal cells were ~  2-fold lower than in the insulin-treated cells. 
Because the analysis o f photolabelling and transport da ta  in the 
basal state involved greater error and used more assumptions 
than the analysis o f the data from insulin-stim ulated cells, we 
place less reliance on the T K  values calculated for the basal cells.
DISCUSSION
Determination of the intrinsic activity of GLUT1 and GLUT4
We have shown tha t 80%  o f the cell-surface transporter 
labelling is im m unoprecipitated by GLUT1 and G LU T 4 anti­
bodies. Thus if other isoforms are present they are not very 
abundant and are not likely to significantly contribute to 
transport. As discussed by Calderhead et al. [21], uptake is thus 
given by the sum o f two M ichaelis-M enten equations repre­
senting the separate flux attributable to each o f the isoform s:
+  - ( 1)(1 + S /K ml) (1 + S /K mi)
where VmSLX and Km are the equilibrium exchange transport 
param eters.
F^ax values are dependent on the transporter concentrations 
and the catalytic rate constants. The 1 /(1 +  S /K m) or Km/( K m +  5) 
terms represent the fraction o f unoccupied sites. Thus eqn. (1) 
can be w ritten as follows:
TK1 STG LU T1] T K 4-ST G L U T 4]
v = -------------------------- h- (2)
(1 + S /K ml) (1 + S /K mi)
where [GLUT1] and [GLUT4] are the transporter isoform 
concentrations and TK 1 and TK4 are the association constants, 
which are equal to turnover number/A^m and thus represent the 
tendency o f the substrate to associate with unoccupied sites.
Values for the GLUT1 and G LU T4 concentrations used for 
substitution into eqn. (2) were determined from ATB-BM PA 
binding data, which we have shown in the Results section gave 
values for Ka and BmAX. The terms in eqn. (2) representing the 
reciprocal o f the fraction o f unoccupied sites can be directly 
obtained from the displacement o f the photolabel, w here:
A °/A  =  l+ S / K m (3)
where A 0/A  values are the ratios o f the radioactivity associated 
with the photolabelled transporters in the presence (A) and 
absence (A0) o f competing 3-O-methyl-D-glucose and used to 
calculate the TK  values shown in rows 1-3 in Table 1. The K m 
values of GLUT1 and G LU T4 can also be obtained from the 3- 
O-methyl-D-glucose displacement o f the photolabel (eqn. 3). 
These K m values can then be used in an alternative method to 
calculate the fraction o f unoccupied sites (rows 4—6 in Table 1).
M ultiplying the 5 max values by the fraction o f unoccupied 
sites (either A /A 0 or l / ( l+ S / .K m) gave x l  and x4 (the 
concentrations o f unoccupied sites). Values o f TK1 and TK 4 
were then derived from eqn. (4) by least-squares regression, by 
the methods described by Cleland [32]:
v /S  =  TK1 -x l + T K 4 x 4  (4)
Table 1 com pares the results o f analysis o f TK  values carried 
out by several different m ethods for calculating the concentration 
of unoccupied sites. The m ethod appears to be quite robust and 
can handle the combined errors involved in using transport data
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Table 1. Calculation of G LUT1 and G L U T 4 TK  values for 3-O-methyl-D-glucose transport in 3T3-L1 cells
Analysis method
10-3 x T K l
(mM- 1 min-1)




3. Combined data from acute
and chronic treatments
4. Combined data from acute
and chronic treatments
Direct use of A0/A  values 
f imax.l =0.19/tM
fimax.4=0-17^M
Direct use of A 0/A  values 
T^ max.l =  0.70 f iM  
ax4 =  0.099/*M
Direct use of A0/A  values 
fima*. values as above 
Acute insulin 
Kml =  23.4 mM
*m 4 =  7-2 mM
Chronic insulin 
Kml =  16.4 mM 
Km, =  6.85 mM
4.90 +  2.03
3.82 +  2.20
3.71+0.31
3.73 +  0.26




5. Combined data from acute 
and chronic treatments
Using average Kn 
Kml =  19.9 mM 
K„,a =  7.0 mM
3.58 +  0.24 11.34+1.06
6. Basal Using average Km: 
K ml =  19.9 mM 
Kmi =  7.0 mM
£ max. i  =  0 0 5 5  /*M 
fimax.4 =  0 015 f lM
1.20 +  0.36 5.73 + 2.02
and A /A 0 values directly. T K  values were obtained which were 
similar to those obtained when the error in x l and x4 was 
decreased by using x l  and x4 values which were calculated from 
the 3-O-methyl-D-glucose K m values. Table 1 shows that the TK  
values for GLUT1 and G LU T4 were similar for both the acute- 
insulin and the chronic-insulin treatm ents. The GLUT1 TK  was 
found to be 0.36 x 104 m M 1 m i n 1, whereas the G LU T 4 T K  was 
~  3-fold higher (1.13 x 104 m M - 1 -m in-1). M ultiplying these 
values by the GLUT1 and G LU T4 average K m values o f 20.0 and 
7.0 m M  respectively gave a GLUT1 turnover number, or catalytic 
rate constant, o f 7.2 x 104 min 1 and a value for G LU T4 turnover 
num ber o f 7.9 x 104 m in-1. Thus, at low concentrations o f 3-O- 
methyl-D-glucose, GLUT1 makes a substantially smaller con­
tribution to flux than does an equal concentration o f the G LU T4 
isoform. However, this is due to the low affinity o f GLUT1 for 
this substrate, which decreases its association with the trans­
porter.
The GLUT1 turnover calculated from this da ta  on 3T3-L1 
cells (7.2 x 104 min 1 at 37 °C) is o f the same order as that 
calculated from GLUT1 in other systems, but a t 20 °C. The 
GLUT1 turnover for 3-O-methyl-D-glucose at 20 °C has been 
determined in oocytes injected with GLUT1 m R N A  [33,34], 
Gould and Lienhard [33] estim ated tha t their oocytes expressed 
7 ng o f GLUT1 per oocyte and calculated a turnover num ber of 
1 x 104 m in-1. However, Keller et al. [34] have estim ated that 
their system expressed 0.2 ng o f GLUT1 per oocyte and 
calculated a 3-O-methyl-D-glucose turnover a t 20 °C of 
13.4 x 104 m in-1. O ur own estim ate o f the rate constant for 
50 /^M-3-0-methyl-D-glucose uptake in erythrocytes a t 20 °C was 
15.2 m in-1 [35], giving a calculated turnover o f 4.3 x 104 m in-1 
(assuming a GLUT1 concentration o f 7 /^m and a 3-O-methyl-D- 
glucose exchange K m o f 20.0 mM). The G LU T 4 turnover that we 
have calculated from the data obtained for 3-O-methyl-D-glucose 
transport in 3T3-L1 cells (7.9 x 104 m in-1 at 37 °C) is very similar 
to that obtained in ra t adipocytes, where the 3-O-methyl-D- 
glucose turnover at 37 °C was calculated by Simpson et al. [36]
to be 5.6 x 104 m in-1. O ur own estimate [37] o f the 3-O-methyl- 
D-glucose exchange Vm&x was 50.4 mM-min-1 at 37 °C. Since the 
G LU T4 concentration was ~  1.5 [ iu  (calculated from [36]), the 
calculated turnover num ber is 3.4 x 104 m in-1.
In the basal state the calculated turnover numbers for GLUT1 
and G LU T4 are ~  2-fold lower than that found for insulin- 
stim ulated 3T3-L1 cells. There are many inaccuracies in 
measuring transport and photolabelling in the basal state. 
However, the result is consistent with the ~  1.5-2-fold sup­
pression o f transport activity in the basal state that we have 
shown in rat adipocytes [23,38].
Assumptions used in the analysis of GLUT1 and GLUT4 
activity
In the analysis above, we have dem onstrated that the ATB- 
BMPA displacement m ethodology can be used to provide 
inform ation on the relative activities o f the GLUT1 and GLUT4 
transporters when these are present in the same cell population. 
The analysis assumes that the radioactivity recovered in the 
im m unoprecipitates reflects the relative abundance of these 
isoforms, and we now examine this assumption.
We have attem pted to determine whether all the sites which 
reversibly bind the photolabel irreversibly react with it when 
irradiated. We have shown from the transport inhibition observed 
at 0.5, 1 and 2 m M  ligand that most o f the sites bind label 
irreversibly when occupied. This would be consistent with 
observations m ade with hum an erythrocyte membranes, where 
close to 100% efficiency o f the photochemical reaction was 
apparent with ATB-BM PA as the probe [26]. The high 
photochem ical efficiency which is observed with the diazirine- 
substituted bis-hexose was much greater than  tha t obtained with 
aryl azide-substituted com pounds, where the estim ated efficiency 
was only ~  25 % [39].
We have found that, after im m unoprecipitation of both 
GLUT1 and G LU T4 from  C 12E9-solubilized cells, <  20 % of the 
radioactivity running in the transporter region o f the gel is left in
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the im m unoprecipitation supernatants. These findings are con­
sistent with previous observations tha t the efficiencies o f im m uno­
precipitation of GLUT1 and G LU T4 in hum an erythrocytes [26] 
and in rat adipocytes [23] are ~  80% .
A nother factor which is relevant to the use o f ATB-BM PA to 
quantify the level o f transporter isoforms is the affinity o f the 
transporter for the ligand. In the present study we have observed 
tha t the Kx is ~  250 /m  in acutely and chronically insulin-treated 
cells. These results are similar to those in which transport 
inhibition by ATB-BM PA in erythrocytes showed a GLUT1 
K , ~  250 / i m  [26]. T ransport inhibition by ATB-BM PA in ra t 
adipocytes (where G LU T4 is the predom inant isoform) showed 
a G LU T4 K. which was also ~  250 f iu  [23]. A more direct way 
of examining the affinities o f the two transporters for the ligand 
is to carry out photolabel-binding experiments a t a range o f 
concentrations. We have shown here tha t the affinity constants 
(in this case Kd) for ATB-BM PA binding to GLUT1 and G LU T4 
are equal and are ~  150/tM. The G LU T2 isoform in liver 
m embranes also has a Kd for ATB-BM PA o f ~  200 /m  (N. J. 
Jordan & G. D. Holm an, unpublished work). Thus the binding 
of ATB-BMPA (a non-transported ligand) is approxim ately 
equal for all the m am m alian isoforms tested (G LUT1, G LU T4 
and GLUT2). However, these isoforms have different K m values 
for transported substrates. The ability to bind a non-transported 
ligand at the outside site is kinetically a simpler reaction than 
that involved in binding and transporting a substrate. The 
apparent K m for equilibrium sugar binding or exchange is 
dependent on rate constants for the m em brane translocation step 
and the affinity constant a t the inside site, and it is these 
param eters tha t may vary between different transporter isoforms.
These considerations suggest that the ATB-BM PA displace­
ment methodology tha t we have used can be considered to give 
a good approxim ation o f the transporter isoform concentrations 
at the cell-surface. We have shown that in acutely insulin-treated 
cells the GLUT1 concentration at the cell surface was 0.19 or 
29.7 ng/35 mm dish, and the G LU T4 concentration was 0.17 /m  
or 27 ng/35 mm dish. This estimate o f G LU T 4 concentration 
com pares reasonably well with the total cellular G LU T4 con­
centration as estim ated by W estern blotting. Calderhead et al.
[21] found 50 ng/35 mm dish, and this is consistent with about 
half of G LU T 4 being at the cells surface. However, the estimated 
cell surface GLU T1 appears to be a low proportion  ( ~  |)  o f the 
total cellular G LU T 1, which was determined by W estern blotting 
to be 150 ng/35 mm dish [21],
We note that an  under-estimate o f the cell-surface glucose 
transporter concentration owing to factors such as low labelling 
or im m unoprecipitation efficiency would lead us to over-estimate 
the transporter turnover numbers.
Regulation of the transport activities in 3T3-L1 cells
Large changes in cell-surface levels of glucose transporters 
occur in 3T3-L1 cells. We have determined tha t in basal cells the 
GLUT1 :G L U T 4 ratio was ~  3:1. This was decreased by acute 
insulin treatm ent to 1:1, but increased to 10:1 owing to a 
prolonged chronic insulin treatm ent ([12]; the present work). It 
has been shown that in adipose cells translocation o f G LU T4 
glucose transporters from an intracellular pool [23,40-42] 
accounts for m ost o f the observed acute insulin response. 
However, we have observed here that the intrinsic activities 
calculated from  data obtained with insulin-stim ulated cells 
cannot account entirely for the low transport rates observed in 
basal cells. This may be because the intrinsic activity o f glucose 
transporters is slightly suppressed in the basal state, as suggested 
by Czech and co-workers [43,44] and by Z orzano et al. [45]. The 
analysis o f intrinsic activity in the basal cells was not as accurate 
as tha t carried out with insulin-stim ulated cells. However,
GLUT1 and GLUT4 appear to have ~  2-fold lower turnovers in 
basal cells. The suppression of GLUT1 activity may be slightly 
greater than suppression of GLUT4 activity.
The discrepancy between transport rate and photolabelling 
that we have observed here and elsewhere [21,38,46] suggest that 
the photolabel can combine with transporters that are at the 
surface but which do not participate fully in transport. We have 
suggested [46] that this suppression of transport activity may 
occur because transporters associate with trafficking proteins 
present as intermediates in the translocation process. An alterna­
tive possibility that has been suggested is that regulation of the 
activity of the GLUT1 isoform may be dependent on intracellular 
small molecules or inhibitory proteins which allosterically modify 
the transport catalysis rate [31,43,44,47]. This possible sus­
ceptibility of GLUT1 to allosteric control may account for the 
unusual kinetic properties of this isoform found in erythrocytes, 
where transport is kinetically asymmetric and shows accelerated 
exchange [28,47]. In contrast with these kinetic features of 
GLUT1 we have found [37] that in rat adipocytes, where GLUT4 
is the predominant isoform and translocation is the predominant 
regulatory mechanism, the transport system is kinetically sym­
metric and does not show accelerated exchange.
Chronic insulin treatment greatly increases, by new protein 
synthesis, the total cellular content and the cell-surface con­
centration of GLUT1 [12,22], and we have suggested that this 
may be a response which compensates for the down-regulation of 
cell surface GLUT4 [12]. Consistent with this possibility is the 
observation that GLUT4 is down-regulated in 4-6 h, whereas 
GLUT1 rises steadily over 24 h. We have suggested [12] that the 
down-regulation of GLUT4 may be due to an impairment of the 
translocation mechanism, so that it may be of regulatory value to 
the cell to be able to produce, by new protein synthesis, an 
isoform which has different transport properties.
We are grateful to the M.R.C. and the British Diabetic Association for 
financial support.
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